About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
Rosuvastatin Calcium
- Company
- Daiichi Sankyo
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- 59 recruiting
Efficacy results: Not yet reported
59 recruiting studies currently listed on ClinicalTrials.gov.
Data source: ClinicalTrials.gov · trial data as of Oct 9, 2026
Find a Clinical Trial Near Me
See recruiting studies for Rosuvastatin Calcium and check eligibility with the study team.
Trial details
-
Recruiting NCT NCT03016819
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
Not yet reported Advenchen Laboratories, LLC 325 participants Est. completion 2028-12 24 sitesObstructive sleep apnea Other conditions: Alveolar Soft Part Sarcoma, Synovial Sarcoma, Soft-Tissue SarcomaView official trial listing → -
Recruiting NCT NCT03511118
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
Duke University 1600 participants Est. completion 2028-07-31 22 sitesOther conditions: Lactating Women on Select DOI, Breastfed Infants of Mothers on Select DOIView official trial listing → -
Recruiting NCT NCT04319627
Statins for Venous Event Reduction in Patients With Venous Thromboembolism
Not yet reported Ottawa Hospital Research Institute 2700 participants Est. completion 2028-04 31 sites Stand-aloneOther conditions: Venous Thromboembolism, Blood Clot, Post Thrombotic SyndromeView official trial listing → -
Recruiting NCT NCT04499859
Low Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin in AMI
Not yet reported Kiyuk Chang, MD,PhD 3548 participants Est. completion 2027-08-30 7 sites Stand-aloneCardiovascular disease Other conditions: Statin Adverse Reaction, HMG-CoA Reductase Inhibitor ToxicityView official trial listing → -
Recruiting NCT NCT04602754
Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia.
Not yet reported EMS 228 participants Est. completion 2027-09 1 site Stand-aloneOther conditions: Dyslipidemia Associated With Type II Diabetes MellitusView official trial listing → -
Recruiting NCT NCT04699279
Protective Effect of Statin Against Negative Cardiovascular Remodeling and Organ Dysfunction After Acute Aortic Syndrome Surgery (PANDA III)
Not yet reported Nanjing Medical University 300 participants Est. completion 2024-12-31 5 sites Stand-aloneOther conditions: Acute Aortic Syndrome, AortopathyView official trial listing → -
Recruiting NCT NCT04847752
Study of Predictive Factors Related to Prognosis of Patients With Ischemic Stroke Due to Large-artery Atherosclerosis
Tongji Hospital 1000 participants Est. completion 2028-12-31 1 siteCardiovascular disease Other conditions: Large-Artery Atherosclerosis (Embolus/Thrombosis)View official trial listing → -
Recruiting NCT NCT04903223
Liver Adiposity Effects on Pediatric Statin
Not yet reported Children's Mercy Hospital Kansas City 50 participants Est. completion 2027-03-31 1 site Stand-aloneOther conditions: Cholesterol; LipidosisView official trial listing → -
Recruiting NCT NCT04968509
Effect of PCSK9 Inhibitors on Calcific Aortic Valve Stenosis
Not yet reported Beijing Anzhen Hospital 160 participants Est. completion 2028-01 1 site Stand-aloneOther conditions: Aortic StenosisView official trial listing → -
Recruiting NCT NCT05155137
Polypill and RiscOMeter to Prevent StrOke and CogniTive ImpairmEnt (PROMOTE)
Not yet reported Hospital Moinhos de Vento 8518 participants Est. completion 2030-12-14 2 sites Stand-aloneCardiovascular disease Other conditions: Cognitive DeclineView official trial listing → -
Recruiting NCT NCT05397405
Improving Blood Lipid Management in Symptomatic Intracranial Atherosclerotic Stenosis on Clinical Outcome
Not yet reported Nanjing First Hospital, Nanjing Medical University 180 participants Est. completion 2026-05-01 2 sites Stand-aloneOther conditions: Intracranial Artery StenosisView official trial listing → -
Recruiting NCT NCT05483010
Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS)
Not yet reported Washington University School of Medicine 16 participants Est. completion 2028-05-31 1 site Stand-aloneOther conditions: Clonal Cytopenia of Undetermined Significance, Myelodysplastic SyndromesView official trial listing → -
Recruiting NCT NCT05614739
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Not yet reported Eli Lilly and Company 677 participants Est. completion 2027-06 82 sites Stand-aloneOther conditions: Urinary Bladder Neoplasms, Neoplasm Metastasis, Ureteral NeoplasmsView official trial listing → -
Recruiting NCT NCT05832229
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 260 participants Est. completion 2029-08-31 13 sites Stand-aloneOther conditions: Cirrhosis, Cirrhosis, Liver, Cirrhosis Early, Cirrhosis Due to Hepatitis B, Cirrhosis Advanced, Cirrhosis Infectious, Cirrhosis Alcoholic, Cirrhosis Due to Hepatitis CView official trial listing → -
Recruiting NCT NCT05845424
High-intensity Statin and Ezetimibe Therapy for Asymptomatic Patients With Positive Coronary Calcium
Not yet reported Samsung Medical Center 6000 participants Est. completion 2030-06-30 1 site Stand-aloneMetabolic syndrome Other conditions: Coronary Artery Calcification, DyslipidemiasView official trial listing → -
Recruiting NCT NCT05912387
Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study
Not yet reported Stanford University 15 participants Est. completion 2027-12-31 1 site Stand-aloneOther conditions: Primary Sclerosing Cholangitis, Inflammatory Bowel DiseasesView official trial listing → -
Recruiting NCT NCT06102863
Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia
Not yet reported Peking University People's Hospital 38 participants Est. completion 2025-09-01 1 site Stand-aloneOther conditions: Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage IView official trial listing → -
Recruiting NCT NCT06186037
Clinical Comparison of Low-dose Rosuvastatin Plus Ezetimibe Combination Therapy and High-dose Rosuvastatin Monotherapy in Patients With Minimal to Intermediate Coronary Artery Disease Without Percutaneous Coronary Intervention
Not yet reported Saint Vincent's Hospital, Korea 6356 participants Est. completion 2029-02-28 1 site Stand-aloneCardiovascular disease Other conditions: Dyslipidemias, Primary PreventionView official trial listing → -
Recruiting NCT NCT06231966
Randomized Comparison of Efficacy and Safety of High-intensity Rosuvastatin/Ezetimibe Combination Versus Treat-to-target Rosuvastatin Monotherapy for Patients With Peripheral Artery or Polyvascular Disease (CARE-PVD Trial)
Not yet reported Yonsei University 2462 participants Est. completion 2029-05-06 1 site Stand-aloneOther conditions: Peripheral Artery Disease, Polyvascular DiseaseView official trial listing → -
Recruiting NCT NCT06338293
Effects of Inclisiran Combined With Statins on the Morphology of Coronary Vulnerable Plaques
Not yet reported Nanjing First Hospital, Nanjing Medical University 40 participants Est. completion 2025-12-31 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Recruiting NCT NCT06358313
Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Small Vessel Stroke
Not yet reported Kafrelsheikh University 600 participants Est. completion 2026-05-30 1 siteCardiovascular diseaseView official trial listing → -
Recruiting NCT NCT06360120
Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic Stroke
Not yet reported Kafrelsheikh University 600 participants Est. completion 2025-10-01 1 siteCardiovascular diseaseView official trial listing → -
Recruiting NCT NCT06488105
Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial
Not yet reported Wake Forest University Health Sciences 130 participants Est. completion 2029-03-31 1 site Stand-aloneCardiovascular disease Other conditions: Lipid Disorder, Hypercholesterolemia, AtherosclerosisView official trial listing → -
Recruiting NCT NCT06501443
LATAM LOWERS LDL-C
Not yet reported Novartis Pharmaceuticals 520 participants Est. completion 2026-11-29 11 sitesOther conditions: HypercholesterolaemiaView official trial listing → -
Recruiting NCT NCT06538649
Effect of Statins on Crohn's Disease
Not yet reported Stanford University 20 participants Est. completion 2028-10-31 1 site Stand-aloneOther conditions: Crohn's Ileocolitis, Crohn DiseaseView official trial listing → -
Recruiting NCT NCT06603363
Changes in Plaque Characteristics After Short-term Statin Therapy as Assessed With Coronary CT
Not yet reported Prof. Maurovich-Horvat Pál 140 participants Est. completion 2028-12-15 1 site Stand-aloneCardiovascular disease Other conditions: Atherosclerotic Plaque, Coronary Computed Tomography Angiography, Statin Therapy, Multidetector Computed Tomography, Heart Diseases, Arteriosclerosis, Vascular Diseases, HyperlipidemiaView official trial listing → -
Recruiting NCT NCT06604117
Efficacy of Probucol Combined with Statins Treatment for Ischemic Stroke
Xuanwu Hospital, Beijing 200 participants Est. completion 2027-10 1 siteCardiovascular disease Other conditions: Atherosclerosis of Artery, Lipid Disorder, StatinView official trial listing → -
Recruiting NCT NCT06698666
Efficacy of Statins Among Major Depressive Disorder
Not yet reported Ain Shams University 145 participants Est. completion 2025-12-31 1 site Stand-aloneOther conditions: Major Depressive Disorder, MDDView official trial listing → -
Recruiting NCT NCT06765265
Impact of Atorvastatin Versus Rosuvastatin on 25 Hydroxy Vitamin D Levels in Patients With Acute Coronary Syndrome
Not yet reported King Edward Medical University 152 participants Est. completion 2026-01-01 1 site Stand-aloneOther conditions: Acute Coronary SyndromesView official trial listing → -
Recruiting NCT NCT06767774
Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus
Not yet reported Korea University Anam Hospital 2000 participants Est. completion 2030-01-31 1 siteCardiovascular disease Other conditions: Diabetes, StatinView official trial listing → -
Recruiting NCT NCT06772168
Evaluate the Efficacy and Safety of CMG190303 in Patients With Type 2 Diabetes and Dyslipidemia
Not yet reported CMG Pharmaceutical Co. Ltd 240 participants Est. completion 2027-02-01 24 sites Stand-aloneType 2 diabetes Other conditions: DyslipidemiaView official trial listing → -
Recruiting NCT NCT06785740
Statins in Frail Older Patients with Ischemic Stroke or Transient Ischemic Attack - the Prospective Cohort Study
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 300 participants Est. completion 2029-09 4 sitesCardiovascular disease Other conditions: TIAView official trial listing → -
Recruiting NCT NCT06804980
DESIFOR-EXPAND (MHIF)
Not yet reported Minneapolis Heart Institute Foundation 100 participants Est. completion 2026-12-31 1 siteOther conditions: Statin Therapy, Statin Adverse Reaction, StatinView official trial listing → -
Recruiting NCT NCT06896708
Effect of Intensive Lipid-Lowering Therapy on Coronary Atherosclerotic Plaque Progression in Young and Middle-Aged Patients With Chronic Coronary Syndrome
Not yet reported Liu yong 766 participants Est. completion 2028-03-01 7 sites Stand-aloneOther conditions: Chronic Coronary SyndromeView official trial listing → -
Recruiting NCT NCT06902740
PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis
Not yet reported Peking Union Medical College Hospital 300 participants Est. completion 2028-12-31 19 sites Stand-aloneOther conditions: Intracranial Atherosclerosis, Intracranial Artery Stenosis, Atherosclerotic PlaqueView official trial listing → -
Recruiting NCT NCT06975111
Focusing on the Menopausal Transition to Improve Mid-Life Women's Health
Not yet reported, Not yet reported University of Colorado, Denver 200 participants Est. completion 2030-10-01 3 sitesOther conditions: Menopause, Menopause Hot Flashes, Menopause Related Conditions, CardiovascularView official trial listing → -
Recruiting NCT NCT07012629
A EUROpean Randomized Study on Blood-thinners and Cholesterol-lowering Treatments to Prevent Future Vascular Events in People With Covert Brain Infarcts (CBI)
Not yet reported Aarhus University Hospital 1652 participants Est. completion 2040-01-01 14 sites Stand-aloneOther conditions: Covert Brain InfarctionView official trial listing → -
Recruiting NCT NCT07032389
A Polypill for Acute Coronary Syndrome
Not yet reported University of Texas Southwestern Medical Center 1000 participants Est. completion 2030-07-31 4 sites Stand-aloneOther conditions: Acute Coronary SyndromeView official trial listing → -
Recruiting NCT NCT07036991
A Cohort Study Comparing PCSK9 Inhibitor Plus Statin With Statin Monotherapy for Carotid Artery Stenosis
Changhai Hospital 406 participants Est. completion 2027-06-01 1 siteOther conditions: Carotid Artery StenosisView official trial listing → -
Recruiting NCT NCT07083206
A Study to Evaluate the Effectiveness and Safety of Fixed-Dose Combination of Pitavastatin/ Ezetimibe
Ahn-Gook Pharmaceuticals Co.,Ltd 4500 participants Est. completion 2029-01 1 siteOther conditions: Hypercholesterolemia, DyslipidemiasView official trial listing → -
Recruiting NCT NCT07128888
Study on Gastric Emptying Effect and Drug-Drug Interactions of GZR18 Injection
Not yet reported Gan & Lee Pharmaceuticals. 60 participants Est. completion 2026-07-05 1 site Stand-aloneOther conditions: Obesity or OverweightView official trial listing → -
Recruiting NCT NCT07232069
PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis
Not yet reported Duke University 1500 participants Est. completion 2031-07 23 sites Stand-aloneCardiovascular disease Other conditions: Prevention & Control, Premature AtherosclerosisView official trial listing → -
Recruiting NCT NCT07303816
Statins to Prevent Cancer Associated Blood Clots
Not yet reported Brigham and Women's Hospital 4000 participants Est. completion 2032-03-31 9 sites Stand-aloneOther conditions: Venous Thromboembolism, Cancer, Cardiovascular EventsView official trial listing → -
Recruiting NCT NCT07307989
Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis
Not yet reported Chang Gung Memorial Hospital 300 participants Est. completion 2029-07-31 1 site Stand-aloneCardiovascular disease Other conditions: HypercholesteremiaView official trial listing → -
Recruiting NCT NCT07339722
A Study of LY4515100 in Healthy Participants
Not yet reported Eli Lilly and Company 123 participants Est. completion 2027-03 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Recruiting NCT NCT07344610
Effects of Short-term Intensive Statin Therapy on Lipid Levels
General Hospital of Shenyang Military Region 800 participants Est. completion 2026-12-30 1 siteCardiovascular diseaseView official trial listing → -
Recruiting NCT NCT07359105
Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)
Not yet reported Sin Gon Kim 2186 participants Est. completion 2029-12-31 2 sites Stand-aloneOther conditions: Dyslipidemia Associated With Type II Diabetes MellitusView official trial listing → -
Recruiting NCT NCT07372625
A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.
Not yet reported PMV Pharmaceuticals, Inc 14 participants Est. completion 2028-01 5 sites Stand-aloneOther conditions: TP53 Y220C Mutation, Advanced Solid TumorsView official trial listing → -
Recruiting NCT NCT07446400
A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together
Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 48 participants Est. completion 2026-11-07 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Recruiting NCT NCT07460960
TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men
Not yet reported Lomonosov Moscow State University Medical Research and Educational Center 150 participants Est. completion 2027-12 1 site Stand-aloneOther conditions: Erectile Dysfunction Due to Arterial Disease, Atheroscleroses, Erectile Disfunction, Endothelial Dysfunction, Androgen Profile, TestosteroneView official trial listing → -
Recruiting NCT NCT07550816
Drug-drug Interaction Study of ZT002 Injection in Overweight and Obese Participants
Not yet reported Beijing QL Biopharmaceutical Co.,Ltd 60 participants Est. completion 2027-03-26 1 site Stand-aloneOther conditions: Overweight,ObesityView official trial listing → -
Recruiting NCT NCT07619118
A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Rosuvastatin on LDL-C in Patients With Hypercholesterolaemia
Not yet reported AstraZeneca 200 participants Est. completion 2027-05-28 45 sites Stand-aloneOther conditions: HypercholesterolaemiaView official trial listing → -
Recruiting NCT NCT07619131
A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
Not yet reported AstraZeneca 600 participants Est. completion 2027-07-30 152 sites Stand-aloneOther conditions: HypercholesterolaemiaView official trial listing → -
Recruiting NCT NCT07629999
Single and Multiple Dose Study to Evaluate Safety and Pharmacokinetics of BMS-986533 in Healthy Participants and Assessments of Food and pH Effects on Relative Bioavailability, and Drug-Drug Interaction Potential in Healthy Participants
Not yet reported Bristol-Myers Squibb 136 participants Est. completion 2027-06-01 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Recruiting NCT NCT07679828
Polypills Approach for Multiple Cardiovascular Risk Factors
Not yet reported China Medical University, China 8252 participants Est. completion 2030-03-01 15 sites Stand-aloneOther conditions: Hypertension, Dyslipidemia, DiabetesView official trial listing → -
Recruiting NCT NCT07704918
Aggressive Lipid Lowering Therapy in ICI-Treated Melanoma
Not yet reported University of Colorado, Denver 40 participants Est. completion 2028-12 1 site Stand-aloneOther conditions: MelanomaView official trial listing → -
Recruiting NCT NCT07820891
A Trial in Healthy Participants to Assess Drug Interaction Potential of BGB-43395
Not yet reported BeOne Medicines 24 participants Est. completion 2026-11-22 1 site Stand-aloneOther conditions: Healthy Adult ParticipantsView official trial listing → -
Recruiting NCT NCT07824323
Early Triple Lipid-Lowering Therapy With Bempedoic Acid After Acute Coronary Syndrome
Not yet reported Taipei Medical University Hospital 400 participants Est. completion 2028-12 1 site Stand-aloneOther conditions: Acute Coronary Syndromes, DyslipidemiaView official trial listing → -
Recruiting NCT NCT07855250
An Open-label DDI Study to Investigate the Effect of Rilzabrutinib on P-gp, BCRP, OATP1B1 and OATP1B3 Inhibition
Not yet reported Sanofi 14 participants Est. completion 2026-11-03 1 site Stand-aloneOther conditions: Healthy VolunteerView official trial listing → -
Completed NCT NCT00079638
Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL
Not yet reported Kos Pharmaceuticals 300 participants Est. completion 2005-05Cardiovascular disease Other conditions: Dyslipidemia, Coronary Heart Disease, Atherosclerosis, DiabetesView official trial listing → -
Completed NCT NCT00090298
Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Drugs in Patients With Elevated Cholesterol Levels (0653A-058)
Not yet reported Organon and Co 2815 participants Est. completion 2004-12Other conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00114491
Rosuvastatin Affecting Aortic Valve Endothelium
Hospital Pedro Hispano 200 participants Est. completion 2005-05 1 siteOther conditions: Atherosclerosis, HypercholesterolemiaView official trial listing → -
Completed NCT NCT00115830
Rho Kinase in Patients With Atherosclerosis
Not yet reported Brigham and Women's Hospital 40 participants Est. completion 2007-02 1 siteOther conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT00117494
Rosuvastatin Versus Pravastatin in HIV Patients Treated With Boosted Protease Inhibitors (PI) (ANRS126)
Not yet reported French National Agency for Research on AIDS and Viral Hepatitis 86 participants Est. completion 2007-06 1 siteOther conditions: Hyperlipidemia, HIV InfectionsView official trial listing → -
Completed NCT NCT00127218
High-Density Lipoprotein (HDL) Cholesterol Increased Plaque Stabilization in the Elderly
Not yet reported Johns Hopkins University 145 participants Est. completion 2008-12 1 site Stand-aloneCardiovascular disease Other conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT00132717
A 12 Week Study of MK0653A in Patients Who Have Been Hospitalized for a Possible Heart Problem (0653A-808)
Not yet reported Organon and Co 450 participants Est. completion 2007-06-01Other conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00160745
Rosuvastatin and Renal Endothelial Function
Not yet reported University of Erlangen-Nürnberg Medical School 46 participants Est. completion 2006-09 1 siteOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00176332
Impact of Rosuvastatin on Endothelial Function and Inflammation in Patients With Chronic Heart Failure
Not yet reported University of Leipzig 40 participants Est. completion 2006-12 1 siteHeart failureView official trial listing → -
Completed NCT NCT00184951
Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients
Not yet reported Radboud University Medical Center 30 participants Est. completion 2005-07 5 sitesOther conditions: HIV Infections, HyperlipidemiaView official trial listing → -
Completed NCT NCT00206310
Crestor Versus Placebo in Subjects With Heart Failure
Not yet reported AstraZeneca 5013 participants Est. completion 2007-07 375 sitesHeart failureView official trial listing → -
Completed NCT NCT00214604
Type III Dysbetalipoproteinemia
Not yet reported AstraZeneca 30 participants Est. completion 2007-02 2 sitesOther conditions: Hyperlipoproteinemia Type IIIView official trial listing → -
Completed NCT NCT00214617
Effect of Crestor on Lipoprotein Metabolism in Humans
Not yet reported Foundation for Atlanta Veterans Education and Research, Inc. 8 participants Est. completion 2006-02 1 siteOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00214630
LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary Syndromes
Not yet reported AstraZeneca 825 participants Est. completion 2007-08 56 sitesOther conditions: Acute Coronary SyndromesView official trial listing → -
Completed NCT NCT00225589
A Study Measuring Effects on Intima Media Thickness: An Evaluation of Rosuvastatin 40 mg (METEOR)
Not yet reported AstraZeneca 840 participants Est. completion 2006-05 57 sitesOther conditions: HypercholesteremiaView official trial listing → -
Completed NCT NCT00228514
Dutch Sub Study: Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA). PET Sub Study
Not yet reported AstraZeneca 40 participants Est. completion 2007-07 1 siteHeart failure Other conditions: Rosuvastatin, Positron Emission Tomography (PET)View official trial listing → -
Completed NCT NCT00231803
The Canadian Prevention of Renal and Cardiovascular Endpoints Trial
Not yet reported Brendan Barrett 474 participants Est. completion 2008-06 5 sites Stand-aloneChronic kidney diseaseView official trial listing → -
Completed NCT NCT00233649
DIALOOG: Crestor in Patients With Diabetes Mellitus Type 2: Lowering of LDL-C Levels to New European Guidelines
AstraZeneca 2500 participants 222 sitesType 2 diabetes Other conditions: Crestor, Rosuvastatin, LDL Cholesterol, ObservationalView official trial listing → -
Completed NCT NCT00235950
Assessment of the Lipid Lowering Effect of Rosuvastatin Compared to Atorvastatin in Subjects With Coronary Heart Disease
Not yet reported AstraZeneca 255 participants Est. completion 2006-03 18 sitesOther conditions: Coronary Heart DiseaseView official trial listing → -
Completed NCT NCT00239330
Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy
Not yet reported AstraZeneca 824 participants Est. completion 2005-02 26 sitesOther conditions: HypercholesteremiaView official trial listing → -
Terminated NCT NCT00239681
JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events
Not yet reported AstraZeneca 17802 participants Est. completion 2008-09 856 sites Stand-aloneOther conditions: Elevated High-sensitivity C-Reactive Protein (hsCRP)View official trial listing → -
Completed NCT NCT00240266
Study of High Density Lipoprotein Cholesterol (HDL-C)-Raising Mechanism of Rosuvastatin (CRESTOR™) by Quantifying the Key Steps of Reverse Cholesterol Transport (RCT)
Not yet reported AstraZeneca 15 participants Est. completion 2004-12 1 siteMetabolic syndrome Other conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT00240279
The Effect of Rosuvastatin on Aortic Stiffness in Hemodialysis Patients in the AURORA Study
Not yet reported AstraZeneca 10 participants Est. completion 2008-10 1 siteOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00240292
Rosuvastatin Impact on Ventricular Remodelling Lipids and Cytokines
Not yet reported AstraZeneca 160 participants 13 sitesHeart failureView official trial listing → -
Completed NCT NCT00240305
A Study to Investigate the Effect of Rosuvastatin (CRESTOR®) on High Density Lipoprotein Kinetics in Patients With the Metabolic Syndrome
Not yet reported AstraZeneca 15 participants Est. completion 2006-05 1 siteMetabolic syndrome Other conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT00240318
A Study To Evaluate the Effect of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden (ASTEROID)
Not yet reported AstraZeneca 450 participants Est. completion 2005-11 61 sitesOther conditions: Coronary ArteriosclerosisView official trial listing → -
Completed NCT NCT00240331
AURORA: Crestor 10mg Versus Placebo in Subjects With End-stage Renal Disease (ESRD)
Not yet reported AstraZeneca 2776 participants Est. completion 2008-10 239 sites Stand-aloneOther conditions: Renal FailureView official trial listing → -
Completed NCT NCT00240344
Study in High Risk Patients Switched From Higher Doses of Other Statins to Crestor on the Percentage of Patients Reaching the New LDL-C Target Goal
AstraZeneca 2650 participants Est. completion 2008-02 75 sitesOther conditions: HypercholesterolemiaView official trial listing → -
Withdrawn NCT NCT00240357
Effect of an Internet Based Compliance Enhancement Tool in Subjects With Hypercholesterolemia
Not yet reported AstraZeneca 1175 participants 109 sitesOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00241488
DISCOVERY Asia - Crestor in Type IIa and IIb Hypercholesteremia
Not yet reported AstraZeneca 1362 participants Est. completion 2007-02 34 sitesOther conditions: HypercholesterolemiaView official trial listing → -
Terminated NCT NCT00249899
Efficacy of Lapaquistat Acetate Alone or Combined With High-Dose Statin Therapy in Subjects With Hypercholesterolemia
Not yet reported Takeda 649 participants Est. completion 2007-03 23 sitesOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00249912
Efficacy of Lapaquistat Acetate Alone or Combined With Rosuvastatin in Subjects With Hypercholesterolemia
Not yet reported Takeda 415 participants Est. completion 2007-04 92 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00251680
Efficacy of Lapaquistat Acetate in Subjects Currently Treated With Lipid-Lowering Therapy.
Not yet reported Takeda 400 participants Est. completion 2007-05 77 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00262548
C-Reactive Protein (CRP) in Obese Diabetic Women
Not yet reported AstraZeneca 100 participants 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT00295373
Exercise And Rosuvastatin Treatment: Is There an Anti-Inflammatory Synergy?
Not yet reported Purdue University 48 participants Est. completion 2007-08 1 siteOther conditions: Nonfamilial Hypercholesterolemia, Physical InactivityView official trial listing → -
Completed NCT NCT00296374
Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease
Not yet reported AstraZeneca 353 participants Est. completion 2009-03 116 sites Stand-aloneOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00296387
Effects in The ApoB/ApoA-I Ratio Using Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome
Not yet reported AstraZeneca 1160 participants Est. completion 2007-10 102 sitesOther conditions: Acute Coronary SyndromeView official trial listing → -
Completed NCT NCT00296400
Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal Disease
Not yet reported AstraZeneca 237 participants Est. completion 2009-06 107 sitesOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT00300430
Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia.
Not yet reported Abbott 1911 participants 1 siteOther conditions: Dyslipidemia, Coronary Heart Disease, Mixed DyslipidemiaView official trial listing → -
Completed NCT NCT00300482
Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calcium in Subjects With Multiple Abnormal Lipid Levels in the Blood
Not yet reported Abbott 1445 participants 1 siteOther conditions: Dyslipidemia, Coronary Heart Disease, Mixed DyslipidemiaView official trial listing → -
Completed NCT NCT00309374
Anti-Inflammatory Effect of Statins in the Human Endotoxin Model
Not yet reported Medical University of Vienna 6 participants Est. completion 2006-07 1 siteOther conditions: EndotoxemiaView official trial listing → -
Completed NCT NCT00315510
Rosuvastatin and Ischemia Reperfusion
Not yet reported Radboud University Medical Center 20 participants Est. completion 2007-08 1 siteOther conditions: IschemiaView official trial listing → -
Completed NCT NCT00329160
Rosuvastatin in the Long-term Treatment of Hypercholesterolaemic Subjects With Coronary Heart Disease
Not yet reported AstraZeneca 214 participants Est. completion 2008-10 27 sitesOther conditions: HypercholesteremiaView official trial listing → -
Completed NCT NCT00329173
PULSAR - A Prospective Study to Evaluate the Utility of Low Doses of the Statins Atorvastatin and Rosuvastatin.
Not yet reported AstraZeneca 1000 participants Est. completion 2004-08Other conditions: HypercholesterolaemiaView official trial listing → -
Completed NCT NCT00329758
Effect of Rosuvastatin on Amnesia and Orientation Through Galveston Outcome Amnesia Test in Moderate Head Injury
Not yet reported Universidad Autonoma de San Luis Potosí 20 participants Est. completion 2007-10 1 siteOther conditions: Head InjuryView official trial listing → -
Completed NCT NCT00335699
Korean Rosuvastatin Effectiveness Study in Nondiabetic Metabolic Syndrome
Not yet reported AstraZeneca 370 participants Est. completion 2007-01 7 sitesOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00336336
GISSI-HF- Effects of n-3 PUFA and Rosuvastatin on Mortality-Morbidity of Patients With Symptomatic CHF
Not yet reported Gruppo di Ricerca GISSI 6975 participants Est. completion 2008-05 337 sites Stand-aloneHeart failureView official trial listing → -
Completed NCT NCT00344123
Pharmacokinetic (PK) Study of Single-dose Rosuvastatin and Tipranavir/Ritonavir in Healthy Subjects
Not yet reported Johns Hopkins University 29 participants Est. completion 2008-05 1 siteOther conditions: HIV InfectionsView official trial listing → -
Completed NCT NCT00347217
Observational to Investigate the Efficacy of CRESTOR 5mg in Reaching LDL-C Target Goals in Patients Who Are at High Risk for a Cardiovascular Event
AstraZeneca 3840 participants Est. completion 2009-01 215 sitesOther conditions: HypercholesteremiaView official trial listing → -
Completed NCT NCT00355615
PLUTO: Pediatric Lipid-redUction Trial of rOsuvastatin
Not yet reported AstraZeneca 173 participants Est. completion 2008-07 20 sitesOther conditions: Familial HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT00357123
Effect of Rosuvastatin in Abdominal Sepsis
Not yet reported Universidad Autonoma de San Luis Potosí 60 participants Est. completion 2011-09 1 siteOther conditions: SepsisView official trial listing → -
Completed NCT NCT00364559
Effect of Rosuvastatin in Intracerebral Hemorrhage
Not yet reported Universidad Autonoma de San Luis Potosí 75 participants Est. completion 2006-12 1 site Stand-aloneCardiovascular disease Other conditions: Intracerebral HemorrhageView official trial listing → -
Completed NCT NCT00371501
Aspirin and Statins for Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus Erythematosus
Not yet reported Tuen Mun Hospital 72 participants Est. completion 2009-12 1 siteOther conditions: Atherosclerosis, Thromboembolism, Systemic Lupus ErythematosusView official trial listing → -
Withdrawn NCT NCT00371579
Rosuvastatin for Hepatitis C
Not yet reported UMC Utrecht Est. completion 2007-10 1 siteOther conditions: Hepatitis CView official trial listing → -
Completed NCT NCT00379249
Rosuvastatin ORBITAL Germany
Not yet reported AstraZeneca 8000 participants Est. completion 2004-02Other conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00388596
A Study Of SB-751689, Atorvastatin, Ketoconazole, And Rosuvastatin In Health Postmenopausal Women.
Not yet reported GlaxoSmithKline 36 participants 1 siteOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00395486
ROMEO (Rosuvastatin in Metabolic syndrOme)
Not yet reported AstraZeneca 258 participants Est. completion 2008-06 3 sites Stand-aloneMetabolic syndromeView official trial listing → -
Completed NCT NCT00396110
Evaluation of the Efficacy of Rosuvastatin in Daily Practice (TARGET)
AstraZeneca 3889 participantsOther conditions: Hypercholesterolemia, Coronary Heart DiseaseView official trial listing → -
Withdrawn NCT NCT00396240
ORBITAL: Open-Label Primary Care Study: Rosuvastatin Based Compliance Initiatives Linked To Achievement Of LDL Goals
Not yet reported AstraZeneca 1294 participantsOther conditions: Primary HypercholesterolaemiaView official trial listing → -
Terminated NCT NCT00427960
Study of Asian Patients With Hypercholesterolaemia in the UK - Rosuvastatin 5mg Versus Atorvastatin 10mg
Not yet reported AstraZeneca 55 participants Est. completion 2008-02 9 sitesOther conditions: HypercholesterolaemiaView official trial listing → -
Completed NCT NCT00446940
Dose Finding Trial of Rosuvastatin and Atorvastatin Versus Hepatitis C
Not yet reported Bader, Ted, M.D. 16 participants Est. completion 2007-03 1 siteOther conditions: Hepatitis CView official trial listing → -
Completed NCT NCT00457652
Does Caffeine Reduce Rosuvastatin-Induced Protection Against Ischemia-Reperfusion Injury?
Not yet reported Radboud University Medical Center 24 participants Est. completion 2007-11 1 siteOther conditions: Ischemia Reperfusion InjuryView official trial listing → -
Completed NCT NCT00462748
A Study to Determine the Number of Patients Who Reach Optimal Cholesterol Levels on Each of Three Different Treatments (0653A-121)
Not yet reported Organon and Co 786 participants Est. completion 2008-06Other conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00463606
A Multicenter Study Comparing the Safety and Efficacy of ABT-335 and Rosuvastatin Calcium Combination Therapy to Monotherapy in Subjects With Dyslipidemia
Not yet reported AstraZeneca 760 participants Est. completion 2008-02 168 sites Stand-aloneOther conditions: Hypercholesterolemia, DyslipidemiaView official trial listing → -
Completed NCT NCT00464503
Statins and the Urinary Proteome
Not yet reported Universiteit Antwerpen 7 participants Est. completion 2007-10 1 siteOther conditions: Statin Induced ProteinuriaView official trial listing → -
Completed NCT NCT00468923
Heart Outcomes Prevention Evaluation-3
Not yet reported Population Health Research Institute 12705 participants Est. completion 2016-01 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT00473655
Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients
Not yet reported AstraZeneca 334 participants Est. completion 2009-02 3 sitesOther conditions: Hypertriglyceridemia, Hyperlipoproteinemia Type IV, Hyperlipoproteinemia Type V, Hyperlipoproteinemia Type IIb, HyperlipidemiaView official trial listing → -
Completed NCT NCT00479713
A Study to Assess the Cholesterol Lowering Effect of an Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Patients With High Cholesterol and With High Cardiovascular Risk (0653A-809)(COMPLETED)
Not yet reported Organon and Co 618 participants Est. completion 2008-03-01 Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00487136
Interaction Between ABT-335, Rosuvastatin and Warfarin
Not yet reported AstraZeneca 45 participants Est. completion 2007-07 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT00487318
Fluvastatin, Rosuvastatin Added to Pegylated Interferon and Ribavirin
Not yet reported Bader, Ted, M.D. 40 participants Est. completion 2010-10 1 site Stand-aloneOther conditions: Chronic Hepatitis CView official trial listing → -
Completed NCT NCT00491530
A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Therapy for Subjects With Mixed Dyslipidemia
Not yet reported Abbott 310 participants Est. completion 2008-11 1 site Stand-aloneOther conditions: Mixed DyslipidemiaView official trial listing → -
Completed NCT NCT00505154
Effect of Rosuvastatin on Left Ventricular Remodeling
Not yet reported Oslo University Hospital 75 participants Est. completion 2013-07 1 siteOther conditions: Dilated CardiomyopathyView official trial listing → -
Completed NCT NCT00506961
Evaluate the Efficacy and Safety of Rosuvastatin Versus Simvastatin in Type 2 Diabetic Patients With Dyslipidemia
Not yet reported Taipei Veterans General Hospital, Taiwan 90 participants Est. completion 2007-07 2 sitesOther conditions: Diabetes Mellitus, DyslipidemiaView official trial listing → -
Completed NCT NCT00525824
12-week Open-label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe
Not yet reported AstraZeneca 1743 participants Est. completion 2008-09 9 sitesOther conditions: Hypercholesterolemia, Coronary Heart Disease, AtherosclerosisView official trial listing → -
Completed NCT NCT00526552
Crestor RAPID (The Efficacy of RosuvAstatin for Korean Dyslipidemia PatIents With Diabetes)
AstraZeneca 5000 participants Est. completion 2007-12 3 sitesOther conditions: Dyslipidemia, DiabetesView official trial listing → -
Completed NCT NCT00526708
Crestor RUSH (The Efficacy of RosUvaStatin for Korean Dyslipidemia Patients With Hypertension )
AstraZeneca 5000 participants Est. completion 2007-11 3 sitesOther conditions: Dyslipidemia, HypertensionView official trial listing → -
Completed NCT NCT00526721
Real-life EValuation Of High Dose RosUvastatin in High Risk Patients After TitraTION
AstraZeneca 1482 participants Est. completion 2008-04 3 sitesOther conditions: HypercholesterolemiaView official trial listing → -
Terminated NCT NCT00532311
Efficacy of Lapaquistat Acetate Co-Administered With Statins in Subjects With Hypercholesterolemia
Not yet reported Takeda 411 participants Est. completion 2008-04 86 sitesOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00549653
A Study Investigating Blood Concentrations Of Rosuvastatin When Co-administered With GW856553 In Healthy Men
Not yet reported GlaxoSmithKline 44 participants Est. completion 2007-12 1 siteCardiovascular disease Other conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT00554138
The Effect of Rosuvastatin on Adenosine Metabolism
Not yet reported Radboud University Medical Center 24 participants Est. completion 2008-04 1 site Stand-aloneOther conditions: Adenosine MetabolismView official trial listing → -
Completed NCT NCT00555230
Effects of HMG-coA Reductase Inhibitor on Rheumatoid Arthritis
Not yet reported Chinese University of Hong Kong 150 participants Est. completion 2009-12 1 site Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00557778
Education and Awareness Program Targeting the Assessment of Adherence of the Treatment of Dyslipidemia
AstraZeneca 600 participants Est. completion 2010-09 1 siteOther conditions: Patients With DyslipidemiaView official trial listing → -
Completed NCT NCT00574782
Evaluation of the Efficacy of Rosuvastatin in Daily Practice in Untreated High Risk Patients (CHALLENGE)
AstraZeneca 2660 participantsOther conditions: Hypercholesterolemia, Coronary Heart Disease, Peripheral Vascular Disease, CVA, DiabetesView official trial listing → -
Completed NCT NCT00585143
Safety Study to Evaluate the Effects of Mild and Moderate Renal Impairment on the Pharmacokinetics of ABT-335 and Rosuvastatin When Administered Concomitantly
Not yet reported AstraZeneca 37 participants Est. completion 2008-10 6 sites Stand-aloneOther conditions: Dyslipidemia, Renal InsufficiencyView official trial listing → -
Completed NCT NCT00620542
CRESTOR Athero Imaging Head to Head IVUS Study
Not yet reported AstraZeneca 2333 participants Est. completion 2011-06 195 sites Stand-aloneOther conditions: Coronary AtherosclerosisView official trial listing → -
Completed NCT NCT00631189
Evaluation of the Efficacy and Safety of Rosuvastatin 5 mg Versus Pravastatin 40 mg and Atorvastatin 10 mg in Type IIa and IIb Hypercholesterolaemic Patients
Not yet reported AstraZeneca 668 participants Est. completion 2008-10 170 sitesOther conditions: Type IIa and IIb HypercholesterolaemiaView official trial listing → -
Completed NCT NCT00651144
Assessment of Potential Interaction Between Ezetimibe and Rosuvastatin in Healthy Subjects With High Cholesterol (P03317)
Not yet reported Organon and Co 40 participants Est. completion 2003-05 Stand-aloneOther conditions: Hypercholesterolemia, AtherosclerosisView official trial listing → -
Terminated NCT NCT00651378
Switching to Rosuvastatin Versus Adding Ezetimibe to Atorvastatin Versus Doubling the Dose of Atorvastatin in Patients With Hypercholesterolemia and Risk Factors (P03708)
Not yet reported Organon and Co 87 participants Est. completion 2005-06-01 Stand-aloneCardiovascular disease Other conditions: Hypercholesterolemia, AtherosclerosisView official trial listing → -
Completed NCT NCT00653445
Compare the Safety & Efficacy of Rosuvastatin 40mg in Combination With Ezetimibe 10mg
Not yet reported AstraZeneca Est. completion 2005-06 Stand-aloneOther conditions: Hypercholesterolemia, Coronary Heart Disease, AtherosclerosisView official trial listing → -
Completed NCT NCT00653588
Polaris - Crestor 40 mg vs Atorvastatin 80 mg for 26 Weeks
Not yet reported AstraZeneca Est. completion 2004-09 Stand-aloneOther conditions: Hypercholesterolemia, Coronary Heart DiseaseView official trial listing → -
Completed NCT NCT00653744
Rosuvastatin Versus Atorvastatin in the Treatment of Hypercholesterolaemia in African American Subjects(ARIES)
Not yet reported AstraZeneca 1700 participants Est. completion 2004-03 Stand-aloneOther conditions: Hypercholesterolemia, DyslipidaemiaView official trial listing → -
Completed NCT NCT00653965
Treatment of Hypercholesterolaemia in Hispanic Subjects (STARSHIP)
Not yet reported AstraZeneca 3000 participants Est. completion 2005-02 Stand-aloneOther conditions: Hypercholesterolemia, DyslipidaemiaView official trial listing → -
Completed NCT NCT00654173
Comparing the Efficacy and Safety of Rosuvastatin With Atorvastatin and Simvastatin (SOLAR)
Not yet reported AstraZeneca 4444 participants Est. completion 2004-09 Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00654225
Treatment of Hypercholesterolaemia in South Asian Subjects (IRIS)
Not yet reported AstraZeneca 2340 participants Est. completion 2005-03 Stand-aloneOther conditions: Hypercholesterolemia, DyslipidaemiaView official trial listing → -
Completed NCT NCT00654303
OLE Study to Evaluate Safety / Efficacy of ZD4522
Not yet reported AstraZeneca 3500 participants Est. completion 2005-02 Stand-aloneOther conditions: HypercholesterolaemiaView official trial listing → -
Completed NCT NCT00654394
Progression of Carotid Artery Atheroma in Moderately Hypercholesterolemic Subjects
Not yet reported AstraZeneca 200 participants Est. completion 2004-08 Stand-aloneOther conditions: Carotid Artery Stenosis, HypercholesterolemiaView official trial listing → -
Completed NCT NCT00654407
Mercury II - Compare the Efficacy and Safety of Lipid Lowering Agents Atorvastatin and Simvastatin With Rosuvastatin in High Risk Subjects With Type IIa and IIb Hypercholesterolemia
Not yet reported AstraZeneca 4875 participants Est. completion 2004-09 Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00654446
IIIb 6 Week Open Label Multicentre Rosuvastatin & Simvastatin
Not yet reported AstraZeneca 442 participants Est. completion 2004-04 Stand-aloneOther conditions: Fredrickson Type IIa & Type IIb DyslipidaemiaView official trial listing → -
Completed NCT NCT00654485
COMETS - Compare the Efficacy of Rosuvastatin With Atorvastatin and Placebo in the Treatment of Non-Diabetic, Non-Atheroscleric, Metabolic Syndrome Subjects
Not yet reported AstraZeneca 940 participants Est. completion 2005-02 Stand-aloneMetabolic syndromeView official trial listing → -
Completed NCT NCT00654537
STELLAR-Rosuvastatin vs. Atorvastatin, Pravastatin, Simvastatin Across Dose Ranges
Not yet reported AstraZeneca 5625 participants Est. completion 2004-10 Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00654602
48-wk Open Label Phase IIIb to Evaluate Efficacy and Safety
Not yet reported AstraZeneca 1500 participants Est. completion 2004-11Other conditions: DyslipidaemiaView official trial listing → -
Completed NCT NCT00657527
Evaluation of Effects of Rosuvastatin 40mg on Myocardial Ischemia in Subjects With Coronary Artery Disease
Not yet reported AstraZeneca 280 participants Est. completion 2002-12 Stand-aloneCardiovascular disease Other conditions: Myocardial IschaemiaView official trial listing → -
Completed NCT NCT00658463
Effects of Rosuvastatin on the, in Vivo, Kinetic of apoB and apoA1, Using Stable Isotopes, in Type 2 Diabetic Patients
Not yet reported Centre Hospitalier Universitaire Dijon 8 participants Est. completion 2007-09 1 site Stand-aloneOther conditions: DiabetesView official trial listing → -
Completed NCT NCT00660764
Assessment of the Efficacy of Rosuvastatin in Patient Groups With a Dissimilar Risk Profile in an Observational Study (HEROS)
AstraZeneca Est. completion 2005-04Other conditions: Hypercholesterolemia, Coronary Heart Disease, Peripheral Vascular Disease, Cerebrovascular Accident, DiabetesView official trial listing → -
Terminated NCT NCT00664469
INdians Followed for INtensive Lipid Lowering Treatment and Its safetY
Not yet reported Sunnybrook Health Sciences Centre 64 participants Est. completion 2010-11 1 siteOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00665834
Comparison of Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome
Not yet reported Queen's University 18 participants Est. completion 2007-09 2 sitesOther conditions: Dyslipidemia, Acute Coronary SyndromesView official trial listing → -
Terminated NCT NCT00673582
Effectiveness of Rosuvastatin at Preventing the Progression of Atherosclerosis in HIV Positive Patients
Not yet reported University of British Columbia 250 participants Est. completion 2013-03 1 site Stand-aloneOther conditions: Atherosclerosis, HIV InfectionsView official trial listing → -
Completed NCT NCT00673660
Observational Study On Compliance Of Statin Treatment Of Patients With High Blood Cholesterol Levels
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 375 participants Est. completion 2009-10 5 sitesOther conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT00679510
Rosuvastatin in Rheumatoid Arthritis (RORA)
Not yet reported, Not yet reported University of Dundee 50 participants Est. completion 2008-01 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00680017
30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease
Not yet reported AstraZeneca 280 participants Est. completion 2011-04 114 sites Stand-aloneOther conditions: Dyslipidemia, Kidney DiseaseView official trial listing → -
Completed NCT NCT00680082
Observational Usage Study of Statins in Primary Care in France
AstraZeneca 2100 participants Est. completion 2009-07 25 sitesOther conditions: HealthyView official trial listing → -
Completed NCT NCT00681395
Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Relative to That From the Co-administration of ABT-335 and Rosuvastatin Calcium
Not yet reported AstraZeneca 64 participants 1 siteOther conditions: Adverse Events, PharmacokineticView official trial listing → -
Completed NCT NCT00683618
Compare the Efficacy of Rosuvastatin to Atorvastatin in High Risk Patients With Hypercholesterolemia
Not yet reported AstraZeneca 934 participants Est. completion 2009-07 6 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00688454
C-Control: Efficacy and Safety of Therapy With Rosuvastatin in Statin-Naive and in Statin-Switched Patients
AstraZeneca 3392 participants Est. completion 2008-01Other conditions: HypercholesteremiaView official trial listing → -
Completed NCT NCT00689416
Effects of Crestor on Inflammation of Atherosclerotic Plaques
Not yet reported AstraZeneca 74 participants Est. completion 2009-06 1 site Stand-aloneOther conditions: Atherosclerosis, Inflammatory Activity in Carotid ArteriesView official trial listing → -
Completed NCT NCT00693589
Effect of Homocysteine-lowering Therapy With Folic Acid, Vitamin B12, and Vitamin B6 on Endothelium-dependent Vasodilatation of Forearm Resistance Vessels in Patients With Coronary Heart Disease
Not yet reported Insel Gruppe AG, University Hospital Bern 36 participants Est. completion 2007-04Cardiovascular disease Other conditions: Endothelial DysfunctionView official trial listing → -
Completed NCT NCT00695539
Rosuvastatin Efficacy and Safety Evaluation in Hypercholesterolaemic Patients
AstraZeneca 810 participants Est. completion 2008-12 6 sitesOther conditions: HypercholesterolaemiaView official trial listing → -
Completed NCT NCT00718796
Naturopathic Treatment for the Prevention of Cardiovascular Disease
Not yet reported The Canadian College of Naturopathic Medicine 300 participants Est. completion 2009-10 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT00719693
Assessment of the Effect of Food on ABT-143 Bioavailability
Not yet reported AstraZeneca 115 participants 1 site Stand-aloneOther conditions: Pharmacokinetic VariablesView official trial listing → -
Completed NCT NCT00728780
Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Capsules Relative to That From Co-administration of ABT-335 and Rosuvastatin for the 5/45mg Dosage Form.
Not yet reported AstraZeneca 32 participants 1 siteOther conditions: Adverse Events, Pharmacokinetic VariablesView official trial listing → -
Completed NCT NCT00730132
Observational Study of Approaches to Lipid-Lowering Therapy in Russian Patients With Coronary Heart Disease <<Treat to Goal>> (Study P05464)
Organon and Co 712 participants Est. completion 2009-08Other conditions: Coronary Heart Disease, HypercholesterolemiaView official trial listing → -
Completed NCT NCT00747149
A Diabetes Study to Treat A Population Previously Not at Target
Not yet reported AstraZeneca 598 participants Est. completion 2009-08 84 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00766025
Study in Taiwanese Subjects Identified as CYP2C19 Poor and Extensive Metabolizers Receiving Rosuvastatin
Not yet reported AstraZeneca 50 participants Est. completion 2009-02 1 site Stand-aloneOther conditions: CYP2C19 Poor, Extensive MetabolizersView official trial listing → -
Status unknown NCT NCT00767130
DNA Diagnostic System for Statin Safety and Efficacy
Genomas, Inc 750 participants Est. completion 2009-12 3 sitesOther conditions: Hypercholesterolemia, MyopathyView official trial listing → -
Completed NCT NCT00781560
Awareness of Chinese National Adult Lipid Treatment Guideline (2007) and Rate of Patients Achieving the Treatment Goal
AstraZeneca 2575 participants Est. completion 2009-07 15 sitesOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT00783042
Exploratory Study of Coronary Flow Reserve Measurements, a Non-Invasive Method for Coronary Function Measurements
Not yet reported AstraZeneca 80 participants Est. completion 2009-05 1 siteOther conditions: Atherosclerosis, Inflammatory Activity in Coronary ArteriesView official trial listing → -
Completed NCT NCT00783263
A Study of Ezetimibe Added On to Rosuvastatin Versus Up Titration of Rosuvastatin in Patients With Hypercholesterolemia (MK0653-139)
Not yet reported Organon and Co 440 participants Est. completion 2010-05 Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00786136
Rosuvastatin Prevent Contrast Induced Acute Kidney Injury in Patients With Diabetes
Not yet reported Shenyang Northern Hospital 2998 participants Est. completion 2011-11 53 sites Stand-aloneChronic kidney disease Other conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00800800
Effects of Rosuvastatin on Aortic Stenosis Progression
Not yet reported AstraZeneca 378 participants Est. completion 2008-09 15 sitesOther conditions: Aortic StenosisView official trial listing → -
Completed NCT NCT00808678
Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) and Rosuvastatin Calcium
Not yet reported AstraZeneca 90 participants 1 siteOther conditions: HealthyView official trial listing → -
Terminated NCT NCT00811356
A First Time in Human Study in Healthy Volunteers to Investigate a New Medicine to Treat Malaria
Not yet reported GlaxoSmithKline 12 participants Est. completion 2009-03-30 1 site Stand-aloneOther conditions: MalariaView official trial listing → -
Completed NCT NCT00812955
Safety and Efficacy Study Comparing ABT-143 to Simvastatin in Subjects With Elevated Levels of Low Density Lipoprotein Cholesterol ("Bad Cholesterol") and Triglycerides
Not yet reported AstraZeneca 474 participants Est. completion 2009-06 129 sites Stand-aloneOther conditions: Dyslipidemia, Hypercholesterolemia, HypertriglyceridemiaView official trial listing → -
Completed NCT NCT00815659
Effect of Crestor (Rosuvastatin) on Lipid Levels in Patients With Metabolic Syndrome
Not yet reported AstraZeneca 97 participants Est. completion 2010-03 6 sites Stand-aloneMetabolic syndromeView official trial listing → -
Completed NCT NCT00826358
Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From 5/45 mg Strength of ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) 45 mg and Rosuvastatin Calcium 5 mg
Not yet reported AstraZeneca 90 participants 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00837083
Evaluation of Crestor® (Rosuvastatin) in Daily Practice
AstraZeneca 602 participants Est. completion 2007-10Other conditions: HypercholesterolemiaView official trial listing → -
Terminated NCT NCT00850460
Quality of Life in Patients With Statin-Associated Myopathy
Not yet reported Rockefeller University 14 participants Est. completion 2013-02 1 siteOther conditions: Statin Adverse ReactionView official trial listing → -
Completed NCT NCT00851175
Is Augmentation of PORH by Rosuvastatin Adenosine-receptor Mediated?
Not yet reported Radboud University Medical Center 8 participants Est. completion 2009-09 1 site Stand-aloneCardiovascular disease Other conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT00854503
Metabolic and Vascular Effects of Statins in Untreated Dyslipidemic Diabetic Patients
Not yet reported University of Rome Tor Vergata 30 participants Est. completion 2010-12 1 siteType 2 diabetes Other conditions: Diabetic DyslipidemiaView official trial listing → -
Completed NCT NCT00862251
Ezetimibe/Simvastatin (MK-0653A) Versus Rosuvastatin Versus Doubling Statin Dose in Participants With Cardiovascular Disease and Diabetes Mellitus (MK-0653A-133)(COMPLETED)
Not yet reported Organon and Co 808 participants Est. completion 2011-03Other conditions: Cardiovascular Disorder, Diabetes MellitusView official trial listing → -
Status unknown NCT NCT00866229
Efficacy and Adverse Effect of Simvastatin Compare to Rosuvastatin in Systemic Lupus Erythematosus (SLE) Patients With Corticosteroid Therapy and High Low-Density Lipoprotein (LDL) Cholesterol Level
Not yet reported Ramathibodi Hospital 140 participants Est. completion 2010-06 1 siteOther conditions: Systemic Lupus Erythematosus, High LDL Cholesterol LevelView official trial listing → -
Completed NCT NCT00871351
Evaluation of Ezetimibe and Atorvastatin Coadministration Versus Atorvastatin or Rosuvastatin Monotherapy in Japanese Patients With Hypercholesterolemia (Study P06027)(COMPLETED)
Not yet reported Organon and Co 125 participants Est. completion 2010-05-01Other conditions: Primary HypercholesterolemiaView official trial listing → -
Completed NCT NCT00874757
Effect of Rosuvastatin Response in Healthy Subjects: Potential Mechanisms of Anti-inflammatory Effects
University of Nebraska 20 participants Est. completion 2011-09-01 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00885495
Darunavir/Ritonavir and Rosuvastatin Pharmacokinetic Study
Not yet reported, Not yet reported University of Cincinnati 17 participants Est. completion 2010-08 1 siteOther conditions: HIV InfectionsView official trial listing → -
Status unknown NCT NCT00885872
Rosuvastatin Evaluation of Atherosclerotic Chinese Patients (REACH)
Not yet reported Chinese PLA General Hospital 60 participants Est. completion 2012-03 1 site Stand-aloneOther conditions: Hyperlipidemia, AtherosclerosisView official trial listing → -
Completed NCT NCT00908011
Addition of Ezetimibe (Ezetrol®) to Ongoing Therapy With Rosuvastatin (Crestor®) in HIV Positive Patients Not Reaching Cholesterol Targets
Not yet reported University of British Columbia 43 participants Est. completion 2015-01 1 siteOther conditions: Hypercholesterolemia, HIV InfectionsView official trial listing → -
Withdrawn NCT NCT00913562
Effect of Rosuvastatin on Endothelial Function in Patients With Diabetes and Glaucoma
Not yet reported Medical University of Vienna Est. completion 2014-11 1 siteOther conditions: Glaucoma, DiabetesView official trial listing → -
Status unknown NCT NCT00923676
Treatment of Hyperlipidemia and Sexual Dysfunction
Not yet reported University of Campania Luigi Vanvitelli 300 participants Est. completion 2016-04 1 siteOther conditions: Sexual Dysfunction, HyperlipidemiaView official trial listing → -
Completed NCT NCT00929734
Effect of Rosuvastatin Therapy in Patients With Stable Chronic Obstructive Pulmonary Disease
Not yet reported University Hospital, Akershus 99 participants Est. completion 2014-01 1 site Stand-aloneOther conditions: Chronic Obstructive Pulmonary Disease (COPD)View official trial listing → -
Completed NCT NCT00930670
Evaluation of the Influence of Statins and Proton Pump Inhibitors on Clopidogrel Antiplatelet Effects
Not yet reported Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec 320 participants Est. completion 2011-12 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Available NCT NCT00934258
Effect of Genes on Rosuvastatin Therapy for Hyperlipidemia
National Taiwan University HospitalOther conditions: HyperlipidemiaView official trial listing → -
Withdrawn NCT NCT00951132
Depression and Cardiovascular Risk Markers: Effects of Rosuvastatin Therapy
Not yet reported University Hospital, Akershus Est. completion 2013-12 1 site Stand-aloneOther conditions: DepressionView official trial listing → -
Completed NCT NCT00964106
Validation Study of Multiple Probe Compounds for Drug Interaction Evaluation
Not yet reported GlaxoSmithKline 87 participants Est. completion 2011-08-29 2 sites Stand-aloneOther conditions: Drug InteractionsView official trial listing → -
Available NCT NCT00965315
A Multicenter Randomized Parallel-group Study to Investigate the Efficacy of a Combination of Rosuvastatin and Fenofibrate in the Patients With Diabetes or Atherosclerotic Vascular Diseases With Metabolic Syndrome
National Taiwan University HospitalOther conditions: Diabetes, CVDView official trial listing → -
Completed NCT NCT00966472
Phase I Study of a Statin + Erlotinib for Advanced Solid Malignancies With Focus on Squamous Cell Carcinomas and NSCLC
Not yet reported Ottawa Hospital Research Institute 24 participants Est. completion 2014-09 1 site Stand-aloneOther conditions: Squamous Cell Carcinoma, Non-Small Cell Lung CancerView official trial listing → -
Terminated NCT NCT00970606
STIP: Statin Trial for Influenza Patients
Not yet reported Gordon Bernard 7 participants Est. completion 2011-07 21 sites Stand-aloneOther conditions: Acute Respiratory Distress Syndrome, Influenza, H1N1 InfluenzaView official trial listing → -
Status unknown NCT NCT00972829
Tolerability and Lipid Lowering Effect of Weekly/Biweekly Crestor in Statin Intolerant Patients Treated With Zetia
Not yet reported Bronx VA Medical Center 30 participants Est. completion 2011-03 1 site Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00978419
Pilot Trial of Statin Use in Burn Patients
Not yet reported Vanderbilt University Medical Center 40 participants Est. completion 2011-05 1 siteOther conditions: BurnsView official trial listing → -
Terminated NCT NCT00979121
Statins for Acutely Injured Lungs From Sepsis
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 745 participants Est. completion 2013-11 40 sitesOther conditions: Sepsis, Acute Lung InjuryView official trial listing → -
Completed NCT NCT00984932
Effect of Rosuvastatin on Systemic Sclerosis-related Pulmonary Hypertension
Not yet reported University of Alexandria 40 participants Est. completion 2009-07 1 site Stand-aloneOther conditions: Systemic SclerosisView official trial listing → -
Terminated NCT NCT00986999
Effect of Rosuvastatin on Endothelial Function
Not yet reported, Not yet reported University of Hawaii 7 participants 1 site Stand-aloneCardiovascular disease Other conditions: HIV InfectionsView official trial listing → -
Completed NCT NCT00987974
Short Term Statin Treatment and Endothelial Dysfunction Due to Ischemia and Reperfusion Injury
Not yet reported Radboud University Medical Center 48 participants Est. completion 2010-03 1 site Stand-aloneOther conditions: Ischemia Reperfusion Injury, Endothelial DysfunctionView official trial listing → -
Completed NCT NCT00990028
Effect of Rosuvastatin on Cytokines After Traumatic Brain Injury
Not yet reported, Not yet reported Universidad Autonoma de San Luis Potosí 40 participants Est. completion 2011-08 1 site Stand-aloneOther conditions: Head InjuryView official trial listing → -
Completed NCT NCT00997880
Statin and Atheroma Vulnerability Evaluation
Not yet reported Seung-Jung Park 312 participants Est. completion 2014-12 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT01007279
Rosuvastatin in Preventing Myonecrosis in Elective Percutaneous Coronary Interventions (PCIs)
Not yet reported University of Roma La Sapienza 160 participants Est. completion 2010-09 1 site Stand-aloneOther conditions: Periprocedural Myocardial NecrosisView official trial listing → -
Status unknown NCT NCT01010516
Comparison of High-Dose Rosuvastatin Versus Low Statin Dose Plus Fenofibrate Versus Low Statin Dose Plus Niacin in the Treatment of Mixed Hyperlipidemia
Not yet reported University of Ioannina 120 participants 1 siteOther conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT01011127
Different Metabolic Effects of Statins
Gachon University Gil Medical Center Est. completion 2010-08 1 siteOther conditions: HypercholesterolemiaView official trial listing → -
Terminated NCT NCT01011478
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Not yet reported NSABP Foundation Inc 406 participants Est. completion 2015-02 587 sites Stand-aloneOther conditions: Colorectal Cancer, Precancerous ConditionView official trial listing → -
Status unknown NCT NCT01021488
Rosuvastatin for Preventing Deep Vein Thrombosis
Not yet reported Hallym University Medical Center 180 participants Est. completion 2012-03 1 site Stand-aloneOther conditions: Deep Vein Thrombosis, Venous, Thrombosis, PreventionView official trial listing → -
Withdrawn NCT NCT01023503
Observational Study To Evaluate Statins Patterns Of Use In Spain
AstraZeneca Est. completion 2012-07 1 siteOther conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT01023607
Evaluation of Statin-induced Lipid-rich Plaque Progression by Optical Coherence Tomography (OCT) Combined With Intravascular Ultrasound (IVUS)
Not yet reported Harbin Medical University 120 participants Est. completion 2013-08 1 siteCardiovascular disease Other conditions: HyperlipidemiaView official trial listing → -
Terminated NCT NCT01033955
Collaborative H1N1 Adjuvant Treatment Pilot Trial
Not yet reported Canadian Critical Care Trials Group 8 participants Est. completion 2010-07 9 sites Stand-aloneOther conditions: Critically Ill, H1N1/Influenza InfectionView official trial listing → -
Completed NCT NCT01047501
Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL)
Not yet reported Amarin Pharma Inc. 702 participants Est. completion 2011-02 80 sitesOther conditions: HypertriglyceridemiaView official trial listing → -
Completed NCT NCT01047683
Efficacy and Safety of AMR101 (Ethyl Icosapentate) in Patients With Fasting Triglyceride (Tg) Levels ≥ 500 and ≤ 2000 mg/dL
Not yet reported Amarin Pharma Inc. 229 participants Est. completion 2011-07 60 sitesOther conditions: HypertriglyceridemiaView official trial listing → -
Terminated NCT NCT01051401
Rosuvastatin in Treating Women With Cardiovascular Complications Who Are Undergoing Chemotherapy For Breast Cancer
Not yet reported Wake Forest University Health Sciences 5 participants Est. completion 2014-01 1 site Stand-aloneOther conditions: Cardiovascular Complications, Recurrent Breast Cancer, Stage I Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast CancerView official trial listing → -
Completed NCT NCT01058915
Influence of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Plaque Composition in Patients With ST-Segment Elevation Myocardial Infarction (MI)
Not yet reported Odense University Hospital 87 participants Est. completion 2009-06 1 siteOther conditions: Acute Coronary SyndromeView official trial listing → -
Completed NCT NCT01068626
Rosuvastatin in Visceral Adiposity
Not yet reported Göteborg University 54 participants Est. completion 2008-12 1 siteOther conditions: Abdominal ObesityView official trial listing → -
Completed NCT NCT01078675
An Study to Evaluate Rosuvastatin in Children and Adolescents With Familial Hypercholesterolaemia
Not yet reported AstraZeneca 315 participants Est. completion 2013-02 15 sites Stand-aloneOther conditions: Familial HypercholesterolaemiaView official trial listing → -
Completed NCT NCT01101568
A Study to Investigate the Interaction of GSK1292263 With Rosuvastatin and Simvastatin in Healthy Subjects
Not yet reported GlaxoSmithKline 28 participants Est. completion 2010-06-24 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01105975
A Study of LY2484595 in Patients With High LDL-C or Low HDL-C
Not yet reported Eli Lilly and Company 398 participants Est. completion 2011-06 59 sites Stand-aloneOther conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT01138072
A Drug Interaction Study Between Simvastatin, Atorvastatin, Rosuvastatin, and GSK2248761 in Healthy Subjects.
Not yet reported GlaxoSmithKline 14 participants Est. completion 2010-08 1 site Stand-aloneOther conditions: Infection, Human Immunodeficiency VirusView official trial listing → -
Completed NCT NCT01146483
Drug-drug Interaction Study in Healthy Male Volunteers Following the Administration of Pantoprazole and Rosuvastatin
Not yet reported Centre hospitalier de l'Université de Montréal (CHUM) 16 participants Est. completion 2011-12 1 siteOther conditions: Drug Interaction PotentiationView official trial listing → -
Completed NCT NCT01153334
Efficacy of Early Intensive ROsuvastatin Therapy in Patients With ST-segment Elevation Myocardial Infarction Undergoing PrimARY Percutaneous Coronary Intervention (the ROSEMARY Trial)
Not yet reported Yonsei University 125 participants Est. completion 2013-06-27 1 site Stand-aloneOther conditions: ST-segment Elevation AMIView official trial listing → -
Completed NCT NCT01154036
MK0653C in High Cardiovascular Risk Patients With High Cholesterol (Switch Study)(MK-0653C-162)
Not yet reported Organon and Co 1547 participants Est. completion 2012-10 Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01164397
Efficiency of Rosuvastatin Versus the Fixed Combination of Ezetimibe/Simvastatin in Outpatients
AstraZeneca 268 participants Est. completion 2010-12 9 sitesOther conditions: DyslipidemiaView official trial listing → -
Withdrawn NCT NCT01164540
Study on the Effect of Rosuvastatin Treatment on the Prevention of Thrombosis in Patients With Previous Thrombosis
Not yet reported AstraZeneca 3000 participants Est. completion 2013-03 Stand-aloneOther conditions: Venous Thrombosis, Pulmonary EmbolismView official trial listing → -
Completed NCT NCT01170585
A Trial of Rosuvastatin in Systemic Lupus Erythematosus
Not yet reported Imperial College London 33 participants Est. completion 2014-06 2 sitesOther conditions: Atherosclerosis, Systemic Lupus ErythematosusView official trial listing → -
Terminated NCT NCT01173939
Primary Prevention of Major Adverse Cardiac Events (MACE) With Standard and Intensive Statin Treatment in Patients With Diabetes: Survival and Cardiovascular Event Assessments
Not yet reported Positive Trial Group 10000 participants 317 sitesType 2 diabetes Other conditions: Hypercholesterolemia, HypertensionView official trial listing → -
Completed NCT NCT01178853
Drug-Drug Interaction Study to Assess the Effects of Steady State Pitavastatin 4 mg or Rosuvastatin 40 mg on Steady-State Warfarin in Healthy Adult Volunteers
Not yet reported Kowa Research Institute, Inc. 48 participants Est. completion 2011-04 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01183585
A Study of RO4917838 With Rosuvastatin in Healthy Volunteers
Not yet reported Hoffmann-La Roche 18 participants Est. completion 2010-09 1 site Stand-aloneOther conditions: Healthy VolunteerView official trial listing → -
Completed NCT NCT01185938
Statin Contrast Induced Nephropathy Prevention
Not yet reported Centro Cardiopatici Toscani 500 participants Est. completion 2012-10 1 siteOther conditions: Acute Coronary SyndromeView official trial listing → -
Completed NCT NCT01200836
Effects of Rosuvastatin on the Immune System in Healthy Volunteers With Normal Cholesterol
National Heart, Lung, and Blood Institute (NHLBI) 20 participants Est. completion 2018-10-04 1 siteOther conditions: Healthy Volunteers, Statins, Immune ModulationView official trial listing → -
Completed NCT NCT01203982
Effect of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Carotid Intima-media Thickness (CIMT)
Not yet reported Odense University Hospital 87 participants Est. completion 2009-06 1 siteCardiovascular disease Other conditions: Subclinical Carotid AtherosclerosisView official trial listing → -
Completed NCT NCT01218347
Influence of Organic Anion Transporting Polypeptide1B1(OATP1B1) Genotype on Rosuvastatin PK, PD and Lipid Profiles
Not yet reported Seoul National University Hospital 34 participants Est. completion 2010-12 1 site Stand-aloneOther conditions: Organic Anion Transporting Polypeptide1B1 (OATP1B1), RosuvastatinView official trial listing → -
Completed NCT NCT01218802
Use of Rosuvastatin in HIV-Infected Subjects to Modulate Cardiovascular Risks
Not yet reported University Hospitals Cleveland Medical Center 147 participants Est. completion 2014-05 1 siteOther conditions: HIV Infections, Heart DiseaseView official trial listing → -
Completed NCT NCT01223625
Effect of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Endothelial Function
Not yet reported Odense University Hospital 87 participants Est. completion 2010-06 1 siteOther conditions: Endothelial Dysfunction, AtherosclerosisView official trial listing → -
Completed NCT NCT01228227
ROsuvastatin Pretreatment to Reduce MyocArdial Periprocedural Necrosis:Comparison With Atorvastatin Reloading
Not yet reported Gennaro Sardella 310 participants Est. completion 2011-08 1 siteOther conditions: Assess the Periprocedural Myocardial NecrosisView official trial listing → -
Completed NCT NCT01241903
Early Use of Rosuvastatin in Acute Coronary Syndromes: Targeting Platelet-Leukocyte Interactions
Not yet reported Susan Smyth 54 participants Est. completion 2014-02 1 site Stand-aloneOther conditions: Acute Coronary Syndrome, Angioplasty, Transluminal, Percutaneous Coronary, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Blood PlateletsView official trial listing → -
Status unknown NCT NCT01245803
Acute Rosuvastatin for Preventing Myocardial Damage in Patients With ACS
Not yet reported Beijing Anzhen Hospital 400 participants Est. completion 2011-05 1 site Stand-aloneOther conditions: Acute Coronary Syndrome, AngioplastyView official trial listing → -
Completed NCT NCT01245894
Influence of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment
Not yet reported Odense University Hospital 87 participants Est. completion 2010-06 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT01259791
Evaluation of Patients With Statin Myopathy Using an N of 1 Trial Design
Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 10 participants Est. completion 2013-08 1 site Stand-aloneOther conditions: Statin MyopathyView official trial listing → -
Completed NCT NCT01288742
TMC435-TiDP16-C108 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and Digoxin and Between TMC435 and Rosuvastatin
Not yet reported Tibotec Pharmaceuticals, Ireland 33 participants Est. completion 2011-05 Stand-aloneOther conditions: Hepatitis C VirusView official trial listing → -
Completed NCT NCT01299038
Rosuvastatin to Lower Circulating Tissue Factor Bearing Microparticles in Metastatic Breast Cancer
Not yet reported Beth Israel Deaconess Medical Center 20 participants Est. completion 2013-12 2 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT01325818
The Effects of Pravastatin and Rosuvastatin on Coronary Plaques in Patients With Stable Angina Pectoris
Not yet reported Yokohama City University Medical Center 150 participants Est. completion 2016-02 1 siteOther conditions: Coronary Disease, HypercholesterolemiaView official trial listing → -
Completed NCT NCT01342211
A Multiple Dose Study of PF-04950615 (RN316) in Subjects on High Doses of Statins
Not yet reported Pfizer 93 participants Est. completion 2012-06 44 sites Stand-aloneOther conditions: Hypercholesterolemia, DyslipidemiaView official trial listing → -
Completed NCT NCT01350141
A Multiple Dose Study Of PF-04950615 (RN316) In Subjects On Maximum Doses Of Statins
Not yet reported Pfizer 46 participants Est. completion 2012-06 35 sitesOther conditions: Hypercholesterolemia, DyslipidemiaView official trial listing → -
Completed NCT NCT01352897
Registry On Efficacy and Safety Of Rosuvastatin, and Atorvastatin and Simvastatin In Hypercholesterolaemia
AstraZeneca 800 participants Est. completion 2010-12 1 siteOther conditions: HypercholesterolaemiaView official trial listing → -
Terminated NCT NCT01364220
The Effects of Very Early Use of Rosuvastatin in Preventing Recurrence of Ischemic Stroke
Not yet reported Severance Hospital 318 participants Est. completion 2013-04 27 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT01378715
Rosuvastatin Pre-Treatment Influences the Risk of Coronary Intervention Study
Not yet reported University Hospital, Motol 400 participants Est. completion 2012-08 4 sitesCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT01382277
Rosuvastatin Effect on Reducing Coronary Atherosclerosis Plaques Volume
Not yet reported Peking University First Hospital 600 participants Est. completion 2013-04 2 sites Stand-aloneCardiovascular disease Other conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT01382472
Microcirculation In Acute Coronary Syndromes
Not yet reported Helse Stavanger HF 25 participants Est. completion 2016-12 3 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT01389388
Effects of Rosuvastatin on Carotid Artery Plaques in Patients With Inflammatory Joint Disease
Not yet reported Diakonhjemmet Hospital 114 participants Est. completion 2013-08 1 site Stand-aloneOther conditions: Carotid Artery Plaque, Ankylosing Spondylitis, Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT01411111
A Repeat Dose Study to Investigate the Interaction of GSK2190915 on the Pharmacokinetics of Rosuvastatin
Not yet reported GlaxoSmithKline 28 participants Est. completion 2011-02-23 1 siteOther conditions: AsthmaView official trial listing → -
Completed NCT NCT01414803
Tolerability and Efficacy of Rosuvastatin - Fenofibrate Combine Therapy in Korean Patients With Combined Hyperlipidemia
Not yet reported Yonsei University 180 participants Est. completion 2011-04 1 site Stand-aloneOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT01415466
Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and CS-866 in Healthy Male Volunteers
Not yet reported Daewoong Pharmaceutical Co. LTD. 36 participants Est. completion 2011-10 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01420549
Efficacy/Safety of Rosuvastatin+Ezetimibe in High Risk Patients With Primary Hypercholesterolemia/Mixed Dyslipidemia
Not yet reported Ache Laboratorios Farmaceuticos S.A. 129 participants Est. completion 2014-11 7 sites Stand-aloneOther conditions: Hypercholesterolemia, DyslipidemiaView official trial listing → -
Completed NCT NCT01425398
A Trial to Evaluate the Effect of Rosuvastatin on Inflammation in Patients Undergoing Isolated Cardiac Valve Surgery
Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 170 participants Est. completion 2013-12 1 site Stand-aloneOther conditions: Valvular Cardiac SurgeryView official trial listing → -
Status unknown NCT NCT01455935
Wake up Symptomatic Stroke - Benefit of Intravenous Clot Busters or Endovascular Intervention
Not yet reported Jacobs Neurological Institute 90 participants Est. completion 2014-02 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT01466608
Influence of OATP1B1 and BRCP Genotype on Rosuvastatin PK, PD and Lipidomics in Hyperlipidemic Patients
Not yet reported Seoul National University Hospital 21 participants Est. completion 2013-08 1 site Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01469416
Drug Interaction Study of Clopidogrel and Rosuvastatin
Not yet reported University of California, San Francisco 10 participants Est. completion 2013-05 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01489943
A Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects
Not yet reported GlaxoSmithKline 24 participants Est. completion 2011-11-10 1 site Stand-aloneOther conditions: Crohn's DiseaseView official trial listing → -
Completed NCT NCT01490398
Rosuvastatin Effect on Serial Echocardiographic Measurement of Coronary Flow Velocity Reserve
Not yet reported Asan Medical Center 56 participants Est. completion 2013-10 1 site Stand-aloneOther conditions: Hypertension, Cardiovascular Risk FactorsView official trial listing → -
Completed NCT NCT01492361
A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High-Risk Patients With Hypertriglyceridemia and on Statin
Not yet reported Amarin Pharma Inc. 8179 participants Est. completion 2018-05 410 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT01493856
A Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Combination of Rosuvastatin and CS-866 and DWJ1276
Not yet reported Daewoong Pharmaceutical Co. LTD. 58 participants Est. completion 2012-03 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Terminated NCT NCT01494090
Statin in Hip Fracture
Not yet reported University Hospital, Brest 36 participants Est. completion 2012-09 6 sitesOther conditions: Hip FractureView official trial listing → -
Completed NCT NCT01507831
Long-term Safety and Tolerability of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY Long Term)
Not yet reported Sanofi 2341 participants Est. completion 2014-11 320 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01524601
The Rosuvastatin In TrAnsplant Recipients Study
Not yet reported University of Oslo School of Pharmacy 20 participants Est. completion 2012-10 1 site Stand-aloneOther conditions: Disorder Related to Renal Transplantation, HypercholesterolemiaView official trial listing → -
Completed NCT NCT01524653
Detecting the Impact of Statin Therapy On Lowering Risk of Venous Thrombo-Embolic Events (DISOLVE)
Not yet reported University of Vermont 38 participants Est. completion 2016-09-01 1 site Stand-aloneOther conditions: Venous Thromboembolism, Deep Vein Thrombosis, NeoplasmsView official trial listing → -
Completed NCT NCT01526317
A Phase 1 Clinical Trial to Investigate Pharmacokinetics and Drug Interaction of Crestor and Glucodown OR SR in Healthy Volunteers
Not yet reported Yuhan Corporation 36 participants Est. completion 2012-05 1 site Stand-aloneOther conditions: Pharmacokinetics and Drug Interaction of Crestor and Glucodown SRView official trial listing → -
Completed NCT NCT01526460
Evaluation of Platelet Function After Statin Loading Dose in Patients Before Percutaneous Coronary Intervention
Not yet reported IRCCS San Raffaele 146 participants Est. completion 2014-02 1 siteOther conditions: Platelet DysfunctionView official trial listing → -
Completed NCT NCT01544309
LIpid Lowering With Highly Potent Statins in Hyperlipidaemia With Type 2 Diabetes patiENts
Not yet reported Listen Trial Group 1049 participants 133 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01547377
Zinc and Selenium Supplementation in Atherosclerosis
Not yet reported Universidade Federal do Rio Grande do Norte 76 participants Est. completion 2009-11 1 site Stand-aloneOther conditions: Dietary Selenium Deficiency, Dietary Zinc DeficiencyView official trial listing → -
Completed NCT NCT01548157
Clinical Trial to Evaluate the Effect on the Pharmacokinetic Characteristics of HCP1007 Capsule
Not yet reported Hanmi Pharmaceutical Company Limited 28 participants Est. completion 2012-12 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01563731
Optimal Blood Pressure and Cholesterol Targets for Preventing Recurrent Stroke in Hypertensives
Not yet reported Istituto Auxologico Italiano 200 participants Est. completion 2021-03-31 1 siteCardiovascular disease Other conditions: Transient Ischemic Attack, HypertensionView official trial listing → -
Status unknown NCT NCT01567774
Pharmacodynamic Effects of Atorvastatin vs. Rosuvastatin on Platelet Reactivity
Not yet reported University of Roma La Sapienza 100 participants Est. completion 2015-06 2 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT01567826
Reduction in YEllow Plaque by Aggressive Lipid LOWering Therapy
Not yet reported Annapoorna Kini 87 participants Est. completion 2012-02 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT01573143
Statin Therapy In Cardiac Surgery
Not yet reported University of Oxford 1922 participants Est. completion 2014-09 1 site Stand-aloneOther conditions: Atrial Fibrillation, Myocardium; InjuryView official trial listing → -
Completed NCT NCT01582165
Women With Chest Pain and no Significant Coronary Artery Stenosis; A Study on Microvascular Resistance
Not yet reported Oslo University Hospital 66 participants Est. completion 2016-06 1 siteOther conditions: Angina PectorisView official trial listing → -
Completed NCT NCT01598363
An Open-Label Study of the Effect of Bardoxolone Methyl on the Single Dose Pharmacokinetics of Digoxin and Rosuvastatin in Healthy Volunteers
Not yet reported Biogen 32 participants Est. completion 2012-07-31 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT01609907
Pharmacokinetic Drug Interaction Between Rosuvastatin and Valsartan
Not yet reported Yuhan Corporation 30 participants Est. completion 2012-05 1 site Stand-aloneOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Status unknown NCT NCT01613729
Efficacy and Safety Study of 5 mg and 10 mg Rosuvastatin
Not yet reported D16 Pharma & Biotec Ltd. 2000 participants Est. completion 2013-12 1 siteOther conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT01613794
Rosuvastatin Use to Improve the Coagulation Profile in Patients With Venous Thrombosis
Not yet reported Leiden University Medical Center 255 participants Est. completion 2016-12 3 sites Stand-aloneOther conditions: Deep Vein Thrombosis, Pulmonary EmbolismView official trial listing → -
Completed NCT NCT01617655
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia (ODYSSEY HIGH FH)
Not yet reported Sanofi 107 participants Est. completion 2015-01 35 sites Stand-aloneOther conditions: HypercholesterolaemiaView official trial listing → -
Completed NCT NCT01622777
The Effect of Rosuvastatin in Diabetic Polyneuropathy: A Phase IIa Randomized Double-blind Placebo-controlled Study
Not yet reported Alejandra Guillermina Miranda Diaz 34 participants Est. completion 2011-06 1 site Stand-aloneOther conditions: Diabetic PolyneuropathyView official trial listing → -
Completed NCT NCT01623115
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy
Not yet reported Sanofi 486 participants Est. completion 2014-12 91 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT01623921
Statins and Selective Cyclooxygenase-2 Receptor Inhibitors in Blunt Chest Trauma
Not yet reported Tel-Aviv Sourasky Medical Center 100 participants Est. completion 2013-08 1 siteOther conditions: Blunt Chest Trauma, Acute Respiratory Distress SyndromeView official trial listing → -
Status unknown NCT NCT01624857
Statin for Depression in Patients Undergoing Coronary Artery Bypass Graft
Not yet reported China National Center for Cardiovascular Diseases 400 participants Est. completion 2014-06 1 siteOther conditions: Coronary Heart DiseaseView official trial listing → -
Completed NCT NCT01634906
Erythrocyte-bound Apolipoprotein B After Withdrawal of Statin Therapy
Not yet reported Sint Franciscus Gasthuis 55 participants Est. completion 2013-03 1 site Stand-aloneOther conditions: Hyperlipidemia, AtherosclerosisView official trial listing → -
Completed NCT NCT01644175
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia (ODYSSEY COMBO I)
Not yet reported Sanofi 316 participants Est. completion 2014-04 76 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01644188
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Ezetimibe on Top of Statin in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY COMBO II)
Not yet reported Sanofi 720 participants Est. completion 2015-07 126 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT01646307
Effect of Atorvastatin Versus Rosuvastatin Intensive Statin Regimens on Chinese Elderly Patients Undergoing PCI
Not yet reported Beijing Anzhen Hospital 1000 participants Est. completion 2013-06 1 siteOther conditions: Focus of StudyView official trial listing → -
Status unknown NCT NCT01653119
Peking and Rotterdam on Mission to Reduce Coronary Artery Disease
Not yet reported Peking University Third Hospital 1000 participants Est. completion 2015-12 1 siteOther conditions: Acute Coronary Syndrome, Diabetes MellitusView official trial listing → -
Completed NCT NCT01660191
A Study Comparing CoQ10 Levels While Taking 3 Different Statins
Not yet reported University of Kansas Medical Center 134 participants Est. completion 2013-10 1 siteOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01660919
Vascular and Metabolic Effects of Rosuvastatin
Not yet reported Gachon University Gil Medical Center 160 participants Est. completion 2013-12 1 siteOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01663402
ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab
Not yet reported Sanofi 18924 participants Est. completion 2018-01-23 1388 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Terminated NCT NCT01697735
The Therapeutic Effects of Statins and Berberine on the Hyperlipemia
Not yet reported Wenzhou Medical University 24 participants Est. completion 2015-09 1 site Stand-aloneOther conditions: DyslipidemiasView official trial listing → -
Completed NCT NCT01699126
The Endothelium Dysfunction in Patients of Obstructive Sleep Apnea Syndrome
Not yet reported Chang Gung Memorial Hospital 46 participants Est. completion 2013-08 1 siteOther conditions: Sleep Apnea, ObstructiveView official trial listing → -
Completed NCT NCT01702987
Evaluation of Ubiquinol on Mitochondrial Oxidative Capacity in Statin Patients Using 31PMRS
Not yet reported Beth Israel Deaconess Medical Center 22 participants Est. completion 2013-10 1 siteOther conditions: Myopathy, HMG COA Reductase Inhibitor Adverse Reaction, HypercholesterolemiaView official trial listing → -
Completed NCT NCT01709500
Study of Alirocumab (REGN727/SAR236553) in Patients With heFH (Heterozygous Familial Hypercholesterolemia) Who Are Not Adequately Controlled With Their LMT (Lipid-Modifying Therapy)
Not yet reported Regeneron Pharmaceuticals 249 participants Est. completion 2015-01 24 sites Stand-aloneOther conditions: Heterozygous Familial HypercholesterolemiaView official trial listing → -
Completed NCT NCT01711749
Rosuvastatin Calcium Bioequivalence Study - Fast
Not yet reported GlaxoSmithKline 60 participants Est. completion 2013-03-13 1 siteOther conditions: HypercholesterolaemiaView official trial listing → -
Completed NCT NCT01725230
Assess the Pharmacokinetics of Rosuvastatin and Simvastatin When Administered Alone or in Combination With Fostamatinib
Not yet reported AstraZeneca 42 participants Est. completion 2013-01 1 site Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT01730040
Study of the Efficacy and Safety of Alirocumab (REGN727/SAR236553) in Combination With Other Lipid-modifying Treatment (LMT) (ODYSSEY OPTIONS I)
Not yet reported Regeneron Pharmaceuticals 355 participants Est. completion 2014-05 97 sitesOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01730053
Study of Alirocumab (REGN727/SAR236553) added-on to Rosuvastatin Versus Other Lipid Modifying Treatments (LMT) (ODYSSEY OPTIONS II)
Not yet reported Regeneron Pharmaceuticals 305 participants Est. completion 2014-05-31 93 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01751074
To Estimate the Potential Effects of Repeat Doses of Darapladib on the Pharmacokinetics (PK) of Rosuvastatin as Well as Evaluating Safety and Tolerability in Healthy Volunteers
Not yet reported GlaxoSmithKline 18 participants Est. completion 2013-03-14 1 site Stand-aloneOther conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT01763866
LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2
Not yet reported Amgen 2067 participants Est. completion 2013-12-04 244 sites Stand-aloneOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT01764295
Clinical Study for Patients With Hypertension Associated With Dyslipidemia
Not yet reported Daewoong Pharmaceutical Co. LTD. 150 participants Est. completion 2013-07 1 siteOther conditions: Hypertension, DyslipidemiaView official trial listing → -
Status unknown NCT NCT01773512
The Prediction of Extent and Risk Profile of Coronary Atherosclerosis and Their Changes During Lipid-lowering Therapy Based on Non-invasive Techniques
Not yet reported General University Hospital, Prague 60 participants Est. completion 2015-06 3 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT01775579
Evaluating a Pharmacokinetic Drug Interaction Between Metformin Hydrochloride and Rosuvastatin Calcium
Not yet reported Hanmi Pharmaceutical Company Limited 36 participants Est. completion 2013-06 1 siteOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT01795937
Investigation of Interactions Between Faldaprevir, Itraconazole, Atorvastatin and Rosuvastatin
Not yet reported Boehringer Ingelheim 51 participants Est. completion 2013-03 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Terminated NCT NCT01798602
Collaborative H1N1 Adjuvant Treatment (CHAT) Pilot Trial
Not yet reported Canadian Critical Care Trials Group 8 participants Est. completion 2010-08 1 site Stand-aloneOther conditions: H1N1 InfluenzaView official trial listing → -
Completed NCT NCT01813357
Does Rosuvastatin Delay Progression of Atherosclerosis in HIV
Not yet reported Bayside Health 84 participants Est. completion 2018-11-01 2 sites Stand-aloneCardiovascular disease Other conditions: HIVView official trial listing → -
Status unknown NCT NCT01816997
The Statins on Glucose Homeostasis in Subjects With Impaired Fasting Glucose
Not yet reported Taipei Veterans General Hospital, Taiwan 160 participants Est. completion 2022-12 1 site Stand-aloneOther conditions: DiabetesView official trial listing → -
Completed NCT NCT01823133
Study for Investigate the Pharmacokinetic Drug Interactions Between Gemigliptin and Rosuvastatin
Not yet reported LG Life Sciences 30 participants Est. completion 2013-08 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01823900
Safety and Pharmacokinetic Comparison of Co-administration and a Combination Drug of Rosuvastatin and Olmesartan in Healthy Male Volunteers
Not yet reported Severance Hospital 58 participants Est. completion 2012-03 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01831479
Investigation of Pharmacokinetic Interaction Between Rosuvastatin and Olmesartan in Healthy Male Volunteers
Not yet reported Severance Hospital 36 participants Est. completion 2011-10 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01837823
YELLOW II Study: Reduction in Coronary Yellow Plaque, Lipids and Vascular Inflammation by Aggressive Lipid Lowering
Not yet reported Icahn School of Medicine at Mount Sinai 91 participants Est. completion 2015-04 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Terminated NCT NCT01863225
Characterization of Multi-dose RVX000222 in Combination With Statin Treatment in Dyslipidemia
Not yet reported Resverlogix Corp 13 participants Est. completion 2013-06 1 site Stand-aloneCardiovascular disease Other conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT01863914
Vascular Protective Effect of Rosuvastatin in Arteriovenous Fistula
Not yet reported National Cheng-Kung University Hospital 60 participants Est. completion 2019-01-31 1 siteOther conditions: End-stage Kidney Disease, Diabetes Mellitus, Arteriovenous FistulaView official trial listing → -
Completed NCT NCT01870466
Pharmacodynamic Drug Interaction Between Cilostazol and Statins
Not yet reported Samsung Medical Center 63 participants Est. completion 2013-12 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01870804
Atorvastatin Versus Rosuvastatin on Contrast Induced Acute Kidney Injury (PRATO-ACS 2)
Not yet reported Centro Cardiopatici Toscani 760 participants Est. completion 2016-09 1 siteOther conditions: Acute Coronary SyndromeView official trial listing → -
Completed NCT NCT01872845
A Trial Comparing the Effect of Pravastatin and Rosuvastatin on Atherosclerosis Progression Measured by Carotid Intima Media Thickness in Patients With Coronary Artery Disease After Biolimus Eluting Stent (Nobori®) Implantation: CPR IMT
Not yet reported Yonsei University 671 participants Est. completion 2017-05-25 1 site Stand-aloneOther conditions: Coronary Artery Occlusive DiseaseView official trial listing → -
Status unknown NCT NCT01874743
Rosuvastatin to Decrease Residual Immune Activation in HIV Infection
Not yet reported Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba 40 participants Est. completion 2013-09 2 sites Stand-aloneOther conditions: HIV-1 InfectionView official trial listing → -
Completed NCT NCT01881971
Statins for Pulmonary and Cardiac Complications of Chronic HIV - Coordinating Center
Not yet reported Alison Morris 23 participants Est. completion 2016-01 3 sitesOther conditions: HIV SeropositivityView official trial listing → -
Completed NCT NCT01890967
A Study of LY3015014 in Participants With High Cholesterol
Not yet reported Eli Lilly and Company 527 participants Est. completion 2014-06 49 sitesOther conditions: HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT01899027
Rosuvastatin for Preventing Complications in Renal Ablation
Not yet reported University of Roma La Sapienza 112 participants Est. completion 2017-12 1 siteOther conditions: Arterial HypertensionView official trial listing → -
Completed NCT NCT01914432
Efficacy and Safety Study of YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and Hyperlipidemia
Not yet reported Yuhan Corporation 210 participants Est. completion 2014-06 1 site Stand-aloneOther conditions: Hyperlipidemia, HypertensionView official trial listing → -
Completed NCT NCT01918332
Efficacy and Safety of Valsartan 160mg and Rosuvastatin 20mg in Patients With Hypertension and Hyperlipidemia
Not yet reported LG Life Sciences 168 participants Est. completion 2013-03 1 site Stand-aloneOther conditions: Hypertension,, HyperlipidemiaView official trial listing → -
Completed NCT NCT01918358
Safety and Pharmacokinetics Between Fixed-dose Combination VR 160/20 mg and Co-administration of Diovan® (Valsartan) Film-coated Tablet 160 mg and Crestor® (Rosuvastatin) 20 mg
Not yet reported LG Life Sciences 60 participants Est. completion 2013-01 1 site Stand-aloneOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT01918709
Drug Interaction and Safety Between Valsartan and Rosuvastatin in Healthy Male Volunteers
Not yet reported LG Life Sciences 30 participants Est. completion 2011-11 1 site Stand-aloneOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT01921946
To Evaluate the Pharmacokinetic Interactions and Safety Between Fimasartan and Rosuvastatin
Not yet reported Boryung Pharmaceutical Co., Ltd 50 participants Est. completion 2013-10 1 siteOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT01923077
Intensive Statin Therapy in Patients With AMI
Not yet reported Svendborg Hospital 140 participants Est. completion 2013-09 1 siteCardiovascular diseaseView official trial listing → -
Withdrawn NCT NCT01925300
Pharmacokinetic Interactions of Bisoprolol and Rosuvastatin
Not yet reported HK inno.N Corporation Est. completion 2013-09 Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01926782
Study to Evaluate the Efficacy and Safety of an Every Four Weeks Treatment Regimen of Alirocumab (REGN727/ SAR236553) in Patients With Primary Hypercholesterolemia (ODYSSEY CHOICE 1)
Not yet reported Regeneron Pharmaceuticals 803 participants Est. completion 2015-04 83 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01929070
A Pilot Study to Evaluate the Pharmacokinetics of Omega-3 Between Rosuvastatin and Omega-3 Coadministration and HCP1007
Not yet reported Hanmi Pharmaceutical Company Limited 12 participants Est. completion 2013-03 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT01929512
Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 20mg
Not yet reported Hanmi Pharmaceutical Company Limited 72 participants Est. completion 2013-08 1 site Stand-aloneOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT01935674
Treatment With Rosuvastatin Versus Switching PI (Protease Inhibitor) in Patients HIV With High Cholesterol Levels
Not yet reported Juan A. Arnaiz 43 participants Est. completion 2014-09 1 site Stand-aloneOther conditions: HIV, HypercholesterolaemiaView official trial listing → -
Completed NCT NCT01936805
ROsuvastatin LOading and Clinical Outcomes Trial
Not yet reported Yuksek Ihtisas Hospital 299 participants Est. completion 2012-01 1 siteOther conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT01953835
A Two-part Study to Investigate the Interaction and Pharmacokinetics of GSK2586184
Not yet reported GlaxoSmithKline 37 participants Est. completion 2014-03-10 1 site Stand-aloneOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Completed NCT NCT01954394
Open Label Study of Long Term Safety Evaluation of Alirocumab
Not yet reported Sanofi 986 participants Est. completion 2017-06-30 177 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT01955759
Atrial Fibrillation and By-pass Surgery
Not yet reported Heart Center BH Tuzla 260 participants Est. completion 2015-02 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT01959399
Drug-Drug Interaction Study Evaluating Effects of ASP015K on Rosuvastatin
Not yet reported Astellas Pharma Global Development, Inc. 24 participants Est. completion 2013-07 1 site Stand-aloneOther conditions: Healthy Subjects, Pharmacokinetics of ASP015KView official trial listing → -
Completed NCT NCT01964365
Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and Fenofibric Acid in Healthy Male Volunteers
Not yet reported Daewoong Pharmaceutical Co. LTD. 30 participants Est. completion 2013-12 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT01968577
Randomized Trial of Creatine-kinase Leak After Rosuvastatin At the Time of Percutaneous Coronary Intervention
Not yet reported Kleber Bomfim Araujo Martins 528 participants Est. completion 2013-12 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT01970215
TA-8995: Its Use in Patients With Mild Dyslipidaemia (TULIP)
Not yet reported Xention Ltd 364 participants Est. completion 2014-07 17 sitesOther conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT01971606
Impact of High-dose Pretreatment of Rosuvastatin in Patients With Acute Coronary Syndrome Following Off-pump Coronary Artery Bypass: Results From the HIROP-ACS (HIgh-dose Pretreatment of Rosuvastatin During Off-Pump Coronary Bypass in Acute Coronary Syndrome) Study
Not yet reported Yonsei University 234 participants Est. completion 2013-03 1 site Stand-aloneOther conditions: A Total of 234 Patients With Acute Coronary Syndrome Who Will Undergo OPCAB.View official trial listing → -
Terminated NCT NCT01972178
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
Not yet reported Pronova BioPharma 113 participants Est. completion 2014-08 29 sites Stand-aloneOther conditions: DyslipidemiaView official trial listing → -
Terminated NCT NCT01975194
Rosuvastatin in African Americans With Cerebrovascular Disease
Not yet reported Wayne State University 20 participants Est. completion 2013-08 1 site Stand-aloneCardiovascular disease Other conditions: Transient Ischemic AttackView official trial listing → -
Completed NCT NCT01975961
PK Study of Telmisartan/Rosuvastatin FDC Compared to Combination of Telmisartan and Rosuvastatin
Not yet reported Yuhan Corporation 185 participants Est. completion 2013-09 1 site Stand-aloneOther conditions: Dyslipidemia & HypertensionView official trial listing → -
Status unknown NCT NCT01982461
A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Hypercholesterolemia.
Not yet reported Pin Siang Medical Biotechnology Co., Ltd. 40 participants 1 site Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01992211
Evaluating of Pharmacokinetic Profile of BCWP_C003 and Co-administration of Rosuvastatin and Metformin
Not yet reported BC World Pharm Co. Ltd. 35 participants Est. completion 2017-07-10 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01992601
A Randomized, Open-label, Multiple-dose, Crossover Study to Investigate the Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan in Healthy Volunteer
Not yet reported Yuhan Corporation 48 participants Est. completion 2013-01 1 site Stand-aloneOther conditions: Healthy VolunteerView official trial listing → -
Terminated NCT NCT02008786
Statin and Angiotensin-converting Enzyme Inhibitor on Symptoms in Patients With SCAD
Not yet reported Cardiology Research UBC 18 participants Est. completion 2019-09-13 1 site Stand-aloneOther conditions: Coronary Artery Dissection, SpontaneousView official trial listing → -
Completed NCT NCT02011633
Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 500mg and Rosuvastatin 10mg
Not yet reported Hanmi Pharmaceutical Company Limited 72 participants Est. completion 2013-12 1 site Stand-aloneOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT02026817
Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 10mg
Not yet reported Hanmi Pharmaceutical Company Limited 36 participants Est. completion 2014-01 1 site Stand-aloneOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT02029625
Compare the Pharmacokinetics of NVP-1205 and Coadministration of Rosuvastatin and Ezetimibe
Not yet reported NVP Healthcare 41 participants Est. completion 2014-03 1 site Stand-aloneOther conditions: DyslipidemiaView official trial listing → -
Status unknown NCT NCT02030054
Pharmacodynamic Comparison of Rosuvastatin Versus Atorvastatin on Platelet Reactivity in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With New P2Y12 Inhibitors (Trial gRANADa)
Not yet reported University of Roma La Sapienza 150 participants Est. completion 2015-09 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT02041117
Resuvastatin Treatment for Symptomatic Middle Cerebral Artery Stenosis Based on High-resolution Magnetic Resonance Imaging
Not yet reported Beijing Tiantan Hospital 162 participants Est. completion 2018-11-06 1 siteOther conditions: Intracranial Arterial StenosisView official trial listing → -
Completed NCT NCT02047175
CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin)
Not yet reported Chong Kun Dang Pharmaceutical 64 participants Est. completion 2014-03 1 site Stand-aloneOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT02060019
Pharmacokinetic Interactions and Safety Between Exforge Tab. and Crestor Tab. in Healthy Male Subjects
Not yet reported HK inno.N Corporation 57 participants Est. completion 2014-12 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02072161
Evaluation of ETC-1002 vs Placebo in Patients Receiving Ongoing Statin Therapy
Not yet reported Esperion Therapeutics, Inc. 133 participants Est. completion 2015-01 40 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT02075619
Relative Bioavailability Study of One Amlodipine 10mg Tablet and One Rosuvastatin 20mg Tablet to Two Fixed Dose Combinations of Amlodipine (10mg) and Rosuvastatin (20mg) in Healthy Subjects Under Fasting Conditions
Not yet reported GlaxoSmithKline 24 participants Est. completion 2014-07-11 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT02077257
LDL-C Lowering Efficacy and Safety of Rosuvastatin 20 mg/Day to10 mg/Day in Chinese ACS(Acute Coronary Syndrome) Patients
Not yet reported Committee of Cardio-Cerebral-Vascular Diseases of GSC 1060 participants Est. completion 2016-05 1 siteOther conditions: Acute Coronary SyndromeView official trial listing → -
Completed NCT NCT02079506
Pharmacokinetic Drug Interaction Between Candesartan and Rosuvastatin
Not yet reported Alvogen Korea 40 participants Est. completion 2014-02 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02082665
Effects of Dabrafenib on the Single Dose Pharmacokinetics (PK) of Rosuvastatin and Midazolam
Not yet reported GlaxoSmithKline 6 participants Est. completion 2016-08-01 4 sites Stand-aloneOther conditions: CancerView official trial listing → -
Completed NCT NCT02083627
A Study to Assess the Effects of Multiple Doses of Fidaxomicin on a Single Dose of Rosuvastatin in Healthy Male Subjects
Not yet reported Astellas Pharma Europe B.V. 25 participants Est. completion 2013-03 1 site Stand-aloneOther conditions: Drug-Drug Interaction (DDI), Intestinal Absorption, Healthy Subjects, Pharmacokinetics of Rosuvastatin, Pharmacokinetics of FidaxomicinView official trial listing → -
Status unknown NCT NCT02087540
Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With Hyperlipidemia
Not yet reported IlDong Pharmaceutical Co Ltd 310 participants 1 site Stand-aloneOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT02089061
Drug Interaction Statin
Not yet reported Bristol-Myers Squibb 26 participants Est. completion 2014-05 Stand-aloneOther conditions: Acute Coronary SyndromesView official trial listing → -
Completed NCT NCT02089399
Pharmacokinetics and Drug Interaction Study Between Amlodipine,Olmesartan and Rosuvastatin in Healthy Adult Volunteers
Not yet reported Daewoong Pharmaceutical Co. LTD. 32 participants Est. completion 2014-06 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02101125
Drug Interaction Study With Rosuvastatin
Not yet reported Bristol-Myers Squibb 26 participants Est. completion 2014-05 1 site Stand-aloneOther conditions: Immunosuppression For DiseaseView official trial listing → -
Completed NCT NCT02104843
Drug Interaction Between Daclatasvir/Asunaprevir/BMS-791325 and Rosuvastatin
Not yet reported Bristol-Myers Squibb 18 participants Est. completion 2014-05 Stand-aloneOther conditions: Hepatitis CView official trial listing → -
Terminated NCT NCT02105623
EARly Prevention of aTHeroma Progression
Not yet reported CHEOL WHAN LEE, M.D., Ph.D 111 participants Est. completion 2018-03 1 site Stand-aloneOther conditions: Coronary ArteriosclerosisView official trial listing → -
Completed NCT NCT02106767
The Effects of Rifampin on the Pharmacokinetics of Rosuvastatin
Not yet reported University of California, San Francisco 16 participants Est. completion 2016-08-07 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02106845
Effect of Regorafenib on Digoxin and Rosuvastatin in Patients With Advanced Solid Malignant Tumors.
Not yet reported Bayer 42 participants Est. completion 2018-06-12 5 sites Stand-aloneOther conditions: NeoplasmsView official trial listing → -
Completed NCT NCT02107898
Efficacy and Safety Evaluation of Alirocumab in Patients With Heterozygous Familial Hypercholesterolemia or High Cardiovascular Risk Patients With Hypercholesterolemia on Lipid Modifying Therapy (ODYSSEY JAPAN)
Not yet reported Sanofi 216 participants Est. completion 2015-09 32 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Terminated NCT NCT02114697
Accelerated Atherosclerosis in High Risk Population Groups: An Assessment by Magnetic Resonance Imaging
Not yet reported Emory University 9 participants Est. completion 2017-07 1 site Stand-aloneOther conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT02117453
Multicenter, Prospective, Randomized, Controlled, Double-blind Trial on the Impact of Rosuvastatin on Subclinical Markers of Atherosclerosis in Patients With Primary Necrotizing Vasculitides
Not yet reported Assistance Publique - Hôpitaux de Paris 121 participants Est. completion 2019-11-07 1 site Stand-aloneOther conditions: ANCA-associated Primary Necrotizing VasculitidesView official trial listing → -
Completed NCT NCT02125227
Phase 1 Clinical Trial to Investigate the Effect on the Pharmacokinetics of YH14755 Compared to Co-administration of Rosuvastatin and Metformin SR in Healthy Volunteers
Not yet reported Yuhan Corporation 56 participants Est. completion 2014-09 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02126358
Gemigliptin-Rosuvastatin Fix-dose Combination Phase 3(BALANCE)
Not yet reported LG Life Sciences 290 participants Est. completion 2016-03 1 site Stand-aloneType 2 diabetes Other conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT02127320
Investigating the Pharmacokinetic Drug Interactions Between Rosuvastatin and Ezetimibe
Not yet reported Hanmi Pharmaceutical Company Limited 24 participants Est. completion 2014-11 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02129231
Statins for Oxidative Stress and Mitochondrial Function in Diabetic Polyneuropathy
Not yet reported University of Guadalajara 74 participants Est. completion 2014-04 1 siteOther conditions: Oxidative Stress, Diabetic PolyneuropathyView official trial listing → -
Status unknown NCT NCT02140489
Evaluating a Pharmacokinetic Drug Interaction Between Amlodipine/Losartan and Rosuvastatin
Not yet reported Hanmi Pharmaceutical Company Limited 30 participants Est. completion 2014-08 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02166814
A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Combination of Fimasartan/Rosuvastatin in Comparison to Each Component Administered Alone in Patients With Essential Hypertension and Dyslipidemia
Not yet reported Boryung Pharmaceutical Co., Ltd 140 participants Est. completion 2015-09 26 sites Stand-aloneOther conditions: Essential Hypertension, DyslipidemiaView official trial listing → -
Completed NCT NCT02185963
Effect of Rosuvastatin on Function of High Density Lipoprotein Cholesterol in Type 2 Diabetes
Not yet reported Seoul National University Bundang Hospital 50 participants Est. completion 2016-05 1 site Stand-aloneOther conditions: DiabetesView official trial listing → -
Completed NCT NCT02186483
Clinical Trial to Investigate the Pharmacokinetics Drug Interaction Between Metformin and Rosuvastatin
Not yet reported Jeil Pharmaceutical Co., Ltd. 24 participants Est. completion 2015-02 1 site Stand-aloneOther conditions: Hyperlipidemia, DiabetesView official trial listing → -
Completed NCT NCT02205190
to Compare the Pharmacokinetics and Safety of Fimasartan/Rosuvastatin Combination Tablet and Coadministration of Fimasartan and Rosuvastatin
Not yet reported Boryung Pharmaceutical Co., Ltd 81 participants Est. completion 2014-09 1 siteOther conditions: HypertensionView official trial listing → -
Terminated NCT NCT02205775
Rosuvastatin for Reduction of Myocardial Damage and Systemic Inflammation During Coronary Angioplasty
Not yet reported G. d'Annunzio University 280 participants Est. completion 2012-06 6 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Terminated NCT NCT02215174
Rosuvastatin Interethnic PK Study
Not yet reported University of California, San Francisco 21 participants Est. completion 2018-12-06 2 sites Stand-aloneOther conditions: Statin Pharmacokinetics Pre and Post Gastric Bypass SurgeryView official trial listing → -
Completed NCT NCT02226198
A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial Hypercholesterolemia
Not yet reported AstraZeneca 20 participants Est. completion 2015-07 9 sitesOther conditions: Homozygous Familial Hypercholesterolemia (HoFH)View official trial listing → -
Completed NCT NCT02231931
Drug-drug Interaction Between Digoxin, Furosemide, Metformin, and Rosuvastatin
Not yet reported Boehringer Ingelheim 24 participants Est. completion 2015-01-01 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT02232360
Effects of Combined Therapy With Statin Plus Fenofibrate on Coronary Atherosclerotic Plaque Compared With Statin Alone
Not yet reported Gachon University Gil Medical Center 106 participants Est. completion 2020-12 6 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT02233218
The Pharmacokinetic Drug-drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers
Not yet reported Yuhan Corporation 60 participants Est. completion 2015-01 1 site Stand-aloneOther conditions: Healthy Male VolunteerView official trial listing → -
Completed NCT NCT02234492
The Effects of Statin Therapy on Coronary Flow Reserve and Inflammatory Markers in HIV-Positive Patients
Not yet reported Ottawa Heart Institute Research Corporation 35 participants Est. completion 2018-10 2 sitesCardiovascular disease Other conditions: Human Immunodeficiency Virus (HIV)View official trial listing → -
Completed NCT NCT02234882
Study on Pharmacokinetics
Not yet reported ViiV Healthcare 50 participants Est. completion 2014-10-31 Stand-aloneOther conditions: HIV InfectionsView official trial listing → -
Status unknown NCT NCT02251847
The Efficacy and Safety of a Combination Therapy of Rosuvastatin and Ezetimibe Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients
Not yet reported IlDong Pharmaceutical Co Ltd 400 participants 1 site Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT02262143
Phase III Study of Rosuvastatin and Fenofibrate Versus Rosuvastatin in Mixed Dyslipidemia
Not yet reported IlDong Pharmaceutical Co Ltd 362 participants Est. completion 2017-06 1 site Stand-aloneOther conditions: Mixed DyslipidemiasView official trial listing → -
Completed NCT NCT02280590
Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With Hyperlipidemia
Not yet reported Dong-A ST Co., Ltd. 223 participants 1 site Stand-aloneOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT02283515
Efficacy of Locally Delivred 1.2% Rosuvastatin Gel in Chronic Periodontitis
Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 65 participants Est. completion 2014-06Other conditions: Chronic PeriodontitisView official trial listing → -
Status unknown NCT NCT02284503
Exploring Efficacy of Intensive Rosuvastatin Treatment Peri-PCI in Chinese Patients With Non ST-segment Elevated Acute Coronary Syndrome(NSTE-ACS)
Not yet reported Shanghai Zhongshan Hospital 1350 participants Est. completion 2016-06 1 site Stand-aloneOther conditions: Non-ST-elevation Acute Coronary SyndromesView official trial listing → -
Completed NCT NCT02289430
to Investigate the Pharmacokinetic Interactions and Safety Between Rosuvastatin and Ezetimibe in Healthy Male Volunteers
Not yet reported NVP Healthcare 59 participants Est. completion 2015-02 Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02289963
Evaluation of Alirocumab in Addition to Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia in South Korea and Taiwan
Not yet reported Sanofi 199 participants Est. completion 2016-04 27 sitesOther conditions: HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT02299245
Rosuvastatin Effect on Telomere-telomerase System in ACS
Not yet reported Xiao-dong Zhuang 400 participants Est. completion 2016-11 Stand-aloneOther conditions: Telomere Shortening, Telomere Length, Mean Leukocyte, 22q Telomere Deletion SyndromeView official trial listing → -
Completed NCT NCT02300363
DDI Study With Multiple-dose LX4211 and Single Dose Rosuvastatin
Not yet reported Lexicon Pharmaceuticals 24 participants Est. completion 2014-11 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02305355
Efficacy and Safety of Prescription Omega-3 Fatty Acid Added to Stable Statin Therapy in Patients With Type 2 Diabetes and Hypertriglyceridemia
Not yet reported Kuhnil Pharmaceutical Co., Ltd. 68 participants Est. completion 2011-02 1 site Stand-aloneType 2 diabetes Other conditions: HypertriglycemiaView official trial listing → -
Status unknown NCT NCT02305862
A High-Resolution Magnetic Resonance Imaging Study to Evaluate the Effect of Rosuvastatin on Carotid Atherosclerotic Plaques
Not yet reported Capital Medical University 150 participants Est. completion 2017-07 1 site Stand-aloneOther conditions: Arteriosclerosis, Diabetes Mellitus, Lipid DisorderView official trial listing → -
Status unknown NCT NCT02314286
Rosuvastatin in Order to Induce Preeclampsia Resolution in Severe PET up to 48 Hours Following Delivery
Not yet reported, Not yet reported Soroka University Medical Center 100 participants Est. completion 2016-07 Stand-aloneOther conditions: Severe Pre-eclampsiaView official trial listing → -
Completed NCT NCT02317016
Study to Assess the Effect of AZD9291 on the Blood Levels of Rosuvastatin, in Patients With EGFRm+ Non-small Cell Lung Cancer
Not yet reported AstraZeneca 44 participants Est. completion 2018-05-22 13 sites Stand-aloneOther conditions: Non Small Cell Lung CancerView official trial listing → -
Status unknown NCT NCT02341794
Rosuvastatin Treatment for Intracranial Arterial Stenosis Based on Magnetic Resonance Angiography
Not yet reported Tokyo Medical University 60 participants Est. completion 2018-07 1 site Stand-aloneOther conditions: Intracranial Arterial DiseasesView official trial listing → -
Completed NCT NCT02364258
Pharmacokinetics of Rosuvastatin and Atorvastatin in Pediatric Dyslipidemia Patients
Not yet reported Children's Mercy Hospital Kansas City 28 participants Est. completion 2017-12-27 1 site Stand-aloneOther conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT02369250
Rosuvastatin Gel With 1:1 Mixture of Platelet-rich Fibrin and Bone Graft in Mandibular Degree II Furcation Defects
Not yet reported Government Dental College and Research Institute, Bangalore 110 participants Est. completion 2014-09 Stand-aloneOther conditions: Furcation DefectsView official trial listing → -
Completed NCT NCT02371603
Drug-drug Interaction Study of GSK1278863 With Pioglitazone, Rosuvastatin and Trimethoprim in Healthy Adult Volunteers
Not yet reported GlaxoSmithKline 70 participants Est. completion 2015-08-12 1 site Stand-aloneOther conditions: AnaemiaView official trial listing → -
Completed NCT NCT02378064
Comparison of Fimasartan Versus Amlodipine Therapy on Carotid PlaquE Inflammation
Not yet reported CHEOL WHAN LEE, M.D., Ph.D 50 participants Est. completion 2017-12 1 site Stand-aloneOther conditions: Inflammation Plaque, Atherosclerotic, Coronary Disease, Renin-Angiotensin SystemView official trial listing → -
Completed NCT NCT02387619
The Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/Amlodipine
Not yet reported Jeil Pharmaceutical Co., Ltd. 41 participants Est. completion 2015-07 1 site Stand-aloneOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT02390375
Phase 3 Study to Evaluate the Efficacy and Safety of the DW0929 in Patients With Primary Hypercholesterolemia
Not yet reported Daewon Pharmaceutical Co., Ltd. 348 participants Est. completion 2016-05 1 siteOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT02397538
Study to Evaluate the Pharmacokinetic Interaction and Safety After Multiple Oral Doses of Fimasartan/Amlodipine and Rosuvastatin in Healthy Male Subjects
Not yet reported Boryung Pharmaceutical Co., Ltd 50 participants Est. completion 2015-04 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02401256
CYP2B6 Genetics and Drug Interactions in Healthy Volunteers
Not yet reported Indiana University 70 participants Est. completion 2016-05-31 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT02411903
The Dynamic Effect of Non-cytochrome P450 Isoenzyme 3A4(CYP3A4)-Metabolized and Cytochrome P450 Isoenzyme 3A4(CYP3A4)-Metabolized Statins on Clopidogrel Resistance in Patients With Cerebral Infarction
Not yet reported The Third Affiliated Hospital of Guangzhou Medical University 160 participants Est. completion 2016-08 Stand-aloneOther conditions: Cerebral Infarction, Clopidogrel,Poor Metabolism of (Disorder)View official trial listing → -
Status unknown NCT NCT02418884
The Impact of Rosuvastatin on the Density Score of Coronary Artery Calcification in CAD Patients With Diabetes Mellitus
Not yet reported Sir Run Run Shaw Hospital 122 participants Est. completion 2018-03Cardiovascular diseaseView official trial listing → -
Status unknown NCT NCT02420899
Different Doses of Rosuvastatin Therapy on Regression of Critical Coronary Atherosclerosis in ACS Patients
Not yet reported Beijing Friendship Hospital 100 participants Est. completion 2016-07 1 site Stand-aloneOther conditions: Acute Coronary SyndromeView official trial listing → -
Status unknown NCT NCT02428374
Role of Immune Responses After Acute Myocardial Infarction
Not yet reported Federal University of São Paulo 300 participants Est. completion 2019-07 1 siteOther conditions: Myocardial FibrosisView official trial listing → -
Completed NCT NCT02433288
Rosuvastatin Adherence App Study in China
Not yet reported AstraZeneca 885 participants Est. completion 2016-10-28 25 sitesOther conditions: Dyslipidemia, HyperlipidemiaView official trial listing → -
Completed NCT NCT02434497
A Study to Evaluate the Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial Hypercholesterolemia
Not yet reported AstraZeneca 9 participants Est. completion 2016-11-17 6 sites Stand-aloneOther conditions: Homozygous Familial Hypercholesterolemia (HoFH)View official trial listing → -
Completed NCT NCT02445352
Efficacy/Safety of DP-R207 Tablet Versus CRESTOR Tablet in Patients With Primary Hypercholesterolemia
Not yet reported Alvogen Korea 379 participants Est. completion 2015-03 1 site Stand-aloneOther conditions: Primary HypercholesterolemiaView official trial listing → -
Completed NCT NCT02449187
Investigate the Effect of Food on the Pharmacokinetics of JLP-1310 in Healthy Male Volunteers
Not yet reported Jeil Pharmaceutical Co., Ltd. 16 participants Est. completion 2018-03-09 1 siteOther conditions: Diabetes, HyperlipidemiaView official trial listing → -
Status unknown NCT NCT02458755
Intensive Statin Treatment in Acute Ischemic Stroke Patients With INtracranial Atherosclerosis
Not yet reported Samsung Medical Center 80 participants Est. completion 2018-06 1 site Stand-aloneCardiovascular disease Other conditions: Intracranial AtherosclerosisView official trial listing → -
Completed NCT NCT02476006
Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-modifying Therapies (ODYSSEY APPRISE)
Not yet reported Sanofi 998 participants Est. completion 2019-04-12 153 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT02477514
A Study to Evaluate the Effects of Tedizolid Phosphate on the Pharmacokinetics and Safety of Midazolam and Rosuvastatin (MK-1986-004)
Not yet reported Merck Sharp & Dohme LLC 18 participants Est. completion 2015-08 Stand-aloneOther conditions: Skin Diseases, BacterialView official trial listing → -
Completed NCT NCT02482207
Effect of Rosuvastatin on Coronary Flow Reserve in Hypertensive Patients With Cardiovascular Risk
Not yet reported Asan Medical Center 96 participants Est. completion 2019-11-26 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Withdrawn NCT NCT02483871
Dose Optimization of Rosuvastatin in Early Stage and Metastatic Estrogen Receptor Positive Breast Cancer Patients on Endocrine Therapy
Not yet reported Duke University Est. completion 2017-05-10 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT02484027
Effect of Rosuvastatin on Prognosis of Clinical Response in Acute Ischemic Stroke Patients(REPAIRS)
Not yet reported Second Affiliated Hospital of Soochow University 456 participants Est. completion 2018-09 1 site Stand-aloneOther conditions: Infarction, Anterior Cerebral ArteryView official trial listing → -
Status unknown NCT NCT02502110
Study of Statin for Reduction of Postoperative Paroxysmal Atrial Fibrillation
Not yet reported The Third Xiangya Hospital of Central South University 346 participants Est. completion 2019-06 Stand-aloneOther conditions: Paroxysmal Atrial FibrillationView official trial listing → -
Status unknown NCT NCT02516826
The Effect of Rosuvastatin and Olmesartan on the Progression of Coronary Atherosclerotic Disease
Not yet reported Samsung Medical Center 504 participants Est. completion 2018-08 1 site Stand-aloneOther conditions: Coronary SyndromeView official trial listing → -
Completed NCT NCT02518503
High Potency Statins and the Risk of Diabetes
Canadian Network for Observational Drug Effect Studies, CNODES 136966 participants Est. completion 2013-02Type 2 diabetesCardiovascular diseaseView official trial listing → -
Completed NCT NCT02518516
High Potency Statins and Acute Kidney Injury
Canadian Network for Observational Drug Effect Studies, CNODES 2067639 participants Est. completion 2013-01 1 siteOther conditions: HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT02532309
A Study to Evaluate the Efficacy and Safety of Rosuvastatin in the Treatment of the Carotid Atherosclerotic Plaques
Not yet reported Wei Liu 308 participants 1 site Stand-aloneOther conditions: Carotid AtherosclerosisView official trial listing → -
Completed NCT NCT02542969
Drug Interaction Study of MGL-3196 With Rosuvastatin and Simvastatin
Not yet reported Madrigal Pharmaceuticals, Inc. 25 participants Est. completion 2015-10 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT02546323
A phase3 Study Measuring the Effect of Rosuvastatin 20 mg on Carotid Intima-Media Thickness in Chinese Subjects With Subclinical Atherosclerosis
Not yet reported AstraZeneca 543 participants Est. completion 2019-01-29 24 sites Stand-aloneOther conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT02546648
PeriOperative ISchemic Evaluation-3 Trial: A Pilot Study
Not yet reported McMaster University 100 participants Est. completion 2016-08 2 sites Stand-aloneOther conditions: Atherosclerotic Disease, Perioperative BleedingView official trial listing → -
Completed NCT NCT02549846
AdminiStration of Statin On Acute Ischemic stRoke patienT Trial
Not yet reported Hyogo Medical University 270 participants Est. completion 2017-03 1 siteCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT02551172
Evaluating the Efficacy and Safety of HCP1105 in Combined Hyperlipidemic Patients With High Risk for CHD
Not yet reported Hanmi Pharmaceutical Company Limited 270 participants Est. completion 2016-02 1 site Stand-aloneOther conditions: HyperlipidemiasView official trial listing → -
Withdrawn NCT NCT02561845
Effectiveness of Statins on Lipid Goal Attainment and Lipid Parameters in PCI Patients
AstraZeneca Est. completion 2015-10Other conditions: PCI PatientsView official trial listing → -
Status unknown NCT NCT02561884
A Single-dose, Randomized, Two-period, Two-treatment, Two-sequence, Crossover Bioequivalence Study on a Olostar Tab Versus Two Co-administered Reference Products Olmesartan Medoxomil and Rosuvastatin Calcium in Healthy Volunteers
Not yet reported Daewoong Pharmaceutical Co. LTD. 58 participants Est. completion 2015-10Other conditions: HealthyView official trial listing → -
Completed NCT NCT02569645
Rosuvastatin in the Treatment of Rectal Cancer
Not yet reported AHS Cancer Control Alberta 45 participants Est. completion 2021-09-24 1 site Stand-aloneOther conditions: Rectal CancerView official trial listing → -
Completed NCT NCT02569814
A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin
Not yet reported Boryung Pharmaceutical Co., Ltd 100 participants Est. completion 2015-12 1 siteOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT02574845
DDI (Effect of Metformin and Furosemide on Rosuvastatin PK)
Not yet reported Boehringer Ingelheim 18 participants Est. completion 2015-12-14 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT02579499
Low-Density Lipoprotein Cholesterol-targeting Statin Therapy Versus the Intensity-based Statin Therapy in Patients With Coronary Artery Disease
Not yet reported Yonsei University 4400 participants Est. completion 2022-11 1 site Stand-aloneOther conditions: Coronary Artery DiseasseView official trial listing → -
Completed NCT NCT02586129
Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes
Not yet reported Yuhan Corporation 249 participants Est. completion 2017-07-07 1 siteOther conditions: Dyslipidemia, Type II DiabetesView official trial listing → -
Completed NCT NCT02586155
Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD
Not yet reported Resverlogix Corp 2425 participants Est. completion 2021-06-21 214 sites Stand-aloneType 2 diabetesCardiovascular diseaseView official trial listing → -
Active, not recruiting NCT NCT02592317
A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer
Not yet reported Aragon Pharmaceuticals, Inc. 23 participants Est. completion 2027-12-31 3 sites Stand-aloneOther conditions: Prostatic Neoplasms, Castration-ResistantView official trial listing → -
Status unknown NCT NCT02593487
Effect of Rosuvastatin Therapy on HDL2 Level
Not yet reported Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 300 participants Est. completion 2017-06 1 site Stand-aloneOther conditions: Hyperlipemia, Coronary Heart DiseaseView official trial listing → -
Completed NCT NCT02594800
Intensive Rosuvastatin Therapy on Cerebral Hemodynamics in Patients With Atherosclerotic Intracranial Arterial Stenosis
Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 50 participants Est. completion 2019-06-30 1 site Stand-aloneOther conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT02600520
Comparison of Rosuvastatin With Atorvastatin in Chronic Periodontitis
Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 45 participants Est. completion 2015-05Other conditions: Chronic PeriodontitisView official trial listing → -
Terminated NCT NCT02608242
PK Study of YH22189 FDC Compared to Combination of Telmisartan/Amlodipine and Rosuvastatin
Not yet reported Yuhan Corporation 123 participants Est. completion 2016-06 1 siteOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT02611518
A Pharmacokinetic Interaction Study Between JNJ-54861911 and Transporter Substrates Rosuvastatin and Metformin in Healthy Participants
Not yet reported Janssen Research & Development, LLC 32 participants Est. completion 2016-06-14 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02612714
Statin Lowering Testosterone and Sexual Function
Not yet reported Chang Gung Memorial Hospital 151 participants Est. completion 2014-12 1 siteOther conditions: Sexual DysfunctionView official trial listing → -
Completed NCT NCT02626234
A Drug-drug Interaction (DDI) Study to Assess the Effect of INC280 on the Pharmacokinetics of Digoxin and Rosuvastatin in Patients With cMET-dysregulated Advanced Solid Tumors
Not yet reported Novartis Pharmaceuticals 32 participants Est. completion 2017-04-28 15 sites Stand-aloneOther conditions: cMET-dysregulated Advanced Solid TumorsView official trial listing → -
Status unknown NCT NCT02643784
Exploratory Study on the Effects of Early Rosuvastatin Treatment in Patients With Acute Ischemic Stroke
Not yet reported RenJi Hospital 100 participants Est. completion 2017-07 Stand-aloneOther conditions: IschemicView official trial listing → -
Completed NCT NCT02645227
Platelet-rich Fibrin With 1.2% Rosuvastatin in Chronic Periodontitis Treatment
Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 90 participants Est. completion 2015-10 1 siteOther conditions: Chronic PeriodontitisView official trial listing → -
Withdrawn NCT NCT02662894
Fixed-dose Combination of Valsartan + Rosuvastatin Versus Their Isolated Components for Hypertension and Dyslipidemia.
Not yet reported EMS Est. completion 2020-12 Stand-aloneOther conditions: Hypertension, DyslipidemiaView official trial listing → -
Status unknown NCT NCT02665832
Study of DWJ1351 in Healthy Male Volunteers
Not yet reported Daewoong Pharmaceutical Co. LTD. 58 participants Est. completion 2016-06 Stand-aloneOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT02670070
BE Study of the Combinations of Gemigliptin 50mg and Rosuvastatin 20mg in Comparison to Each Component Administered Alone
Not yet reported LG Life Sciences 37 participants Est. completion 2016-06 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02671097
Drug-drug Interaction Study Using Rosuvastatin as a Breast Cancer Resistant Protein (Efflux Transporter), Organic Anion-transporting Polypeptide (OATP)1B1, and OATP1B3 (Uptake Transporters) Probe Substrate
Not yet reported Bayer 30 participants Est. completion 2016-08 1 site Stand-aloneOther conditions: Healthy Volunteers, Pharmacokinetics, Drug InteractionView official trial listing → -
Completed NCT NCT02675309
A Study to Investigate the Effect of MT-8554 on the Pharmacokinetics of Simvastatin and Rosuvastatin in Healthy Subjects
Not yet reported Tanabe Pharma Corporation 28 participants Est. completion 2016-03 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT02679664
StAtins for Venous Event Reduction in Patients With Venous Thromboembolism Pilot Study
Not yet reported Ottawa Hospital Research Institute 312 participants Est. completion 2020-07 6 sites Stand-aloneOther conditions: Venous ThromboembolismView official trial listing → -
Completed NCT NCT02685462
Pharmacokinetic and Safety Study of Cenicriviroc and HMG-CoA Reductase Inhibitors, Caffeine and Digoxin
Not yet reported Tobira Therapeutics, Inc. 36 participants Est. completion 2016-02-23 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02704702
A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Fimasartan and Rosuvastatin in Healthy Male Subjects
Not yet reported Boryung Pharmaceutical Co., Ltd 36 participants Est. completion 2016-06Other conditions: HypertensionView official trial listing → -
Completed NCT NCT02705547
Rosuvastatin (Crestor) in Friedreich Ataxia
Not yet reported Children's Hospital of Philadelphia 12 participants Est. completion 2017-08-04 1 site Stand-aloneOther conditions: Friedreich AtaxiaView official trial listing → -
Completed NCT NCT02707224
Clinical Trial to Compare the Pharmacokinetics of DP-R208
Not yet reported Alvogen Korea 40 participants Est. completion 2015-06 Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02709187
DP-R208 Pharmacokinetic Study
Not yet reported Alvogen Korea 37 participants Est. completion 2016-05 Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02715726
Evaluation of Alirocumab Versus Ezetimibe on Top of Statin in Asia in High Cardiovascular Risk Patients With Hypercholesterolemia
Not yet reported Sanofi 615 participants Est. completion 2018-08-06 62 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT02730689
A Study to Compare the Pharmacokinetics of DP-R207 in Comparison to Each Component Administered Alone
Not yet reported Alvogen Korea 66 participants Est. completion 2015-01 Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT02737319
A Randomized Trial of Rosuvastatin in Elective Angioplasty to Prevent Contrast-induced Nephropathy (CLEAR-CIN).
Not yet reported University of Sao Paulo 493 participants Est. completion 2013-12 1 site Stand-aloneOther conditions: NephropathyView official trial listing → -
Terminated NCT NCT02740699
CT COMPARE: CT Coronary Angiography to Measure Plaque Reduction
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 79 participants Est. completion 2022-03-11 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT02741245
A Study of the Efficacy and Safety of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-832)
Not yet reported Organon and Co 321 participants Est. completion 2017-01-18 Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT02748057
A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-833)
Not yet reported Organon and Co 135 participants Est. completion 2017-12-11 Stand-aloneOther conditions: Hypercholesterolemia, Familial HypercholesterolemiaView official trial listing → -
Completed NCT NCT02749994
A Clinical Trial to Compare the Efficacy and Safety of a Combination Therapy of Ezetimibe and Rosuvastatin Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients (I-ROSETTE Study)
Not yet reported IlDong Pharmaceutical Co Ltd 396 participants Est. completion 2017-02 1 site Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT02767310
Study to Determine the Bioequivalence of Two Products Containing Rosuvastatin (20 mg/Tablet)
Not yet reported Verisfield UK Ltd. Greek Branch 49 participants Est. completion 2016-06 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02767401
The Success of Opening Single CTO Lesions to Improve Myocardial Viability Study (SOS-comedy)
Not yet reported The First Affiliated Hospital of Dalian Medical University 200 participants Est. completion 2018-12-15Other conditions: Hibernation, Myocardial, Complete Occlusion of Coronary ArteryView official trial listing → -
Completed NCT NCT02770261
Phase III Clinical Trial to Evaluate the Efficacy and Safety of DP-R208 and Each Monotherapy
Not yet reported Alvogen Korea 219 participants Est. completion 2016-10 1 site Stand-aloneOther conditions: Hypertension, CholesterolemiaView official trial listing → -
Completed NCT NCT02772640
Effectiveness of Treatment of Hypercholesterolemia With Rosuvastatin and Ezetimibe
Not yet reported Collegium Medicum w Bydgoszczy 83 participants Est. completion 2020-05 1 siteOther conditions: HypercholesterolemiaView official trial listing → -
Terminated NCT NCT02785874
Statin With Palliative Therapy for HCC
Not yet reported Taipei Medical University WanFang Hospital 4 participants Est. completion 2016-11-01 1 siteOther conditions: HCCView official trial listing → -
Status unknown NCT NCT02789475
DP-R212 Pharmacokinetic Study
Not yet reported Alvogen Korea 38 participants Est. completion 2016-07 1 site Stand-aloneOther conditions: Hypertension, HyperlipidemiasView official trial listing → -
Completed NCT NCT02800902
Locally Delivered Atorvastatin & Rosuvastatin for Treatment of Furcation Defects in Chronic Periodontitis
Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 90 participants Est. completion 2016-02 1 siteOther conditions: Chronic PeriodontitisView official trial listing → -
Status unknown NCT NCT02814500
DP-R212 Pharmacokinetic Study Phase I
Not yet reported Alvogen Korea 36 participants Est. completion 2016-09 Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02827903
Metformin/Rosuvastatin Combination Therapy With in Patients With Type 2 Diabetes and Dyslipidemia
Not yet reported Jeil Pharmaceutical Co., Ltd. 237 participants Est. completion 2018-03-16 33 sites Stand-aloneType 2 diabetes Other conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT02841774
High Intensity Lipid Lowering Following Acute Coronary Syndromes for Persons Living With HIV
Not yet reported Matthew Feinstein 10 participants Est. completion 2021-06 1 site Stand-aloneOther conditions: HIV Infection, Coronary Heart DiseaseView official trial listing → -
Terminated NCT NCT02850081
Statin Neuroprotection and Carotid Endarterectomy: Safety, Feasibility and Outcomes
Not yet reported Columbia University 31 participants Est. completion 2020-03-31 7 sites Stand-aloneCardiovascular disease Other conditions: Carotid Artery StenosisView official trial listing → -
Completed NCT NCT02854527
Transporter Cocktail Mutual Interaction
Not yet reported Boehringer Ingelheim 30 participants Est. completion 2016-11-19 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02859129
Study to Evaluate the 2-Way Interaction Between Multiple Doses of Epanova™ and a Single Dose of Rosuvastatin (Crestor®)
Not yet reported AstraZeneca 114 participants Est. completion 2013-11 1 site Stand-aloneOther conditions: HypertriglyceridemiaView official trial listing → -
Status unknown NCT NCT02859480
Dose-dependent Effect of Rosuvastatin on Long-term Clinical Outcomes After PCI
Not yet reported Korea University Anam Hospital 300 participants Est. completion 2019-12 1 site Stand-aloneCardiovascular disease Other conditions: Coronary DiseaseView official trial listing → -
Terminated NCT NCT02901067
STAT-STatin and Aspirin in Trauma
Not yet reported Denver Health and Hospital Authority 43 participants Est. completion 2021-08-01 1 site Stand-aloneOther conditions: Wounds and Injuries, Venous ThromboembolismView official trial listing → -
Completed NCT NCT02913794
Fimasartan and Rosuvastatin for Hypertension and Dyslipidemia Control
Boryung Pharmaceutical Co., Ltd 541 participants Est. completion 2018-03-29 1 siteCardiovascular disease Other conditions: HyperlipidemiasView official trial listing → -
Completed NCT NCT02933658
Study of Multiple Oral Dosing to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers
Not yet reported Daewon Pharmaceutical Co., Ltd. 71 participants Stand-aloneOther conditions: Hypertension and DyslipidemiaView official trial listing → -
Completed NCT NCT02951962
A Study to Investigate Pharmacokinetic Drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin
Not yet reported Yuhan Corporation 60 participants Est. completion 2016-09 1 siteOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT02962310
Bio Equivalence Study of Torrent Pharmaceutical Ltd's Rosuvastatin Calcium Tablets Under Fasting Condition.
Not yet reported Torrent Pharmaceuticals Limited 48 participants Est. completion 2009-11 Stand-aloneOther conditions: Healthy SubjectsView official trial listing → -
Completed NCT NCT02962323
Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions
Not yet reported Torrent Pharmaceuticals Limited 48 participants Est. completion 2009-12 Stand-aloneOther conditions: Healthy SubjectsView official trial listing → -
Completed NCT NCT02963116
A Study to Estimate the Effect of AZD5718 on the Pharmacokinetics (What Does the Body Does to the Drug) of Rosuvastatin to Measure the Relative Bioavailability (the Extent to Which a Drug or Other Substance Becomes Available to the Body) of AZD5718 Oral Suspension vs AZD5718 Immediate Release Tablet
Not yet reported AstraZeneca 12 participants Est. completion 2017-03-01 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Terminated NCT NCT02968160
A Clinical Trial of YMC017 in Hypertensive and Hypercholesterolemic Patients With Metabolic Syndrome
Not yet reported Yuhan Corporation 55 participants Est. completion 2018-02 1 site Stand-aloneMetabolic syndromeView official trial listing → -
Completed NCT NCT02977065
To Assess the Safety, Efficacy and Tolerability of CKD-519, Administered With HMG-CoA Reductase Inhibitors
Not yet reported Chong Kun Dang Pharmaceutical 62 participants Est. completion 2018-01-30 1 site Stand-aloneOther conditions: DyslipidemiasView official trial listing → -
Status unknown NCT NCT02979704
A Comparative Study of Rosuvastatin and Atorvastatin in Patients With Hyperlipidemia
Not yet reported, Not yet reported Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 90 participants Est. completion 2017-07 1 siteOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT02982798
The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers
Not yet reported Jeil Pharmaceutical Co., Ltd. 40 participants Est. completion 2018-01-31 1 site Stand-aloneOther conditions: Diabetes, HyperlipidemiaView official trial listing → -
Completed NCT NCT02984982
Evaluation of Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients Hospitalized for Acute Coronary Syndrome With Hypercholesterolemia
Not yet reported Sanofi 206 participants Est. completion 2018-07-27 39 sites Stand-aloneOther conditions: Hypercholesterolemia, Acute Coronary SyndromeView official trial listing → -
Completed NCT NCT02985099
1.2% Rosuvastatin Subgingivally Delivered In Chronic Periodontitis With Type 2 Diabetes Mellitus
Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 80 participants Est. completion 2016-07 1 siteType 2 diabetes Other conditions: Chronic PeriodontitisView official trial listing → -
Completed NCT NCT02995720
A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin
Not yet reported Boryung Pharmaceutical Co., Ltd 60 participants Est. completion 2017-05-30 Stand-aloneOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Status unknown NCT NCT03007524
Early Vascular Healing in Acute Coronary Syndrome Patients With Different Doses of Rosuvastatin
Not yet reported Nanjing First Hospital, Nanjing Medical University 80 participants Est. completion 2019-12 1 site Stand-aloneOther conditions: Acute Coronary SyndromeView official trial listing → -
Completed NCT NCT03009474
Pharmacokinetics Study of CJ-30060 After Single Dose Administration in Health Male Volunteers
Not yet reported HK inno.N Corporation 52 participants Est. completion 2015-04 1 site Stand-aloneOther conditions: Hypertension, HyperlipidemiasView official trial listing → -
Completed NCT NCT03009487
A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and Hyperlipidemia
Not yet reported Daewoong Pharmaceutical Co. LTD. 265 participants Est. completion 2018-04 1 site Stand-aloneOther conditions: Hypertension, HyperlipidemiasView official trial listing → -
Completed NCT NCT03010475
A Trial Investigating the Effect of Oral Semaglutide on the Pharmacokinetics of Furosemide and Rosuvastatin in Healthy Subjects
Not yet reported Novo Nordisk A/S 41 participants Est. completion 2017-08-09 1 site Added to GLP-1Other conditions: Diabetes, HealthyView official trial listing → -
Completed NCT NCT03011775
Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease
Not yet reported Ukrainian Medical Stomatological Academy 43 participants Est. completion 2015-09 1 site Stand-aloneOther conditions: Adverse Effect, Atherosclerosis, Coronary, Insulin Resistance SyndromeView official trial listing → -
Completed NCT NCT03019549
A Study of Lanabecestat (LY3314814) in Healthy Participants When Taken With Rosuvastatin
Not yet reported AstraZeneca 42 participants Est. completion 2017-05-22 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT03026933
Evaluate the Efficacy and Safety of KI1107 in Patients Whose TG Level is Not Adequately Controlled With Rosuvastatin Calcium Monotherapy While LDL-C is Properly Controlled
Not yet reported Kuhnil Pharmaceutical Co., Ltd. 215 participants Est. completion 2016-03Other conditions: DyslipidemiasView official trial listing → -
Status unknown NCT NCT03037372
Statin Adjunct Therapy Among ART-treated Adults in Sub-Saharan Africa: Atorvastatin and Rosuvastatin Equivalence Trial
Not yet reported Makerere University 320 participants Est. completion 2022-12-31 Stand-aloneOther conditions: HIV InfectionView official trial listing → -
Completed NCT NCT03043196
1.2% Rosuvastatin Gel As A Local Agent In Smokers With Chronic Periodontitis
Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 60 participants Est. completion 2016-04 1 siteOther conditions: Chronic PeriodontitisView official trial listing → -
Status unknown NCT NCT03044665
RAndomized Comparison of Efficacy and Safety of Lipid-lowerING With Statin Monotherapy Versus Statin/Ezetimibe Combination for High-risk Cardiovascular Diseases (RACING Trial)
Not yet reported Yonsei University 3780 participants Est. completion 2023-02-15 1 site Stand-aloneCardiovascular disease Other conditions: Cerebrovascular Disease, Peripheral Atherosclerotic DiseaseView official trial listing → -
Completed NCT NCT03044873
Effect of BMS-986165 on the Pharmacokinetics of Rosuvastatin
Not yet reported Bristol-Myers Squibb 20 participants Est. completion 2017-03-27 1 site Stand-aloneOther conditions: Autoimmune Diseases, Inflammatory DiseasesView official trial listing → -
Status unknown NCT NCT03061487
Influence of Statins in Artery Aneurysms
University of Catanzaro 20 participants Est. completion 2018-04-27 1 siteOther conditions: Statin, Aneurysm, Extracellular Matrix AlterationView official trial listing → -
Completed NCT NCT03067688
Clinical Trial of Temisartan/Amlodipine & Rosuvastatin in Subjects With Hypertension and Hyperlipidemia
Not yet reported Yuhan Corporation 202 participants Est. completion 2018-03-27 1 site Stand-aloneOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT03074630
Dapagliflozin and Cholesterol Metabolism in Type 2 Diabetes (DM2)
Not yet reported Amsterdam UMC, location VUmc 12 participants Est. completion 2018-04 1 site Stand-aloneType 2 diabetes Other conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT03088254
Study to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine/Rosuvastatin
Not yet reported Jeil Pharmaceutical Co., Ltd. 126 participants Est. completion 2017-12-04 12 sites Stand-aloneOther conditions: Dyslipidemia With HypertensionView official trial listing → -
Terminated NCT NCT03113994
Statin Monotherapy for Treatment of Endocrine Metabolic Disease Risk
Not yet reported Dr. B. Catharine. Craven 8 participants Est. completion 2022-12-31 2 sitesMetabolic syndrome Other conditions: Spinal Cord Injuries, OsteoporosisView official trial listing → -
Completed NCT NCT03116516
Clinical Trial to Compare the Safety and Pharmacokinetics of YHP1604 in Comparison to the Co-administration of Telmisartan/Amlodipine and Rosuvastatin
Not yet reported Yuhan Corporation 62 participants Est. completion 2017-05-26 1 siteOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Active, not recruiting NCT NCT03127631
A Study for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
Not yet reported McMaster University 5000 participants Est. completion 2026-12-31 61 sitesCardiovascular disease Other conditions: Prostate CancerView official trial listing → -
Completed NCT NCT03136237
A Drug-Drug Interaction Study to Evaluate Drug Transporter Interactions
Not yet reported BioCryst Pharmaceuticals 54 participants Est. completion 2017-08-15 1 site Stand-aloneOther conditions: Hereditary AngioedemaView official trial listing → -
Completed NCT NCT03156842
Combination of Fimasartan/Amlodipine/Rosuvastatin in Patients With Essential Hypertension and Dyslipidemia
Not yet reported Boryung Pharmaceutical Co., Ltd 138 participants Est. completion 2018-12-07 1 site Stand-aloneOther conditions: Essential Hypertension, DyslipidemiaView official trial listing → -
Active, not recruiting NCT NCT03169985
Randomized Controlled Trial of Moderate-Intensity Rosuvastatin With Ezetimibe Combination Therapy Versus High-Intensity Rosuvastatin on Progression of Coronary Atherosclerotic Plaque
Not yet reported Samsung Medical Center 280 participants Est. completion 2027-01-28 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT03174041
A Drug-Drug Interaction Study Between GDC-0853 and Midazolam, Itraconazole, Rosuvastatin, and Simvastatin
Not yet reported Genentech, Inc. 63 participants Est. completion 2017-06-23 3 sites Stand-aloneOther conditions: Healthy ParticipantsView official trial listing → -
Completed NCT NCT03175835
Study to Evaluate the Drug Interaction Between CKD-519 and Rosuvastatin in Healthy Male Subjects
Not yet reported Chong Kun Dang Pharmaceutical 30 participants Est. completion 2017-06-19 1 site Stand-aloneOther conditions: DyslipidemiasView official trial listing → -
Completed NCT NCT03187496
Drug-drug Interaction Study Between EDP-305, Midazolam, Caffeine and Rosuvastatin in Healthy Volunteers.
Not yet reported Enanta Pharmaceuticals, Inc 24 participants Est. completion 2017-06-14 1 site Stand-aloneMASHView official trial listing → -
Completed NCT NCT03192579
Effect of Rosuvastatin and Eicosapentaenoic Acid on Neoatherosclerosis: The LINK-IT Trial
Not yet reported Kobe University 50 participants Est. completion 2017-06-02 Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT03204058
Locally Delivered Metformin & Rosuvastatin for Treatment of Intrabony Defects in Chronic Periodontitis
Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 90 participants Est. completion 2017-02-23Other conditions: Chronic PeriodontitisView official trial listing → -
Completed NCT NCT03210532
Evaluate the Efficacy and Safety of Combination Treatment With DW1501-R1+DW1501-R2 Versus DW1501-R1 or DW1501-R2+DW1501-R3 in Patients With Hypertension and Dyslipidemia
Not yet reported Daewon Pharmaceutical Co., Ltd. 129 participants Est. completion 2017-09 1 site Stand-aloneOther conditions: Hypertension, DyslipidemiaView official trial listing → -
Completed NCT NCT03216304
Safinamide Steady State Interaction With Rosuvastatin
Not yet reported Cross Research S.A. 24 participants Est. completion 2017-07-06 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT03217409
A Study to Compare Rosuvastatin/Ezetimibe and Rosuvastatin in Patients With Diabetes Mellitus and Hypercholesterolemia
Not yet reported Yuhan Corporation 85 participants Est. completion 2019-05-23 4 sites Stand-aloneOther conditions: Diabetes Mellitus and HypercholesterolemiaView official trial listing → -
Completed NCT NCT03233243
Rosuvastatin Effect on Atherosclerotic Plaque Metabolism
Not yet reported University of Coimbra 40 participants Est. completion 2022-10-27 1 site Stand-aloneCardiovascular disease Other conditions: Atherosclerosis, Molecular ImagingView official trial listing → -
Completed NCT NCT03245229
A Study in Healthy Male Subjects to Investigate Whether Administration of ACT-132577 Can Affect Rosuvastatin's Fate in the Body (Amount and Time of Presence in the Blood)
Not yet reported Idorsia Pharmaceuticals Ltd. 20 participants Est. completion 2017-09-18 1 site Stand-aloneOther conditions: Healthy SubjectsView official trial listing → -
Completed NCT NCT03247140
The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Male Volunteers Volunteers
Not yet reported Jeil Pharmaceutical Co., Ltd. 40 participants Est. completion 2017-11-27 1 site Stand-aloneOther conditions: Hypertension With DyslipidemiaView official trial listing → -
Completed NCT NCT03255044
Comparison of Lipophilic Versus Hydrophilic Statins on Patients With Heart Failure
Not yet reported Ain Shams University 85 participants Est. completion 2019-04-01 1 siteHeart failureView official trial listing → -
Completed NCT NCT03267329
Duowell® vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With Hypertension
Not yet reported Yuhan Corporation 80 participants Est. completion 2020-09-02 1 site Stand-aloneOther conditions: Hypertension, DyslipidemiaView official trial listing → -
Completed NCT NCT03288038
The Efficacy and Safety of Combination Therapy of Rosuvastatin and Ezetimibe and Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia
Not yet reported Shin Poong Pharmaceutical Co. Ltd. 382 participants Est. completion 2015-11-19 20 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT03307252
This Study Tests the Effect of Certain Medicines on the Transport of Other Medicines in the Body of Healthy Men
Not yet reported Boehringer Ingelheim 45 participants Est. completion 2018-05-02 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT03311841
Pharmacokinetics of Midazolam, Dabigatran, Pitavastatin, Atorvastatin, and Rosuvastatin in Participants With Renal Insufficiency in the Presence and Absence of Rifampin (MK-0000-386)
Not yet reported Merck Sharp & Dohme LLC 32 participants Est. completion 2018-08-02 2 sites Stand-aloneOther conditions: Renal InsufficiencyView official trial listing → -
Completed NCT NCT03329729
PLATOREL® STUDY IN CARDIOVASCULAR RISΚ ASSESMENT
Elpen Pharmaceutical Co. Inc. 4700 participants Est. completion 2019-01-30 1 siteOther conditions: Dyslipidemias, Hyperlipidemias, Risk Factor, Cardiovascular, Quality of LifeView official trial listing → -
Completed NCT NCT03339752
A Study in Healthy Male Subjects to Investigate Whether Administration of ACT-541468 Can Affect the Fate in the Body (Amount and Time of Presence in the Blood) of Rosuvastatin
Not yet reported Idorsia Pharmaceuticals Ltd. 20 participants Est. completion 2017-12-02 1 siteOther conditions: Healthy SubjectsView official trial listing → -
Status unknown NCT NCT03355027
Investigating the Lowest Threshold of Vascular Benefits From LDL Cholesterol Lowering in Patients With Stable CV Disease
Not yet reported Cambridge University Hospitals NHS Foundation Trust 60 participants Est. completion 2023-11-30 1 site Stand-aloneCardiovascular disease Other conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT03359291
Clinical Study to Investigate the Effect of Macitentan on the Concentrations of Rosuvastatin in the Blood of Healthy Male Subjects
Not yet reported Actelion 20 participants Est. completion 2017-12-04 1 site Stand-aloneOther conditions: Healthy SubjectsView official trial listing → -
Completed NCT NCT03363815
A Study to Evaluate the Effect of Multiple Doses of CC-90001 on the Pharmacokinetics of Omeprazole, Midazolam, Warfarin, Rosuvastatin, Metformin, Digoxin, and Nintedanib in Healthy Adult Subjects
Not yet reported Celgene 56 participants Est. completion 2018-07-29 1 site Stand-aloneOther conditions: Heathy VolunteerView official trial listing → -
Status unknown NCT NCT03372785
The Success of Opening Concurrent CTO leSion to Improve Cardiac Function Trial in Patients With Multi-vessel Disease
Beijing Anzhen Hospital 240 participants Est. completion 2022-04 1 siteCardiovascular disease Other conditions: Chronic Total Occlusion of Coronary Artery, Percutaneous Coronary Intervention, Viable MyocardiumView official trial listing → -
Completed NCT NCT03395470
Safety, Tolerability and PK of PXL770 in Healthy Male Subjects
Not yet reported Poxel SA 60 participants Est. completion 2018-03-16 1 site Stand-aloneOther conditions: Metabolic DiseaseView official trial listing → -
Status unknown NCT NCT03403556
High-intensity Rosuvastatin vs. Moderate-intensity Rosuvastatin/Ezetimibe in High Atherosclerotic Cardiovascular Disease Risk Patients With Type 2 Diabetes
Not yet reported Yuhan Corporation 140 participants Est. completion 2021-12 6 sites Stand-aloneCardiovascular diseaseType 2 diabetesView official trial listing → -
Completed NCT NCT03415178
Usability Study of the Commercial Auto-injector Device and the New Auto-injector Device (SYDNEY) in Patients With High or Very High CV Risk With Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy
Not yet reported Sanofi 69 participants Est. completion 2018-08-09 13 sites Stand-aloneOther conditions: HypercholesterolaemiaView official trial listing → -
Active, not recruiting NCT NCT03417388
Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
Not yet reported Cedars-Sinai Medical Center 2476 participants Est. completion 2026-09-14 81 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT03418974
Safety and Efficacy of Statins for Chinese Patients With Dyslipidemia
Not yet reported Fudan University 10000 participants Est. completion 2021-12-31 2 sites Stand-aloneOther conditions: DyslipidemiasView official trial listing → -
Completed NCT NCT03434613
Phase IV Study to Evaluate the Effects of Statin Monotherapy or Statin / Ezetimibe Combination Therapy on Hepatic Steatosis in Patients With Hyperlipidemia and Nonalcoholic Fatty Liver Disease
Not yet reported Yonsei University 64 participants Est. completion 2019-09-11 1 site Stand-aloneMASLD Other conditions: DyslipidemiasView official trial listing → -
Completed NCT NCT03446261
Rosuvastatin/Ezetimibe vs Rosuvastatin in Korean Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia
Not yet reported Yuhan Corporation 140 participants Est. completion 2019-03-05 2 sites Stand-aloneType 2 diabetes Other conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT03474562
High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension
Not yet reported Yuhan Corporation 100 participants Est. completion 2019-06-07 4 sites Stand-aloneCardiovascular diseasePrediabetes Other conditions: HypertensionView official trial listing → -
Completed NCT NCT03494270
High-intensity Rosuvastatin and Moderate-intensity Rosuvastatin/Ezetimibe in ASCVD Patients
Not yet reported Yuhan Corporation 270 participants Est. completion 2019-09-26 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT03510715
An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia
Not yet reported Sanofi 18 participants Est. completion 2020-02-17 10 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT03510884
An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia
Not yet reported Sanofi 153 participants Est. completion 2022-08-05 43 sites Stand-aloneOther conditions: HypercholesterolaemiaView official trial listing → -
Completed NCT NCT03515772
Drug-drug Interactions Between Antiretroviral Drugs and Cardiovascular Drugs in Elderly Patients
Centre Hospitalier Universitaire Vaudois 21 participants Est. completion 2019-08-29 2 sitesCardiovascular disease Other conditions: HIV Infections, Drug InteractionsView official trial listing → -
Completed NCT NCT03516955
Efficacy and Safety of a Generic Rosuvastatin in a Real-world Setting
Hikma Pharmaceuticals LLC 317 participants Est. completion 2015-08Other conditions: Primary HypercholesterolemiaView official trial listing → -
Completed NCT NCT03521700
Compare Effects of Intensive Versus Conventional Lipid-lowering Therapy in Patients With Severe Atherosclerotic Renal Artery Stenosis Undergoing Stent Placement
Not yet reported, Not yet reported Chinese Academy of Medical Sciences, Fuwai Hospital 150 participants Est. completion 2015-12-30 1 site Stand-aloneOther conditions: Renal Artery Obstruction, Stents, Lipids, Glomerular Filtration Rate, Blood PressureView official trial listing → -
Withdrawn NCT NCT03526367
A Randomized Trial of Rosuvastatin Loading Combined With Early hydrAtion Versus Standard-of-care Medications for the Prevention of CIAKI in Patient With AMI Undergoing Emergency PCI
Not yet reported Shenyang Northern Hospital Est. completion 2019-12-31 1 site Stand-aloneCardiovascular disease Other conditions: Contrast-induced Acute Kidney Injury, Primary PCI, Rosuvastatin, HydrationView official trial listing → -
Completed NCT NCT03527069
Efficacy and Safety of Cipros 10 Association on the Isolated Hypertriglyceridemia and Dyslipidemia Treatment
Not yet reported EMS 146 participants Est. completion 2025-07-25 1 siteOther conditions: Hypertriglyceridemia, DyslipidemiaView official trial listing → -
Status unknown NCT NCT03529253
Effect of Alirocumab(Proprotein Convertase Subtilisin/Kexin type9 Inhibitor) and Rosuvastatin or Rosuvastatin Alone on Lipid Core Plaques in Coronary Artery Disease Evaluated by Near-infrared Spectroscopy Intravascular Ultrasound
Not yet reported Kobe University 30 participants Est. completion 2020-09-30 1 site Stand-aloneCardiovascular disease Other conditions: Angina PectorisView official trial listing → -
Completed NCT NCT03532139
Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study)
Not yet reported Beth Israel Deaconess Medical Center 24 participants Est. completion 2024-05-31 2 sites Stand-aloneOther conditions: Ovarian CancerView official trial listing → -
Completed NCT NCT03532854
Evaluating a Pharmacokinetic Drug Interaction Between LGEV1801 and LGEV1802
Not yet reported LG Chem 42 participants Est. completion 2019-01-30 1 site Stand-aloneOther conditions: Healthy Male VolunteersView official trial listing → -
Status unknown NCT NCT03533959
To Evaluate the Efficacy of Alirocumab for Neoatherosclerosis by Using OCT, in Comparison With Standard Statin Therapy
Kobe University 31 participants Est. completion 2025-12 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT03536598
Study to Evaluate the Safety and Efficacy of CJ-30060 in Hypertensive Patients With Hyperlipidemia
Not yet reported HK inno.N Corporation 203 participants Est. completion 2017-09-04 Stand-aloneOther conditions: Hypertension With HyperlipidemiaView official trial listing → -
Completed NCT NCT03540355
Efficacy and Safety of Cipros 20 Association on Dyslipidemia Treatment
Not yet reported EMS 406 participants Est. completion 2025-01-23 1 siteOther conditions: DyslipidemiasView official trial listing → -
Status unknown NCT NCT03550859
HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria
Not yet reported Yuhan Corporation 374 participants Est. completion 2021-12 16 sites Stand-aloneChronic kidney disease Other conditions: ProteinuriaView official trial listing → -
Status unknown NCT NCT03552432
The Efficacy of Alirocumab for Thin-cap fIbroatheroma in Patients With Coronary Artery Disease Estimated by Optical Coherence Tomography
Not yet reported Kobe University 24 participants Est. completion 2021-09-30 1 site Stand-aloneCardiovascular disease Other conditions: Thin-cap fIbroatheromaView official trial listing → -
Completed NCT NCT03561298
A Pharmacokinetic Study to Assess Drug-drug Interaction Between Zanubrutinib and a Cocktail of Substrates in Healthy Subjects
Not yet reported BeiGene 18 participants Est. completion 2018-07-02 1 site Stand-aloneOther conditions: Healthy SubjectsView official trial listing → -
Completed NCT NCT03566316
Efficacy/Safety of Telmisartan/Amlodipine/Rosuvastatin in Hypertensive Patients With Hyperlipidemia
Not yet reported IlDong Pharmaceutical Co Ltd 134 participants Est. completion 2017-06-16 1 site Stand-aloneOther conditions: Hypertension With HyperlipidemiaView official trial listing → -
Completed NCT NCT03571087
Efficacy and Safety of Combination of Rosuvastatin and Ezetimibe in Patients With Primary Hypercholesterolemia
Not yet reported Hanlim Pharm. Co., Ltd. 374 participants Est. completion 2015-09 Stand-aloneOther conditions: Primary HypercholesterolemiaView official trial listing → -
Completed NCT NCT03597412
Rosuvastatin/Ezetimibe Versus Rosuvastatin in ASCVD Patients With Type 2 DM
Not yet reported Yuhan Corporation 236 participants Est. completion 2020-08-12 1 site Stand-aloneCardiovascular diseaseType 2 diabetesView official trial listing → -
Status unknown NCT NCT03610321
Lipid-lowering Effects of Gefarnate in Statin-treated Coronary Heart Disease Patients With Residual Hypertriglyceridemia
Not yet reported, Not yet reported First Affiliated Hospital of Harbin Medical University 70 participants Est. completion 2021-12-31 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT03639493
Bioequivalence Study of CJ-30060 in Healthy Male Volunteers
Not yet reported HK inno.N Corporation 52 participants Est. completion 2018-05-17 1 site Stand-aloneOther conditions: Healthy Male SubjectsView official trial listing → -
Status unknown NCT NCT03657758
Lesional Evaluation of High Risk Patients With Neoatherosclerosis Treated With Rosuvastatin and Eicosapentaenoic Acid Using Optical Coherence Tomography(OCT)[LINK IT TWO]
Not yet reported Kobe University 75 participants Est. completion 2021-08-31 1 siteCardiovascular disease Other conditions: Angina PectorisView official trial listing → -
Completed NCT NCT03677297
"Efficacy Of 1.2% Rosuvastatin Gel In The Management Of Infrabony Defects"
Not yet reported Dr. D. Y. Patil Dental College & Hospital 10 participants Est. completion 2017-11-10 1 site Stand-aloneOther conditions: Adult PeriodontitisView official trial listing → -
Completed NCT NCT03690778
The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers.
Not yet reported Jeil Pharmaceutical Co., Ltd. 42 participants Est. completion 2019-02-01 1 site Stand-aloneOther conditions: Diabetes, HyperlipidemiasView official trial listing → -
Completed NCT NCT03699774
Effect of Repeated Doses of DS-8500a on Pharmacokinetics of Rosuvastatin in Healthy Volunteers
Not yet reported Daiichi Sankyo 24 participants Est. completion 2015-07-06 1 site Stand-aloneOther conditions: Drug Pharmacokinetics in Healthy VolunteersView official trial listing → -
Completed NCT NCT03707899
The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Adult Volunteers Volunteers
Not yet reported Jeil Pharmaceutical Co., Ltd. 49 participants Est. completion 2019-05-22 1 site Stand-aloneOther conditions: Hypertension With DyslipidemiaView official trial listing → -
Completed NCT NCT03715101
A Clinical Study to Evaluate PK, PD, and PG of Rosuvastatin in the Elderly
Not yet reported Seoul National University Hospital 20 participants Est. completion 2016-04 Stand-aloneOther conditions: ElderlyView official trial listing → -
Status unknown NCT NCT03719820
Stroke Imaging Package Study of Intracranial Atherosclerosis ( SIPS-ICAS )
Wei-Hai Xu 550 participants Est. completion 2021-06-30 38 sitesCardiovascular disease Other conditions: Intracranial Atherosclerosis ICASView official trial listing → -
Status unknown NCT NCT03720067
Propranolol, Carvedilol and Rosuvastatin in the Prevention of Variceal Bleeding in Cirrhotic Portal Hypertension
Not yet reported, Not yet reported Universidade Federal do Rio de Janeiro 80 participants Est. completion 2022-12-20 1 siteOther conditions: Cirrhosis, Portal Hypertension, Variceal HemorrhageView official trial listing → -
Completed NCT NCT03720366
A Study of Perpetrator Drug Interactions of Enasidenib in AML Patients
Not yet reported Celgene 40 participants Est. completion 2023-12-22 10 sites Stand-aloneOther conditions: Leukemia, Myeloid, AcuteView official trial listing → -
Status unknown NCT NCT03742544
Post Marketing Surveillance of Telostop TAB (Telmisartan/Rosuvastatin) for Evaluating the Safety and Efficacy
IlDong Pharmaceutical Co Ltd 600 participants Est. completion 2020-10-30Other conditions: Hypertension, DyslipidemiasView official trial listing → -
Completed NCT NCT03753477
Clinical Trial to Investigate the Efficacy and Safety of DWJ1351
Not yet reported Daewoong Pharmaceutical Co. LTD. 64 participants Est. completion 2018-02-01 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT03757390
Bioequivalence Study of CJ-30060 in Healthy Volunteers
Not yet reported HK inno.N Corporation 52 participants Est. completion 2018-12-14 1 site Stand-aloneOther conditions: Healthy SubjectsView official trial listing → -
Completed NCT NCT03772262
Assessing Goldenseal-drug Interactions Using a Probe Drug Cocktail Approach
Not yet reported Washington State University 16 participants Est. completion 2019-03-31 1 site Stand-aloneOther conditions: Interaction Drug FoodView official trial listing → -
Completed NCT NCT03784703
Type 2 Diabetic Patients Maintained on Statin Therapy
Not yet reported Damanhour University 160 participants Est. completion 2020-01-31 1 site Stand-aloneOther conditions: Dyslipidemia Associated With Type II Diabetes MellitusView official trial listing → -
Completed NCT NCT03801733
Drug-Drug Interaction Study of Vadadustat With Rosuvastatin, Sulfasalazine, Pravastatin, Atorvastatin and Simvastatin
Not yet reported Akebia Therapeutics 134 participants Est. completion 2018-11-24 1 site Stand-aloneOther conditions: Drug Interaction PotentiationView official trial listing → -
Completed NCT NCT03806101
Study of PF-04965842 Effect on Rosuvastatin Pharmacokinetics in Healthy Participants
Not yet reported Pfizer 12 participants Est. completion 2019-04-11 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT03847506
Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets
Not yet reported HK inno.N Corporation 127 participants Est. completion 2020-12-02 1 site Stand-aloneOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT03860220
The Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin
Not yet reported Hyo-Soo Kim 252 participants Est. completion 2023-09-07 9 sitesOther conditions: Hypertension, DyslipidemiasView official trial listing → -
Completed NCT NCT03864042
Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors
Not yet reported Pfizer 56 participants Est. completion 2023-05-29 29 sites Stand-aloneOther conditions: Advanced Solid Tumors, Metastatic MelanomaView official trial listing → -
Status unknown NCT NCT03867942
BE Study of Bilayer Combination of Gemigliptin/Rosuvastatin 50/20mg in Comparison to Monolayer Combination.
Not yet reported LG Chem 48 participants Est. completion 2019-08-31 Stand-aloneType 2 diabetes Other conditions: DyslipidemiasView official trial listing → -
Completed NCT NCT03872232
Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan
Not yet reported Addpharma Inc. 180 participants Est. completion 2020-08-12 1 site Stand-aloneOther conditions: Hypercholesterolemia, HypertensionView official trial listing → -
Status unknown NCT NCT03874260
Cinical Trial to Explore the Efficacy of Statin/Choline Fenofibrate Combination Therapy vs Statin Monotherapy in Patients With Inadequately Controlled TG Despite Receiving Statin Monotherapy
Not yet reported Daewon Pharmaceutical Co., Ltd. 180 participants Est. completion 2020-03-31 1 site Stand-aloneOther conditions: DyslipidemiasView official trial listing → -
Status unknown NCT NCT03889314
The DEtermining Statin Intolerance FOr Rosuvastatin (DESIFOR) Trial
Not yet reported Minneapolis Heart Institute Foundation 25 participants Est. completion 2022-12-31 1 site Stand-aloneCardiovascular disease Other conditions: Cardiovascular Risk Factor, Adverse EffectView official trial listing → -
Completed NCT NCT03903029
Efficacy of Low-dose (10 mg) Rosuvastatin in Korean 4 Statin Benefit Groups Per 2013 ACC/AHA Guideline
Seoul National University Hospital 242 participants Est. completion 2019-12-05Other conditions: DyslipidemiasView official trial listing → -
Completed NCT NCT03907423
Rosuvastatin on Diabetic Patients Treated With Glimepiride/Metformin
Not yet reported Rehab Werida 70 participants Est. completion 2021-01-31 1 site Stand-aloneType 2 diabetesView official trial listing → -
Status unknown NCT NCT03947866
Ezetimibe-Rosuvastatin Evaluation Study
Elpen Pharmaceutical Co. Inc. 600 participants Est. completion 2023-09-30 1 siteOther conditions: Hypercholesterolemia, Hyperlipidemias, Combinations of Drugs; DependenceView official trial listing → -
Completed NCT NCT03949374
Clinical Trial to Evaluate Efficacy and Safety of ROVASRO 10mg Versus CRESTOR 10mg in Hypercholesterolemic Patients
Not yet reported Yonsei University 126 participants Est. completion 2018-06-01 1 siteOther conditions: Hypercholesterolemia, DyslipidemiasView official trial listing → -
Completed NCT NCT03951207
Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia
Not yet reported Yuhan Corporation 259 participants Est. completion 2021-09-29 1 site Stand-aloneOther conditions: Dyslipidemias, HypertensionView official trial listing → -
Completed NCT NCT03954366
Drug-Drug Interaction Study of Rucaparib, Rosuvastatin and Oral Contraceptives
Not yet reported pharmaand GmbH 36 participants Est. completion 2021-06-09 7 sitesOther conditions: NeoplasmsView official trial listing → -
Completed NCT NCT03970798
A Drug Interaction Study of KW-6356 With Midazolam, Caffeine, or Rosuvastatin
Not yet reported Kyowa Kirin Co., Ltd. 50 participants Est. completion 2019-07-31 1 site Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT03988101
Role of Statin in Venous Dysfunction in Patients With Venous Thromboembolism Event
Not yet reported Yonsei University 100 participants Est. completion 2025-05-30 1 site Stand-aloneOther conditions: Venous Thromboembolism, DyslipidemiasView official trial listing → -
Completed NCT NCT03993236
Study on Rosuvastatin+Ezetimibe and Rosuvastatin for LDL-C Goal in Patients With Recent Ischemic Stroke
Not yet reported Keun-Sik Hong 584 participants Est. completion 2021-09-27 12 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT04008186
A Clinical Drug-Drug Interaction (DDI) Study With Omaveloxolone
Not yet reported Biogen 61 participants Est. completion 2019-08-28 1 site Stand-aloneOther conditions: Healthy Adult SubjectsView official trial listing → -
Completed NCT NCT04056169
Comparison of High-dose Rosuvastatin Versus Low-dose Rosuvastatin Plus Ezetimibe on Carotid Plaque Inflammation in Patients With Acute Coronary Syndrome
Not yet reported Yuhan Corporation 50 participants Est. completion 2019-07-23 2 sites Stand-aloneOther conditions: Acute Coronary Syndrome, Carotid Atherosclerotic Plaque With InflammationView official trial listing → -
Completed NCT NCT04061824
Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia
Not yet reported Yonsei University 150 participants Est. completion 2018-12-20 1 site Stand-aloneOther conditions: Hypertension, DyslipidemiasView official trial listing → -
Completed NCT NCT04074551
A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia
Not yet reported Hanmi Pharmaceutical Company Limited 145 participants Est. completion 2020-03-17 1 siteOther conditions: Hypertension, DyslipidemiasView official trial listing → -
Completed NCT NCT04080310
Efficacy and Safety of Combination Therapy of Moderate-intensity Statin and Ezetimibe Compared to High-intensity Statin
Not yet reported Seoul National University Bundang Hospital 270 participants Est. completion 2019-09-17 2 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT04081844
A Study to Evaluate the Pharmacokinetic and Pharmacodynamic Interactions Between HGP0904, HGP0608, and HCP1306 in Healthy Male Subjects.
Not yet reported Hanmi Pharmaceutical Company Limited 31 participants Est. completion 2018-06-28 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT04092595
A Study of PF-06651600 Effect on Rosuvastatin Pharmacokinetics in Healthy Participants
Not yet reported Pfizer 12 participants Est. completion 2020-01-15 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT04094519
A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects With Prostate Cancer
Not yet reported Astellas Pharma Global Development, Inc. 24 participants Est. completion 2020-12-27 1 site Stand-aloneOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT04098003
Investigation of the Gut Microbiome and Statin Response
Not yet reported Sony Tuteja 45 participants Est. completion 2026-03-01 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT04099732
A Study in Healthy Men to Test the Influence of BI 1358894 on the Amount of the Medicines Rosuvastatin and Dabigatran in the Blood
Not yet reported Boehringer Ingelheim 26 participants Est. completion 2019-12-10 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT04124003
A Study to Assess the Drug-drug Interaction of BMS-963272 and Rosuvastatin
Not yet reported Bristol-Myers Squibb 28 participants Est. completion 2020-01-03 1 site Stand-aloneOther conditions: Healthy ParticipantsView official trial listing → -
Completed NCT NCT04158076
Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan/Amlodipine
Not yet reported Addpharma Inc. 131 participants Est. completion 2021-01-14 1 site Stand-aloneOther conditions: Hypercholesterolemia, HypertensionView official trial listing → -
Status unknown NCT NCT04161001
Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451
Not yet reported Daewoong Pharmaceutical Co. LTD. 237 participants Est. completion 2022-02-02 1 site Stand-aloneOther conditions: Hypertension, DyslipidemiaView official trial listing → -
Status unknown NCT NCT04174456
Combination of Olmesartan Effect on Myocardial Viability of Patients With Dilated Cardiomyopathy
Not yet reported Dong-A University 40 participants Est. completion 2021-12-31 1 site Stand-aloneOther conditions: Dilated CardiomyopathyView official trial listing → -
Withdrawn NCT NCT04176978
PsA T2T Statin Trial on Carotid and Coronary Atherosclerosis
Not yet reported Chinese University of Hong Kong Est. completion 2022-12-31 1 site Stand-aloneOther conditions: Psoriatic Arthritis, AtherosclerosisView official trial listing → -
Status unknown NCT NCT04185090
To Evaluate the Pharmacokinetic/Pharmacodynamic Interactions and Safety Between ID1801 and ID1803 in Healthy Male Adults
Not yet reported IlDong Pharmaceutical Co Ltd 30 participants Est. completion 2020-04 Stand-aloneOther conditions: Hypertension, DyslipidemiasView official trial listing → -
Completed NCT NCT04211272
A 2-part Study to Investigate the Effect of Macitentan in Healthy Male Participants
Not yet reported Actelion 47 participants Est. completion 2021-04-19 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT04231435
Influence of Fedratinib on the Pharmacokinetics of the Transporter Probe Substrates Digoxin, Rosuvastatin, and Metformin
Not yet reported Celgene 24 participants Est. completion 2020-02-21 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT04233437
Drug-Drug Interaction Study of MLC1501 Using Cocktail of Drugs Acting as Sensitive Clinical Probes/Substrates of Cytochrome P450 Isoenzymes and Transporters in Healthy Subjects
Not yet reported Moleac Pte Ltd. 27 participants Est. completion 2020-05-16 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT04252300
Study to Learn the Effect of Drug BAY1817080 on the Way the Body Absorbs, Distributes and Excretes Another Drug Rosuvastatin in Healthy Adult Participants
Not yet reported Bayer 14 participants Est. completion 2020-12-07 1 site Stand-aloneOther conditions: Drug InteractionsView official trial listing → -
Completed NCT NCT04253353
A Drug-Drug Interaction Study To Estimate The Effect Of Tafamidis On Rosuvastatin Pharmacokinetics
Not yet reported Pfizer 12 participants Est. completion 2020-08-10 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT04257032
A Study in Healthy Men to Test the Influence of BI 1323495 on the Amount of the Medicines Rosuvastatin and Dabigatran in the Blood
Not yet reported Boehringer Ingelheim 28 participants Est. completion 2020-09-23 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT04268394
A Study to Evaluate Potential Cytochrome P450 and Transporter Protein Interactions With CC-99677
Not yet reported Celgene 48 participants Est. completion 2021-06-02 1 site Stand-aloneOther conditions: Healthy VolunteerView official trial listing → -
Status unknown NCT NCT04303806
Effect of Rosuvastatin on the Clinical Features of Preeclampsia
Not yet reported Assiut University 80 participants Est. completion 2023-12 Stand-aloneOther conditions: PreeclampsiaView official trial listing → -
Completed NCT NCT04322266
A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination and Co-Administration of HGP0904, HGP0608 and HCP1306 Tablets in Healthy Male Subjects.
Not yet reported Hanmi Pharmaceutical Company Limited 61 participants Est. completion 2019-02-13 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT04328064
The Role of Rosuvastatin on Vascular Involvement in Behçet's Disease
Not yet reported University of Alexandria 56 participants Est. completion 2011-06Other conditions: Behcet's DiseaseView official trial listing → -
Completed NCT NCT04359095
Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia
Not yet reported, Not yet reported Universidad Nacional de Colombia 650 participants Est. completion 2021-06-30 6 sitesOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT04398771
To Evaluate Safety and Effectiveness of RovatitanTab.
LG Chem 1000 participants Est. completion 2022-05-31Other conditions: Hypertension, HyperlipidemiasView official trial listing → -
Withdrawn NCT NCT04417114
SystemIc iNflammation and Microvascular diSease PreventIon in psoRiatic diseasE
Not yet reported Brigham and Women's Hospital Est. completion 2025-03-31 Stand-aloneOther conditions: Psoriasis, Psoriatic Arthritis, Cardiovascular Risk FactorView official trial listing → -
Completed NCT NCT04428086
A Pharmacokinetic Interaction Study Between Apatinib and Rosuvastatin or Metformin in Solid Tumor Subjects.
Not yet reported Jiangsu HengRui Medicine Co., Ltd. 19 participants Est. completion 2021-08-22 1 site Stand-aloneOther conditions: Solid Tumor, AdultView official trial listing → -
Status unknown NCT NCT04433533
Compare the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy Versus Rosuvastatin Monotherapy in Korean Patients With Left Ventricular Diastolic Dysfunction and Hyperlipidemia
Not yet reported Yonsei University 200 participants Est. completion 2023-12 1 siteOther conditions: Left Ventricular Diastolic Dysfunction, HyperlipidemiasView official trial listing → -
Status unknown NCT NCT04434365
Effect of Berberine for Endothelial Function and Intestinal Microflora in Patients With Coronary Artery Disease
Not yet reported, Not yet reported Peking Union Medical College Hospital 24 participants Est. completion 2020-12-30 1 siteCardiovascular disease Other conditions: Percutaneous Coronary InterventionView official trial listing → -
Status unknown NCT NCT04455581
A Study to Determine the Safety, Tolerability, and Efficacy of SHR-1209 in Patients With Familial Hypercholesterolemia
Not yet reported Jiangsu HengRui Medicine Co., Ltd. 8 participants Est. completion 2021-08-31 Stand-aloneOther conditions: Familial HypercholesterolemiaView official trial listing → -
Completed NCT NCT04472611
Colchicine/Statins for the Prevention of COVID-19 Complications (COLSTAT) Trial
Not yet reported Yale University 250 participants Est. completion 2022-03-30 4 sites Stand-aloneOther conditions: SARS-CoV-2View official trial listing → -
Completed NCT NCT04481789
Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Males (Drug Interaction Study and Preliminary Regimen-Finding Study)
Not yet reported Shionogi 84 participants Est. completion 2019-01-08 1 site Stand-aloneOther conditions: Healthy Adult SubjectsView official trial listing → -
Completed NCT NCT04491643
Megestrol Acetate Plus Rosuvastatin in Young Women With Early Endometrial Carcinoma
Not yet reported Fudan University 48 participants Est. completion 2025-04-11 1 site Stand-aloneOther conditions: Endometrial Carcinoma Stage IView official trial listing → -
Completed NCT NCT04491682
Megestrol Acetate Plus Rosuvastatin in Young Women With Atypical Endometrial Hyperplasia
Not yet reported, Not yet reported Fudan University 36 participants Est. completion 2022-06-20 1 site Stand-aloneOther conditions: Atypical Endometrial HyperplasiaView official trial listing → -
Completed NCT NCT04498741
Drug-Drug Interaction Study Between EDP-938, Tacrolimus, Dabigatran, Rosuvastatin and Midazolam in Healthy Subjects
Not yet reported Enanta Pharmaceuticals, Inc 89 participants Est. completion 2021-06-01 1 site Stand-aloneOther conditions: RSV InfectionView official trial listing → -
Status unknown NCT NCT04504851
Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct
Not yet reported National University Hospital, Singapore 154 participants Est. completion 2021-03-31 6 sites Stand-aloneOther conditions: Pulmonary TuberculosisView official trial listing → -
Completed NCT NCT04515628
Study to Assess the Effect of Branebrutinib on the Drug Levels of Rosuvastatin in Healthy Participants
Not yet reported Bristol-Myers Squibb 22 participants Est. completion 2020-10-26 1 site Stand-aloneOther conditions: Healthy ParticipantsView official trial listing → -
Completed NCT NCT04542382
Identification and Validation of Biomarkers for Breast Cancer Resistance Protein (BCRP)
Not yet reported University of California, San Francisco 11 participants Est. completion 2023-08-11 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Status unknown NCT NCT04581759
Endovascular Treatment and RIPC in Acute Ischemic Stroke
Not yet reported First Affiliated Hospital Xi'an Jiaotong University 300 participants Est. completion 2023-10-30 1 siteCardiovascular disease Other conditions: Endovascular TreatmentView official trial listing → -
Completed NCT NCT04590937
A Study in Healthy People to Test Whether BI 730357 Affects How 4 Other Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Taken up in the Body
Not yet reported Boehringer Ingelheim 15 participants Est. completion 2021-01-11 1 siteOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT04603508
Efficacy and Safety of Berlim 25/10 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia
Not yet reported EMS 240 participants Est. completion 2025-08 Stand-aloneType 2 diabetes Other conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT04608344
Study to Evaluate Organic Anion Transporting Polypeptide (OATP) Transporter-Mediated Drug-Drug Interactions Between Filgotinib and Statins as Probe Drugs in Healthy Participants
Not yet reported Gilead Sciences 27 participants Est. completion 2021-01-13 1 site Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT04621227
Study To Evaluate The Effect Of Two Steady State Doses of PF 06882961 On Rosuvastatin And Midazolam Pharmacokinetics In Otherwise Healthy Adult Participants With Obesity
Not yet reported Pfizer 16 participants Est. completion 2021-05-13 1 siteOther conditions: ObesityView official trial listing → -
Completed NCT NCT04621669
Drug-durg Interaction of SHR3680 With Digoxin, Rosuvastatin Calcium and Metformin Hydrochloride
Not yet reported Jiangsu HengRui Medicine Co., Ltd. 36 participants Est. completion 2021-09-08 1 site Stand-aloneOther conditions: Drug-drug Interaction,SHR3680View official trial listing → -
Completed NCT NCT04626973
Effects of Ezetimibe Combination Therapy for Patients With Atherosclerotic Cardiovascular Disease; Randomized Comparison of LDL-cholesterol Targeting <70 Versus <55mg/dL; Ez-PAVE Trial
Not yet reported Yonsei University 3048 participants Est. completion 2025-09-24 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Active, not recruiting NCT NCT04656028
Genetic Testing and Motivational Counseling for FH
Not yet reported National Medical Research Center for Therapy and Preventive Medicine 180 participants Est. completion 2025-03-30 1 site Stand-aloneOther conditions: Hypercholesterolemia, Familial, Hypercholesterolemia, Familial, 1, Hypercholesterolemia, Familial, 2, Hypercholesterolemia, Familial, 3, Hypercholesterolemia, Familial, 4, Hypercholesterolemia, Familial, 4, Autosomal Recessive, Familial Hypercholesterolemia With Hyperlipemia, Hypercholesterolemia, Autosomal Dominant, Type B, Hypercholesterolemia, Autosomal Dominant, Hypercholesterolemia, Autosomal Dominant, 3, Apolipoprotein B-100, Familial Defective, Genetic Testing, Motivational Interviewing, Therapeutic Adherence, Therapeutic Adherence and Compliance, Treatment Adherence, Medication Adherence, Treatment Adherence and Compliance, Patient Adherence, Compliance, Patient Compliance, Familial Hypercholesterolemia, Familial Hypercholesterolemia - Heterozygous, Adherence, Patient, Adherence, Medication, AdherenceView official trial listing → -
Status unknown NCT NCT04659070
To Evaluate the Efficacy and Safety of Co-administrated Ezetimibe/Rosuvastatin and Telmisartan in Patients With Essential Hypertension and Primary Hypercholesterolemia
Not yet reported Hanlim Pharm. Co., Ltd. 156 participants Est. completion 2022-05-19 1 site Stand-aloneOther conditions: Primary Hypercholesterolemia, HypertensionView official trial listing → -
Completed NCT NCT04669041
A Study to Evaluate the Efficacy and the Safety of Single Pill Combination (SPC) Ezetimibe/Rosuvastatin in Chinese Adult Patients With Primary Hypercholesterolemia Not Adequately Controlled on Statin Therapy
Not yet reported Sanofi 305 participants Est. completion 2022-06-15 40 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT04700436
Efficacy and Safety of EzetimiBe/Rosuvastatin in Diabetic Dislipidemia With Hypertriglyceridaemia
Not yet reported Seoul National University Hospital 146 participants Est. completion 2024-02-13 26 sites Stand-aloneType 2 diabetes Other conditions: Endocrine System Diseases, Nutritional and Metabolic Diseases, DyslipidemiasView official trial listing → -
Status unknown NCT NCT04737408
Influence of Intensive Lipid-lowering on FFRCT (The FLOW-PROMOTE Study)
Not yet reported Bjarne Linde Noergaard 120 participants Est. completion 2023-08 3 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT04744571
Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Total Occlusions
Not yet reported Beijing Anzhen Hospital 200 participants Est. completion 2023-01 1 site Stand-aloneCardiovascular disease Other conditions: Coronary Occlusion, Percutaneous Coronary Intervention, Chronic Total Occlusion of Coronary Artery, Drug-Eluting StentsView official trial listing → -
Completed NCT NCT04749914
A Study of Lasmiditan in Healthy Volunteers
Not yet reported Eli Lilly and Company 97 participants Est. completion 2021-07-06 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Terminated NCT NCT04764851
Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates
Not yet reported Emalex Biosciences Inc. 30 participants Est. completion 2021-05-07 1 siteOther conditions: Drug-InteractionsView official trial listing → -
Completed NCT NCT04776889
The Prognosis of Lipid Reprogramming With Rosuvastatin, in Castrated Egyptian Prostate Cancer Patients
Not yet reported National Cancer Institute, Egypt 70 participants Est. completion 2020-12-30 1 site Stand-aloneOther conditions: Prostate Cancer MetastaticView official trial listing → -
Status unknown NCT NCT04817904
Evaluation of the Effect of Rosuvastatin on Cisplatin-induced Nephrotoxicity and Ototoxicity
Not yet reported Cairo University 65 participants Est. completion 2021-08 1 site Stand-aloneOther conditions: Cisplatin Adverse ReactionView official trial listing → -
Completed NCT NCT04824911
Statin and Dual Antiplatelet Therapy to Prevent Early Neurological Deterioration in Branch Atheromatous Disease
Not yet reported Chang Gung Memorial Hospital 376 participants Est. completion 2025-02-28 1 site Stand-aloneCardiovascular disease Other conditions: Dual Antiplatelet Therapy, StatinView official trial listing → -
Completed NCT NCT04826354
Effects of Statin for Elderly Patients With Atherosclerotic Cardiovascular Disease
Not yet reported Korea University Anam Hospital 582 participants Est. completion 2023-06-28 2 sites Stand-aloneOther conditions: Atheroscleroses, CoronaryView official trial listing → -
Completed NCT NCT04829149
Statin Monotherapy and Rosuzet Tab.(Rosuvastatin/Ezetimibe) Administration in Patients With Dyslipidemia in Korea
Hanmi Pharmaceutical Company Limited 5717 participants Est. completion 2019-08-29 1 siteOther conditions: DyslipidemiasView official trial listing → -
Status unknown NCT NCT04833764
Mechanisms of Deep Vein Thrombosis (DVT) and Vein Wall Fibrosis
Not yet reported, Not yet reported Khanh Nguyen 30 participants Est. completion 2025-06-01 1 site Stand-aloneOther conditions: Post-thrombotic Syndrome, Deep Vein Thrombosis LegView official trial listing → -
Completed NCT NCT04846231
Supplements, Placebo, or Rosuvastatin Study
Not yet reported The Cleveland Clinic 203 participants Est. completion 2022-07-19 1 siteOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT04851769
Impact of PCSK9 Inhibitors on Coronary Plaque Composition and Vulnerability Assessed by Optical Coherence Tomography
Not yet reported Beijing Anzhen Hospital 60 participants Est. completion 2021-03-01 1 site Stand-aloneOther conditions: Randomized Controlled TrialsView official trial listing → -
Completed NCT NCT04862962
Study to Evaluate the Safety of the Fixed-dose Combination Rosuvastatin/Ezetimibe for Patients With Dyslipidaemia
Laboratorios Silanes S.A. de C.V. 120 participants Est. completion 2022-02-15 1 siteOther conditions: DyslipidemiasView official trial listing → -
Terminated NCT NCT04883840
Drug Repurposing - Statins as Microbiota Modulating Agents in Ulcerative Colitis
Not yet reported, Not yet reported Universitaire Ziekenhuizen KU Leuven 177 participants Est. completion 2025-10-11 3 sites Stand-aloneOther conditions: Ulcerative ColitisView official trial listing → -
Completed NCT NCT04887194
PK Study to Assess Drug-drug Interaction and QTc Between Sitravatinib and a Cocktail of Substrates
Not yet reported Mirati Therapeutics Inc. 40 participants Est. completion 2022-12-22 5 sites Stand-aloneOther conditions: Advanced Solid TumorView official trial listing → -
Completed NCT NCT04889287
A Study to Learn How Much Rosuvastatin Gets Into the Blood When Taken With or Without Elinzanetant and to Learn About the Safety of Elinzanetant in Healthy Participants
Not yet reported Bayer 16 participants Est. completion 2021-09-29 1 site Stand-aloneOther conditions: Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and MenView official trial listing → -
Completed NCT NCT04895059
Study of no Pharmacokinetic Interaction Between Rosuvastatin 20mg and Ezetimibe10mg, Fixed Dose vs Individual Components
Not yet reported Laboratorios Silanes S.A. de C.V. 36 participants Est. completion 2018-01-22 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT04895098
Statin Monotherapy or Statins in Combination With Ezetimibe in Patients for Prevention of CVD
Akrikhin 1000 participants Est. completion 2022-07-08 31 sitesCardiovascular disease Other conditions: Lipid Metabolism DisordersView official trial listing → -
Completed NCT NCT04921657
Genome-wide Analysis of Lipid-lowering Efficacy and Drug Level of Simvastatin and Rosuvastatin
Chinese University of Hong Kong 362 participants Est. completion 2021-08 1 siteOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT04923152
Effective Dose of Statin Post PCI
Not yet reported Shiraz University of Medical Sciences 582 participants Est. completion 2021-04-01 1 site Stand-aloneOther conditions: Statin DoseView official trial listing → -
Completed NCT NCT04931147
A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers
Not yet reported Redx Pharma Ltd 90 participants Est. completion 2023-03-08 1 site Stand-aloneOther conditions: Fibrosis, Inflammation, Idiopathic Pulmonary Fibrosis, Non-alcoholic Steatohepatitis, Liver Diseases, Kidney DiseasesView official trial listing → -
Completed NCT NCT04964544
Technology-Assisted Cholesterol Trial in Consumers (TACTiC)
Not yet reported AstraZeneca 1196 participants Est. completion 2023-03-01 1 siteOther conditions: High CholesterolView official trial listing → -
Status unknown NCT NCT04974814
Effect of Statin Preloading in STEMI in Improving PCI Outcomes
Not yet reported Beni-Suef University 99 participants Est. completion 2023-04 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT05002244
A Drug-Drug Interaction Study of CTL0801 and CTL0802 Compared to Coadministration in Healthy Adult Volunteers
Not yet reported Celltrion 37 participants Est. completion 2021-09-13 1 site Stand-aloneOther conditions: Health, SubjectiveView official trial listing → -
Completed NCT NCT05045638
Effect of Coadministration of Sotorasib on the Pharmacokinetics of Rosuvastatin in Healthy Participants
Not yet reported Amgen 13 participants Est. completion 2021-10-10 1 site Stand-aloneOther conditions: Healthy ParticipantsView official trial listing → -
Completed NCT NCT05064488
Drug-Drug Interaction Study of Evobrutinib and Transporter Substrates
Not yet reported Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 40 participants Est. completion 2021-12-10 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT05072054
Comparison of Effects of Atorvastatin Versus Rosuvastatin on Cardiac Function in Heart Failure Patients
Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 80 participants Est. completion 2022-08-31 1 siteHeart failureView official trial listing → -
Completed NCT NCT05072405
The Interaction of Herbs and Statins
Not yet reported Chinese University of Hong Kong 38 participants Est. completion 2021-08-28 1 siteOther conditions: Drug InteractionView official trial listing → -
Completed NCT NCT05076877
A Study of Lazertinib (JNJ-73841937) in Healthy Participants
Not yet reported Janssen Research & Development, LLC 20 participants Est. completion 2022-02-10 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT05088343
Effect of Hetrombopag on the Pharmacokinetics of Rosuvastatin in Healthy Subjects
Not yet reported Jiangsu HengRui Medicine Co., Ltd. 14 participants Est. completion 2021-01-16 1 site Stand-aloneOther conditions: Healthy SubjectsView official trial listing → -
Completed NCT NCT05154123
Drug-drug Interaction Study of Rosuvastatin and AT-527 (R07496998)
Not yet reported Atea Pharmaceuticals, Inc. 29 participants Est. completion 2021-12-23 1 site Stand-aloneOther conditions: Healthy Volunteer StudyView official trial listing → -
Completed NCT NCT05176314
A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LY3527727) and Rosuvastatin in Healthy Participants
Not yet reported Loxo Oncology, Inc. 32 participants Est. completion 2022-04-20 2 sites Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT05184179
Observational Study to Evaluate the Therapeutic Effectiveness and Safety of Olomax Tab
Daewoong Pharmaceutical Co. LTD. 5450 participants Est. completion 2022-08-16 1 siteOther conditions: Hypertension, DyslipidemiaView official trial listing → -
Completed NCT NCT05192941
Study of Efficacy, Safety, Tolerability and Quality of Life of Inclisiran (KJX839) vs Placebo, on Top of Ongoing Individually Optimized Lipid-lowering Therapy, in Participants With Hypercholesterolemia
Not yet reported Novartis Pharmaceuticals 1770 participants Est. completion 2025-03-19 136 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT05197517
Bioequivalence Study of Rosuvastatin in Healthy Volunteers Under Fasting Condition
Not yet reported Rania Mahmoud Mohamed 38 participants Est. completion 2020-10-01 1 site Stand-aloneOther conditions: BioequivalenceView official trial listing → -
Completed NCT NCT05236530
Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Midazolam, Repaglinide, Dextromethorphan, Metformin, Rosuvastatin and Dolutegravir
Not yet reported Novartis Pharmaceuticals 48 participants Est. completion 2022-10-17 1 site Stand-aloneOther conditions: MalariaView official trial listing → -
Status unknown NCT NCT05259020
To Evaluate the Pharmacokinetics and the Safety of ID14009 Compared to Coadministration of ID1805 With ID1803 in Healthy Adult Volunteers
Not yet reported IlDong Pharmaceutical Co Ltd 60 participants Est. completion 2022-03-30 1 site Stand-aloneOther conditions: Dyslipidemias, HypertensionView official trial listing → -
Completed NCT NCT05273775
A Pharmacokinetic Study to Evaluate the Drug Interaction Between HRS5091 and Probe Drugs in Healthy Volunteers
Not yet reported Jiangsu HengRui Medicine Co., Ltd. 22 participants Est. completion 2022-06-23 1 site Stand-aloneOther conditions: Chronic Hepatitis BView official trial listing → -
Completed NCT NCT05285085
Real World Evidence Study of Statin Use in Brazil
Hospital Israelita Albert Einstein 2133900 participants Est. completion 2021-12-15 1 siteCardiovascular disease Other conditions: Hypertension, Diabetes Mellitus, DyslipidemiasView official trial listing → -
Status unknown NCT NCT05298475
Low-dose PCSK9 Inhibitor Combined With Stains on Serum Lipids in Chinese Population With Acute Coronary Syndrome
Not yet reported The First Affiliated Hospital with Nanjing Medical University 100 participants Est. completion 2024-04-01 1 site Stand-aloneOther conditions: Acute Coronary SyndromeView official trial listing → -
Completed NCT NCT05306990
Statins in Patients With Type 2 Diabetes Mellitus and Previous History of Acute Coronary Syndrome
Not yet reported Helwan University 108 participants Est. completion 2021-01-31 1 siteOther conditions: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Diabetes MellitusView official trial listing → -
Completed NCT NCT05334108
Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates for Drug Metabolism and Transport
Not yet reported Emalex Biosciences Inc. 56 participants Est. completion 2022-08-26 1 siteOther conditions: Drug InteractionView official trial listing → -
Completed NCT NCT05338723
Possible Protective Effect of Rosuvastatin in Chemotherapy-induced Cardiotoxicity in HER2 Positive Breast Cancer Patients
Not yet reported Tanta University 50 participants Est. completion 2023-09-15 1 siteOther conditions: Chemotherapy-induced Cardiotoxicity, Breast CancerView official trial listing → -
Completed NCT NCT05368545
Influence of Lipid Lowering on Impaired Coronary Flow
Not yet reported Aarhus University Hospital 109 participants Est. completion 2024-04-17 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT05368805
Fruquintinib DDI Study With P-gp and BCRP Substrates
Not yet reported Hutchmed 32 participants Est. completion 2022-04-22 1 site Stand-aloneOther conditions: Metastatic Colorectal CancerView official trial listing → -
Status unknown NCT NCT05373277
KF2019#1-trial: Effects of a Thrombocyte Inhibitor on a Cholesterol-lowering Drug
Not yet reported Helsinki University Central Hospital 10 participants Est. completion 2022-12-31 1 siteOther conditions: PharmacokineticsView official trial listing → -
Completed NCT NCT05384262
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD0780 in Healthy Subjects
Not yet reported AstraZeneca 183 participants Est. completion 2024-06-14 3 sitesOther conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT05389722
A Study to Assess the Drug Levels of CC-92480 After Coadministration With Rifampin and Itraconazole, and the Drug Levels of Digoxin and Rosuvastatin After Coadministration With CC-92480 in Healthy Participants
Not yet reported Bristol-Myers Squibb 24 participants Est. completion 2022-11-12 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT05395117
A Study to Assess the Effect of AZD5462 on the Pharmacokinetics of Midazolam, Rosuvastatin and Digoxin
Not yet reported AstraZeneca 32 participants Est. completion 2022-09-12 1 site Stand-aloneOther conditions: Healthy ParticipantsView official trial listing → -
Active, not recruiting NCT NCT05411887
Study to Evaluate the Effect of Improving Systolic BP and LDL-C Compared to Conventional Treatments and the Convenience of Taking Medication of Olostar Tab
Daewoong Pharmaceutical Co. LTD. 2845 participants Est. completion 2025-12-31 1 siteOther conditions: Hyperlipidemias, HypertensionView official trial listing → -
Completed NCT NCT05444556
A Study of Imlunestrant (LY3484356) in Female Healthy Participants
Not yet reported Eli Lilly and Company 113 participants Est. completion 2022-11-02 3 sites Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT05450575
An Observational Study to Evaluate Effectiveness and Safety of Amosartan Q Tablet
Hanmi Pharmaceutical Company Limited 5400 participants Est. completion 2021-07-20 1 siteOther conditions: Hypertension, DyslipidemiaView official trial listing → -
Active, not recruiting NCT NCT05457582
PCSK 9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients With ACS After PCI
Not yet reported Nanjing First Hospital, Nanjing Medical University 1212 participants Est. completion 2030-12-30 1 siteOther conditions: Acute Coronary Syndrome, Hyperlipidemias, Percutaneous Coronary Intervention, Cardiovascular EventsView official trial listing → -
Completed NCT NCT05480475
A Study to Examine the Effect of Daridorexant on the Way the Body Absorbs, Distributes, and Gets Rid of Dabigatran and Rosuvastatin in Healthy Male Subjects
Not yet reported Idorsia Pharmaceuticals Ltd. 24 participants Est. completion 2022-09-17 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT05514938
Polypill in Acute Coronary Syndrome
Not yet reported University of Texas Southwestern Medical Center 140 participants Est. completion 2025-06-05 2 sites Stand-aloneCardiovascular disease Other conditions: Acute Coronary Syndrome, Lipid DisorderView official trial listing → -
Status unknown NCT NCT05565976
Dapagliflozin Effect in Cognitive Impairment in Stroke Trial
Not yet reported, Not yet reported Jaime Daniel Mondragon 270 participants Est. completion 2025-07-01 1 site Stand-aloneCardiovascular diseaseMetabolic syndrome Other conditions: Mild Cognitive Impairment, Dementia, VascularView official trial listing → -
Enrolling by invitation NCT NCT05579626
Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus (PROVE-DM)
Not yet reported Seung-Whan Lee, M.D., Ph.D. 4000 participants Est. completion 2030-12-31 31 sitesCardiovascular disease Other conditions: Pre DiabetesView official trial listing → -
Status unknown NCT NCT05585151
High-Resolution Assessment of Extracranial Plaques in a Multiple Centers Evolocumab Randomized Study
Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 200 participants Est. completion 2024-10-01 1 siteOther conditions: Cerebral AtherosclerosisView official trial listing → -
Completed NCT NCT05594615
Drug-Drug Interaction Study Between EDP-235, Midazolam, Caffeine and Rosuvastatin in Healthy Subjects
Not yet reported Enanta Pharmaceuticals, Inc 24 participants Est. completion 2022-11-18 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Terminated NCT NCT05613426
Effect of Very Early and Rapid Lowering Cholesterol With Evolocumab on Left Ventricular Remodeling in Patients With Anterior STEMI Undergoing Primary PCI
Not yet reported Henan Institute of Cardiovascular Epidemiology 119 participants Est. completion 2026-05-16 6 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT05615012
A Study Investigating Interactions Between BMS-986322 and Rosuvastatin, Metformin and Methotrexate in Healthy Participants
Not yet reported Bristol-Myers Squibb 76 participants Est. completion 2023-12-13 1 site Stand-aloneOther conditions: Healthy ParticipantsView official trial listing → -
Status unknown NCT NCT05624658
Effect of Combined Lipid-lowering Therapy on Atherosclerotic Plaque Vulnerability in Patients With ACS
Not yet reported Samara Regional Cardiology Dispensary 200 participants Est. completion 2024-05 1 siteOther conditions: DyslipidemiasView official trial listing → -
Completed NCT NCT05637060
Bioequivalence Study of Rosuvastatin Tablet
Not yet reported University of Karachi 36 participants Est. completion 2022-12-15 1 siteOther conditions: Healthy IndividualsView official trial listing → -
Completed NCT NCT05652660
A Study to Understand the Effect of a Study Medicine Called ARV-471 on Rosuvastatin in Healthy Adults
Not yet reported Pfizer 12 participants Est. completion 2023-03-06 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT05657613
Drug-Drug Interaction Study of Pacritinib and CYP450,Transporter Substrates, and CYP450 3A4 in Healthy Male Subjects
Not yet reported CTI BioPharma 60 participants Est. completion 2023-06-08 1 site Stand-aloneOther conditions: Drug InteractionsView official trial listing → -
Status unknown NCT NCT05658692
Platform Adaptive Embedded Trial for Acute Respiratory Distress Syndrome
Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 1000 participants Est. completion 2023-12 11 sites Stand-aloneOther conditions: Acute Respiratory Distress SyndromeView official trial listing → -
Active, not recruiting NCT NCT05660135
Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia
Daewoong Pharmaceutical Co. LTD. 4000 participants Est. completion 2025-12-31 1 siteOther conditions: Hypertension, DyslipidemiasView official trial listing → -
Completed NCT NCT05661552
Effect of Early Initiation of Evolocumab on Lipid Profiles Changes in Patients With ACS Undergoing PCI
Not yet reported Yonsei University 108 participants Est. completion 2025-02-05 1 site Stand-aloneOther conditions: Low-Density-Lipoprotein-Type [LDL] HyperlipoproteinemiaView official trial listing → -
Completed NCT NCT05708573
Potential Drug Interaction Between ALXN2040 and Rosuvastatin
Not yet reported Alexion Pharmaceuticals, Inc. 20 participants Est. completion 2023-04-05 1 site Stand-aloneOther conditions: Healthy ParticipantsView official trial listing → -
Status unknown NCT NCT05731596
Comparative Clinical Study to Evaluate the Efficacy and Safety of Rosuvastatin Vs CoQ10 on Nonalcoholic Steatohepatitis
Not yet reported Tanta University 46 participants Est. completion 2024-04MASHView official trial listing → -
Completed NCT NCT05738291
A Study in Healthy Men to Test How Well Multiple Doses of BI 1839100 Are Tolerated and How BI 1839100 Influences the Amount of Other Medicines in the Blood
Not yet reported Boehringer Ingelheim 67 participants Est. completion 2024-06-14 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT05741372
A Study to Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver Cirrhosis
Not yet reported Boehringer Ingelheim 28 participants Est. completion 2024-12-30 1 site Stand-aloneOther conditions: Liver CirrhosisView official trial listing → -
Completed NCT NCT05742841
EMERALD (Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders)
Not yet reported Wake Forest University Health Sciences 22 participants Est. completion 2023-07-15 1 site Stand-aloneOther conditions: Lipid DisorderView official trial listing → -
Status unknown NCT NCT05747768
A Clinical Study to Evaluate the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Healthy Volunteers and Renal Impairment Patients
Not yet reported Peking University Third Hospital 60 participants Est. completion 2024-12-31 1 site Stand-aloneChronic kidney diseaseView official trial listing → -
Completed NCT NCT05763459
A Phase 1 Study of ABBV-CLS-7262, Rosuvastatin, and Digoxin in Healthy Subjects
Not yet reported Calico Life Sciences LLC 12 participants Est. completion 2023-06-02 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT05768360
A Study to Assess the Effects of Savolitinib on the Pharmacokinetics of Digoxin, Rosuvastatin, Metformin, and Furosemide in Healthy Male Subjects
Not yet reported AstraZeneca 6 participants Est. completion 2023-06-24 1 site Stand-aloneOther conditions: Healthy Male SubjectsView official trial listing → -
Completed NCT NCT05787002
A Study to Assess the Effect of AZD0780 on the Pharmacokinetics of Rosuvastatin.
Not yet reported AstraZeneca 16 participants Est. completion 2023-05-15 1 site Stand-aloneOther conditions: DyslipidemiaView official trial listing → -
Terminated NCT NCT05788328
A Drug-Drug Interaction Study to Estimate the Effect of PF-07081532 on the Pharmacokinetics of Dabigatran and Rosuvastatin in Overweight or Obese Adult Participants
Not yet reported Pfizer 16 participants Est. completion 2023-09-11 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT05789342
A Study to Evaluate the Drug-drug Interactions (DDIs) of GP681 With Rosuvastatin, Digoxin, Itraconazole, Oseltamivir in Chinese Healthy Volunteers
Not yet reported Jiangxi Qingfeng Pharmaceutical Co. Ltd. 54 participants Est. completion 2023-10-31 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Status unknown NCT NCT05814692
BIOchemical Urine Analysis of Adherence to Statins and Associated FACTorS in Coronary Artery Disease
Heinrich-Heine University, Duesseldorf 130 participants Est. completion 2024-09 1 siteOther conditions: Coronary Heart DiseaseView official trial listing → -
Withdrawn NCT NCT05828303
A Phase 1 Study to Evaluate the Potential Drug Interactions Between Repotrectinib and Metformin, Digoxin, and Rosuvastatin in Patients With Advanced Solid Tumors
Not yet reported Turning Point Therapeutics, Inc. Est. completion 2025-11-30 33 sites Stand-aloneOther conditions: Advanced Solid Tumor, Metastatic Solid TumorView official trial listing → -
Active, not recruiting NCT NCT05850091
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine
Not yet reported Massachusetts General Hospital 200 participants Est. completion 2027-06-01 1 siteCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT05884502
A Multicenter Study to Evaluate the Effect of High Dose Rosuvastatin Versus Rosuvastatin and Ezetimibe in Stroke
Not yet reported Korea University Anam Hospital 330 participants Est. completion 2024-12-31 3 sites Stand-aloneCardiovascular disease Other conditions: DyslipidemiasView official trial listing → -
Active, not recruiting NCT NCT05889143
A Study to Evaluate the Efficacy and Safety of CREZET Tablet
Daewoong Pharmaceutical Co. LTD. 15000 participants Est. completion 2026-03-01 1 siteOther conditions: DyslipidemiasView official trial listing → -
Status unknown NCT NCT05893849
Pharmacokinetics of Clinical Probes and Characteristics of Endogenous Biomarker in Chinese Older Adults
Peking University Third Hospital 624 participants Est. completion 2024-04 1 siteOther conditions: AgingView official trial listing → -
Completed NCT NCT05895123
Comparison Between the Effects of High Doses Statin on Ventricular Remodeling in STEMI Patients
Not yet reported Damanhour University 80 participants Est. completion 2023-04-01 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT05898672
A Study to Learn About the Study Medicine Called Nirmatrelvir/Ritonavir in People Who Are Healthy Volunteers Co-administered the Medicine Rosuvastatin
Not yet reported Pfizer 12 participants Est. completion 2023-08-10 1 site Stand-aloneOther conditions: Pharmacokinetics, Healthy VolunteersView official trial listing → -
Completed NCT NCT05906836
A Drug Drug Interaction (DDI) Study of Selpercatinib (LY3527723) and Rosuvastatin in Healthy Participants
Not yet reported Eli Lilly and Company 28 participants Est. completion 2023-10-31 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Active, not recruiting NCT NCT05910476
Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg (TOLERANT Trial)
Not yet reported Yonsei University 200 participants Est. completion 2026-09-22 1 siteCardiovascular disease Other conditions: DyslipidemiasView official trial listing → -
Completed NCT NCT05926180
Assessing the Effect of DZD9008 on the Pharmacokinetics of the Cocktail Probes Representative for CYP3A4, P-gp, BCRP and OATP1B1 in Patients with EGFR or HER2 Mutant Advanced Non-small Cell Lung Cancer (WU-KONG19)
Not yet reported Dizal Pharmaceuticals 25 participants Est. completion 2024-09-28 1 site Stand-aloneOther conditions: Non-small Cell Lung CancerView official trial listing → -
Completed NCT NCT05954624
Drug-durg Interaction of ZSP1273 With Digoxin, Rosuvastatin,Itraconazole and Probenecid
Not yet reported Guangdong Raynovent Biotech Co., Ltd 49 participants Est. completion 2023-11-30 1 site Stand-aloneOther conditions: Drug Drug InteractionView official trial listing → -
Completed NCT NCT05981365
Voxelotor CYP and Transporter Cocktail Interaction Study
Not yet reported Pfizer 44 participants Est. completion 2023-10-04 1 site Stand-aloneOther conditions: Sickle Cell DiseaseView official trial listing → -
Completed NCT NCT05984953
Rosuvastatin and Evolocumab for Coronary Artery Disease
Icahn School of Medicine at Mount Sinai 195 participants Est. completion 2022-10-28 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT06031454
Drug-durg Interaction of Leritrelvir(RAY1216) With Midazolam, Omeprazole, Rosuvastatin, Verapamil, and Rifampin
Not yet reported Guangdong Raynovent Biotech Co., Ltd 56 participants Est. completion 2023-12-31 1 site Stand-aloneOther conditions: Drug Drug InteractionView official trial listing → -
Completed NCT NCT06036784
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of MBX 1416 in Healthy Subjects
Not yet reported MBX Biosciences 69 participants Est. completion 2024-12-05 1 site Stand-aloneOther conditions: Postbariatric HypoglycemiaView official trial listing → -
Completed NCT NCT06048588
YN001 in Healthy Subjects and Patients With Coronary Atherosclerosis
Not yet reported, Not yet reported Beijing Inno Medicine Co., Ltd. 144 participants Est. completion 2025-04-27 6 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT06053983
Comparison Between Atorvastatin and Rosuvastatin in Reduction of Inflammatory Biomarkers in Patients With Acute Coronary Syndrome
Not yet reported Rawalpindi Medical College 126 participants Est. completion 2023-08-01 1 site Stand-aloneOther conditions: Mi Q WaveView official trial listing → -
Completed NCT NCT06071442
Potential Drug Interaction Study Between Vemircopan and Rosuvastatin, Metformin, Levonorgestrel/Ethinyl Estradiol-containing Oral Contraceptives, and Carbamazepine
Not yet reported Alexion Pharmaceuticals, Inc. 60 participants Est. completion 2024-04-12 1 site Stand-aloneOther conditions: Healthy ParticipantsView official trial listing → -
Completed NCT NCT06081166
A Drug-drug Interaction Study Evaluating the PK Effects of Obicetrapib on Atorvastatin and Rosuvastatin
Not yet reported NewAmsterdam Pharma 74 participants Est. completion 2024-01-22 1 siteOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT06092931
A Drug-Drug Interaction Study Evaluating the Perpetrator Potential of DC-806 on Cocktails of CYP450 Enzyme and Transporter Substrates in Healthy Participants
Not yet reported DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company 28 participants Est. completion 2023-11-28 1 site Stand-aloneOther conditions: Healthy ParticipantsView official trial listing → -
Completed NCT NCT06094244
Statins in Patients With Spontaneous Intracerebral Hemorrhage
Not yet reported Pomeranian Medical University Szczecin 153 participants Est. completion 2021-03-17 1 site Stand-aloneOther conditions: Intracerebral HemorrhageView official trial listing → -
Not yet recruiting NCT NCT06096909
Early Initiation of Tafolecimab for Patients With Acute Coronary Syndromeundergoing Percutaneous Coronary Intervention in Chinese Population
Not yet reported China National Center for Cardiovascular Diseases 3684 participants Est. completion 2027-11-01 Stand-aloneOther conditions: Acute Coronary Syndrome, Non ST Segment Elevation Acute Coronary SyndromeView official trial listing → -
Completed NCT NCT06105060
Clinical Effects of New Approach on Patients With Non-alcoholic Steatohepatitis
Not yet reported Beni-Suef University 175 participants Est. completion 2024-06-27 1 siteOther conditions: Non-alcoholic SteatohepatitisView official trial listing → -
Completed NCT NCT06105255
A Study to Evaluate the Effects of D-1553 on PK of Midazolam, Caffeine, Rosuvastatin, Furosemide, Digoxin, and Itraconazole or Omeprazole on PK of D-1553
Not yet reported InventisBio Co., Ltd 45 participants Est. completion 2024-02-02 1 site Stand-aloneOther conditions: Healthy MaleView official trial listing → -
Completed NCT NCT06111521
A Drug-Drug Interaction Study of LY3537982 on Midazolam, Digoxin, and Rosuvastatin in Healthy Participants
Not yet reported Eli Lilly and Company 35 participants Est. completion 2024-04-01 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Not yet recruiting NCT NCT06112028
Clinical Study of Tongxinluo Capsule in Preventing and Treating Restenosis After Intracranial and External Arterial Stenting
Not yet reported Yanbin Li 200 participants Est. completion 2026-11 Stand-aloneOther conditions: Stent RestenosisView official trial listing → -
Status unknown NCT NCT06134635
Short-term Effect of PCSK9 Inhibitor in Patients With Acute Ischemic Stroke
Xuanwu Hospital, Beijing 80 participants Est. completion 2024-12-01Cardiovascular diseaseView official trial listing → -
Status unknown NCT NCT06153433
Clinical Trial to Evaluate the Efficacy and Safety of Suvaro®OD Tablet in Patients With Dyslipidemia
Not yet reported Yonsei University 112 participants Est. completion 2024-08 1 site Stand-aloneOther conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT06160414
A Study to Investigate the Potential Drug Interactions Between ALXN2080 and Rosuvastatin and Metformin in Healthy Adult Participants
Not yet reported Alexion Pharmaceuticals, Inc. 20 participants Est. completion 2024-02-05 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT06162169
A Clinical Trial to Evaluate JAB-21822 Drug-drug Interactions in Healthy Subjects
Not yet reported Allist Pharmaceuticals, Inc. 66 participants Est. completion 2024-02-20 1 site Stand-aloneOther conditions: Healthy SubjectsView official trial listing → -
Completed NCT NCT06186622
A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese Participants
Not yet reported Eli Lilly and Company 50 participants Est. completion 2024-07-10 2 sites Stand-aloneOther conditions: Healthy, Obese, OverweightView official trial listing → -
Completed NCT NCT06191991
A Phase 1 Study to Evaluate the Drug-Drug Interaction Potential Between ALG-055009 and Statin Therapy(Ies)
Not yet reported Aligos Therapeutics 14 participants Est. completion 2023-12-04 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT06225635
A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Ezerosu Tab
Not yet reported Shin Poong Pharmaceutical Co. Ltd. 60 participants Est. completion 2022-03-07 1 site Stand-aloneOther conditions: HyperlipidemiasView official trial listing → -
Completed NCT NCT06247748
Influence of JY09 on Pharmacokinetics of Metformin , Rosuvastatin , and Digoxin and the QT Interval Study in Overweight Chinese Subjects
Not yet reported Beijing Dongfang Biotech Co., Ltd. 28 participants Est. completion 2024-04-15 1 site Stand-aloneType 2 diabetes Other conditions: OverweightView official trial listing → -
Status unknown NCT NCT06262685
Efficacy, Safety and Cost-efficacy of a Pre-emptive Genotyping Strategy in Patients Receiving Statins
Not yet reported Instituto de Investigación Hospital Universitario La Paz 216 participants Est. completion 2025-03-04 1 site Stand-aloneCardiovascular disease Other conditions: Dyslipidemias, Statin Adverse Reaction, Pharmacogenic MyopathyView official trial listing → -
Status unknown NCT NCT06273215
Evaluation of the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Diabetic Patients
Not yet reported Peking University Third Hospital 48 participants Est. completion 2025-12-31 1 site Stand-aloneOther conditions: DiabetesView official trial listing → -
Completed NCT NCT06279234
A Study to Learn How Different Amounts of PF-06954522 Are Tolerated and Act in Adults With Type 2 Diabetes Mellitus
Not yet reported Pfizer 50 participants Est. completion 2025-04-11 2 sites Stand-aloneType 2 diabetes Other conditions: ObesityView official trial listing → -
Completed NCT NCT06293261
Multicenter, Prospective, Non-interventional, Observational Study to Confirm the Long-term Efficacy and Safety of Rosuampin Tab. in Patients With Hypertension and Hypercholesterolemia
Yuhan Corporation 5047 participants Est. completion 2024-03-31 39 sitesOther conditions: Hypertension, HypercholesterolemiaView official trial listing → -
Completed NCT NCT06293742
ECC5004 DDI Study With Atorvastatin, Rosuvastatin, Digoxin and Midazolam in Healthy Participants
Not yet reported Eccogene 48 participants Est. completion 2024-04-15 1 site Stand-aloneType 2 diabetesView official trial listing → -
Status unknown NCT NCT06304896
Colchicine Versus Beta-blockers, Angiotensin-converting Enzyme Inhibitors, and Statins for Prevention of Chemotherapy-Induced Cardiomyopathy
Not yet reported Arab Contractors Medical Centre 150 participants Est. completion 2025-12-01 1 siteOther conditions: Chemotherapy Induced Systolic DysfunctionView official trial listing → -
Active, not recruiting NCT NCT06317051
Optimising Metabolic Management for People With Human Immunodeficiency Virus (HIV) on Integrase Based Antiretroviral Therapy (ART)
Not yet reported Kirby Institute 300 participants Est. completion 2027-12 10 sitesOther conditions: HIV Infections, Weight GainView official trial listing → -
Completed NCT NCT06329895
A Study to Learn About How BAY2927088 Affects the Level of Dabigatran or Rosuvastatin in the Blood When These Drugs Are Taken Together in Healthy Participants
Not yet reported Bayer 15 participants Est. completion 2024-06-10 1 site Stand-aloneOther conditions: Advanced Non-small Cell Lung Cancer, EGFR Mutation, HER2 Mutation, Healthy VolunteersView official trial listing → -
Completed NCT NCT06335134
A Drug-Drug Interaction Study Between XW003 and Metformin, Warfarin, Rosuvastatin or Digoxin
Not yet reported Hangzhou Sciwind Biosciences Co., Ltd. 57 participants Est. completion 2024-06-28 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Status unknown NCT NCT06348290
Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects
Not yet reported Jemincare 72 participants Est. completion 2024-09-15 Stand-aloneOther conditions: Solid Tumor, AdultView official trial listing → -
Status unknown NCT NCT06371495
Statins Role in Acute Ischemic Stroke
Assiut University 105 participants Est. completion 2025-08-30Cardiovascular diseaseView official trial listing → -
Completed NCT NCT06416800
A Study to Assess the Effect of Povorcitinib on Digoxin, Rosuvastatin, and Metformin Pharmacokinetics and the Effect of Probenecid on Povorcitinib Pharmacokinetics When Administered Orally to Healthy Adult Participants
Not yet reported Incyte Corporation 71 participants Est. completion 2025-01-15 1 site Stand-aloneOther conditions: Healthy ParticipantsView official trial listing → -
Not yet recruiting NCT NCT06460896
Analysis of the Influence of Gastric By-Pass on the Pharmacokinetics of Common Drugs
Not yet reported Assistance Publique - Hôpitaux de Paris 64 participants Est. completion 2027-09 1 siteOther conditions: Bypass Bariatric SurgeryView official trial listing → -
Completed NCT NCT06475872
Study to Evaluate the Bioequivalence of "Crecheck Tablet 2.5 mg (Rosuvastatin Calcium)" and "Crestor Tablet 5 mg (Rosuvastatin Calcium)" in Healthy Adult Subjects
Not yet reported Hanlim Pharm. Co., Ltd. 36 participants Est. completion 2023-12-07 1 siteOther conditions: Primary Hypercholesterolemia, Combined HyperlipidemiaView official trial listing → -
Completed NCT NCT06491550
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4144 as Well as the Impact of AZD4144 on the Pharmacokinetics of Rosuvastatin and Furosemide in Healthy Participants
Not yet reported AstraZeneca 91 participants Est. completion 2025-06-11 2 sites Stand-aloneOther conditions: Healthy ParticipantsView official trial listing → -
Completed NCT NCT06503679
A Drug-drug Interaction Study Evaluating the Perpetrator Potential of LY4100511 (DC-853) on Midazolam, Repaglinide, Digoxin, Rosuvastatin in Healthy Participants
Not yet reported DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company 49 participants Est. completion 2024-12-31 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT06504862
A Study in Healthy Men to Test Whether Zongertinib Influences the Amount of 4 Other Medicines (Dabigatran, Rosuvastatin, Metformin, and Furosemide) in the Blood
Not yet reported Boehringer Ingelheim 32 participants Est. completion 2024-12-18 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT06515652
To Compare the Effects of Herbal Medicines With Traditional Allopathic Medicines in Cases of Patients With Metabolic Syndrome
Not yet reported Hamdard University 200 participants Est. completion 2024-08-30 1 siteMetabolic syndromeView official trial listing → -
Withdrawn NCT NCT06533280
VH3739937 Phase 1 Multiple Ascending Dose (MAD) Study in Healthy Volunteers Including Relative Bioavailability (RBA), Optional Food Effect (FE), and Drug-drug Interaction (DDI)
Not yet reported ViiV Healthcare Est. completion 2024-08-14 1 site Stand-aloneOther conditions: HIV InfectionsView official trial listing → -
Completed NCT NCT06553157
Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy
Not yet reported, Not yet reported Minia University 56 participants Est. completion 2025-10-01 1 site Stand-aloneOther conditions: Solid Tumors, OtotoxicityView official trial listing → -
Completed NCT NCT06554821
A Study to Investigate the Effect of Oral Ticagrelor on the Pharmacokinetics of Oral Rosuvastatin When Given in Healthy Participants
Not yet reported AstraZeneca 28 participants Est. completion 2024-10-08 1 site Stand-aloneOther conditions: Healthy ParticipantsView official trial listing → -
Completed NCT NCT06567327
A Study to Learn How the Study Medicine Danuglipron is Taken Up Into the Blood and If Danuglipron Changes How the Body Processes Other Study Medicines (Atorvastatin and Rosuvastatin) in Healthy Adults Who Are Overweight or Obese
Not yet reported Pfizer 82 participants Est. completion 2025-04-14 3 sites Stand-aloneOther conditions: ObesityView official trial listing → -
Status unknown NCT NCT06578676
To Evaluate the Safety and Pharmacokinetic Interaction Between HODO-22251 and HODO-22252 in Healthy Adults
Not yet reported Hyundai Pharm 56 participants Est. completion 2024-11-30 1 site Stand-aloneType 2 diabetes Other conditions: DyslipidemiasView official trial listing → -
Completed NCT NCT06594159
A Study of LY4065967 in Healthy Japanese Participants
Not yet reported Eli Lilly and Company 59 participants Est. completion 2025-03-11 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT06601517
A Drug-Drug Interaction (DDI) Study of HDM1002 With Repaglinide, Atorvastatin, Digoxin and Rosuvastatin in Healthy Subjects and Overweight Subjects.
Not yet reported Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 30 participants Est. completion 2025-04 1 site Stand-aloneOther conditions: Healthy Adult Subject, Overweight SubjectView official trial listing → -
Enrolling by invitation NCT NCT06646354
To Evaluate the Efficacy and Safety of Co-administrated HODO-2224-1 and HODO-2224-2 in Patients With Essential Hypertension and Primary Hypercholesterolemia
Not yet reported Hyundai Pharm 125 participants Est. completion 2028-12-31 1 site Stand-aloneOther conditions: Hypertension, Primary HypercholesterolaemiaView official trial listing → -
Completed NCT NCT06677957
A Clinical Trial to Investigate the Clinical Drug-Drug Interaction of Divarasib With Probe Substrates of P-Glycoprotein and Breast Cancer Resistance Protein in Healthy Participants
Not yet reported Genentech, Inc. 19 participants Est. completion 2024-12-30 1 site Stand-aloneOther conditions: Healthy ParticipantsView official trial listing → -
Active, not recruiting NCT NCT06686615
A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 2000 participants Est. completion 2028-01-31 163 sitesOther conditions: Primary Hypercholesterolemiia, Mixed DyslipidemiaView official trial listing → -
Completed NCT NCT06696820
Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke
Not yet reported, Not yet reported Xiang Luo 429 participants Est. completion 2026-06-03 2 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT06717269
A Single and Multiple Ascending Doses, Relative Bioavailability, Food Effect, and Drug-Drug Interaction Study of NX-5948 in Healthy Volunteers
Not yet reported Nurix Therapeutics, Inc. 223 participants Est. completion 2026-05-01 2 sites Stand-aloneOther conditions: Healthy VolunteerView official trial listing → -
Completed NCT NCT06742853
A Study to Investigate the Pharmacokinetics, Safety, Tolerability, and Efficacy of AZD0780 With Ezetimibe Combinations in Healthy Adults With Elevated LDL-C.
Not yet reported AstraZeneca 81 participants Est. completion 2025-10-29 3 sites Stand-aloneOther conditions: DyslipidemiaView official trial listing → -
Active, not recruiting NCT NCT06767345
Comparison of Moderate-Intensity Statin Plus Ezetimibe vs. High-Intensity Statin for Coronary Plaque Stabilization
Not yet reported Korea University Anam Hospital 408 participants Est. completion 2028-06-25 7 sites Stand-aloneCardiovascular disease Other conditions: Atherosclerosis of Coronary Artery, Plaque, AtheroscleroticView official trial listing → -
Completed NCT NCT06779253
A Study to Investigate The Effect of Pimicotinib on The Pharmacokinetics of Metformin, Fexofenadine and Rosuvastatin In Healthy Subjects
Not yet reported Abbisko Therapeutics Co, Ltd 39 participants Est. completion 2025-05-22 1 siteOther conditions: Healthy SubjectsView official trial listing → -
Completed NCT NCT06782243
Comparison of High and Moderate Intensity Statins in Achieving the Target LDL-C Level After Acute Coronary Syndrome
Not yet reported Khyber Medical University Peshawar 190 participants Est. completion 2025-08-25 1 siteOther conditions: Acute Coronary SyndromeView official trial listing → -
Not yet recruiting NCT NCT06785727
StAtins in Frail OldEr Patients with Ischemic Stroke or Transient Ischemic Attack - the Randomized Controlled Trial
Not yet reported Prof. dr. Nathalie van der Velde 612 participants Est. completion 2029-07-01 Stand-aloneCardiovascular disease Other conditions: Transient Ischemic AttackView official trial listing → -
Not yet recruiting NCT NCT06791031
PCSK9 inhibitoRs for Early Passivation of coRonary athEroSclerotic plaqueS in Acute Coronary Syndromes (REPRESS)
Not yet reported West China Hospital 212 participants Est. completion 2028-06 Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT06813924
A Research Study of the Effect of Etavopivat on Other Drugs in Healthy Participants
Not yet reported Novo Nordisk A/S 37 participants Est. completion 2025-05-27 1 site Stand-aloneOther conditions: Healthy Volunteers Sickle Cell Disease, ThalassemiaView official trial listing → -
Active, not recruiting NCT NCT06820086
Polygenic Risk Driven Pragmatic Statin Trial for Heart Disease Prevention
Not yet reported Mikk JÜRISSON 2714 participants Est. completion 2034-03 2 sites Stand-aloneOther conditions: PRS-based Primary Prevention of CVDView official trial listing → -
Completed NCT NCT06821698
To Determine the Effect of KP-001 on Rosuvastatin, Caffeine PK and the Effect of Fluvoxamine on KP-001 PK in Volunteers
Not yet reported Kaken Pharmaceutical 38 participants Est. completion 2025-05-20 1 site Stand-aloneOther conditions: Healty VolunteersView official trial listing → -
Active, not recruiting NCT NCT06834932
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 in Participants With Dyslipidaemia
Not yet reported, Not yet reported AstraZeneca 432 participants Est. completion 2027-02-22 42 sites Stand-aloneOther conditions: DyslipidaemiaView official trial listing → -
Not yet recruiting NCT NCT06856772
Randomized Comparison of Morning Versus Bedtime Administration of Statins: A Cardiovascular Circadian Chronotherapy (C3) Trial
Not yet reported Tor Biering-Sørensen 42000 participants Est. completion 2028-03-28 1 site Stand-aloneCardiovascular disease Other conditions: Drug EffectView official trial listing → -
Completed NCT NCT06877390
Effect of Enhanced External Counterpulsation
Not yet reported Chongming Hospital Affiliated to Shanghai University of Health & Medicine Sciences 60 participants Est. completion 2024-04-30 1 siteCardiovascular disease Other conditions: Enhanced External Counterpulsation (EECP), Drug-coated Balloon, Cardiac RehabilitationView official trial listing → -
Active, not recruiting NCT NCT06899061
Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib
Not yet reported AstraZeneca 41 participants Est. completion 2028-05-19 4 sitesOther conditions: Advanced Solid MalignanciesView official trial listing → -
Completed NCT NCT06910098
Impact of Rosuvastatin Doses on LDL Levels, CPK Levels and Aspartate Aminotransferase Levels
Not yet reported Central Park Medical College 195 participants Est. completion 2024-08-31 1 site Stand-aloneOther conditions: LDL - Low Density Lipoprotein Receptor Disorder, RosuvastatinView official trial listing → -
Completed NCT NCT06917508
A Study to Evaluate the Drug-Drug Interaction of EDP-323 With Midazolam, Caffeine, and Rosuvastatin in Healthy Participants
Not yet reported Enanta Pharmaceuticals, Inc 24 participants Est. completion 2025-06-13 1 site Stand-aloneOther conditions: RSV Infection, Drug Drug InteractionView official trial listing → -
Completed NCT NCT06921941
Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Digoxin and Rosuvastatin
Not yet reported Atea Pharmaceuticals, Inc. 38 participants Est. completion 2025-07-02 1 site Stand-aloneOther conditions: Healthy Volunteer StudyView official trial listing → -
Active, not recruiting NCT NCT06924684
High-Dose Rosuvastatin Preloading for Enhanced Outcomes in STEMI Patients Undergoing Primary PCI
Not yet reported Sheikh Zayed Federal Postgraduate Medical Institute 66 participants Est. completion 2025-07-02 2 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT06925854
A Study to Investigate How AZD4144 Affects the Pharmacokinetics of Rosuvastatin in Healthy Participants
Not yet reported AstraZeneca 12 participants Est. completion 2025-06-12 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT06948747
A Study to Investigate the Effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the Effect of Erythromycin on AZD5004 in Healthy Participants
Not yet reported AstraZeneca 49 participants Est. completion 2025-10-03 1 site Stand-aloneOther conditions: Healthy ParticipantsView official trial listing → -
Completed NCT NCT06949124
A Phase 1 Clinical Study to Evaluate the Effects of SHR7280 on the Pharmacokinetics of Midazolam, S-warfarin, Omeprazole, Digoxin, and Rosuvastatin in Healthy Subjects
Not yet reported Jiangsu HengRui Medicine Co., Ltd. 20 participants Est. completion 2025-06-05 1 siteOther conditions: Endometriosis, Uterine Fibroids, Assisted ReproductionView official trial listing → -
Completed NCT NCT06975605
Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered Drugs.
Not yet reported GRIN Therapeutics, Inc. 18 participants Est. completion 2025-07-10 1 site Stand-aloneOther conditions: Tuberous Sclerosis Complex (TSC), Focal Cortical Dysplasia, Other Neurological DisordersView official trial listing → -
Completed NCT NCT06979973
A Drug-drug Interaction Study to Investigate the Pharmacokinetic Interactions Between CKD-508, Midazolam, and Rosuvastatin in Healthy Adult Male Participants
Not yet reported Chong Kun Dang Pharmaceutical 24 participants Est. completion 2025-08-17 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT06981299
A Phase 1 Study of PROT-001.
Not yet reported Protego Biopharma Pty Ltd 102 participants Est. completion 2025-12-23 1 siteOther conditions: HealthyView official trial listing → -
Active, not recruiting NCT NCT06982131
A Study Investigating the Safety of RO7795081 and the Effect of RO7795081 on How the Body Processes Pitavastatin and Rosuvastatin in Otherwise Healthy Overweight or Obese Adult Participants
Not yet reported Hoffmann-La Roche 40 participants Est. completion 2026-12-07 1 site Stand-aloneOther conditions: Overweight, ObesityView official trial listing → -
Not yet recruiting NCT NCT07001787
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HS-10510 in Healthy Subjects
Not yet reported Jiangsu Hansoh Pharmaceutical Co., Ltd. 88 participants Est. completion 2026-03Other conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT07008794
Effect of Genetic Variation on Efficacy and Safety of Lipid-Lowering Drugs
Assiut University 200 participants Est. completion 2023-03-31 1 siteOther conditions: Acute Coronary SyndromesView official trial listing → -
Completed NCT NCT07011992
A Study to Assess the Effects of BPN14770 on Rosuvastatin
Not yet reported Shionogi 12 participants Est. completion 2025-08-07 1 site Stand-aloneOther conditions: Healthy ParticipantsView official trial listing → -
Completed NCT NCT07065058
A Drug Drug Interaction Study to Evaluate the Effect of VCT220 on the Pharmacokinetics of Repaglinide, Rosuvastatin, and Digoxin in Healthy, Overweight, and Obese Subjects
Not yet reported Vincentage Pharma Co., Ltd 24 participants Est. completion 2025-08-11 1 site Stand-aloneOther conditions: Obesity &Amp; OverweightView official trial listing → -
Completed NCT NCT07074834
Metoprolol and Trimetazidine for Coronary Heart Disease With Angina
Not yet reported Shiyan City Renmin Hospital 102 participants Est. completion 2022-12-31 1 site Stand-aloneOther conditions: Coronary Heart Disease (CHD)View official trial listing → -
Completed NCT NCT07088913
A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Rosuvastatin in Healthy Participants
Not yet reported AstraZeneca 20 participants Est. completion 2026-02-20 1 site Stand-aloneOther conditions: Healthy ParticipantsView official trial listing → -
Completed NCT NCT07097831
A Clinical Trial of HRS-1301 on the Pharmacokinetics of Rosuvastatin Calcium Tablets in Healthy Subjects
Not yet reported Shandong Suncadia Medicine Co., Ltd. 16 participants Est. completion 2025-11-07 1 site Stand-aloneOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT07158398
Evaluate the Effect of Vimseltinib on the Pharmacokinetics of a BCRP and OATP1B1 Substrate
Not yet reported Deciphera Pharmaceuticals, LLC 20 participants Est. completion 2025-12-08 1 site Stand-aloneOther conditions: Healthy ParticipantsView official trial listing → -
Completed NCT NCT07182383
Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid, Ezetimibe, and Rosuvastatin
Not yet reported Daiichi Sankyo 58 participants Est. completion 2025-11-24 1 site Stand-aloneOther conditions: Healthy SubjectsView official trial listing → -
Completed NCT NCT07201545
Evaluating Bioequivalence of a Fixed Dose Combination Versus Tablets of Bempedoic Acid / Ezetimibe and Rosuvastatin
Not yet reported Daiichi Sankyo 58 participants Est. completion 2025-12-10 1 site Stand-aloneOther conditions: Healthy SubjectsView official trial listing → -
Completed NCT NCT07215260
A Study in Healthy People to Test Whether BI 3000202 Affects How 2 Other Medicines (Rosuvastatin and Digoxin) Are Taken up in the Body
Not yet reported Boehringer Ingelheim 14 participants Est. completion 2025-12-18 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Active, not recruiting NCT NCT07216482
A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)
Not yet reported Merck Sharp & Dohme LLC 996 participants Est. completion 2026-11-05 87 sites Stand-aloneOther conditions: HyperlipidemiaView official trial listing → -
Active, not recruiting NCT NCT07218900
A Study to Investigate the Effect of AZD0780 Tablets in Combination With Rosuvastatin Tablets on Low Density Lipoprotein Cholesterol Levels (LDL-C) in Adult Participants With Dyslipidaemia
Not yet reported AstraZeneca 76 participants Est. completion 2026-09-30 8 sites Stand-aloneOther conditions: DyslipidaemiaView official trial listing → -
Completed NCT NCT07222098
A Clinical Study of Calderasib (MK-1084) With Rosuvastatin and Metformin in Healthy People (MK-1084-016)
Not yet reported Merck Sharp & Dohme LLC 16 participants Est. completion 2025-12-29 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT07223671
Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates in Healthy Adult Participants
Not yet reported Bristol-Myers Squibb 30 participants Est. completion 2026-03-19 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT07235748
Drug-drug Interaction Study of Vorasidenib With Bupropion, Repaglinide, Flurbiprofen, Omeprazole, Midazolam, and Rosuvastatin in Healthy Adult Participants
Not yet reported Institut de Recherches Internationales Servier (I.R.I.S.) 28 participants Est. completion 2025-12-23 1 site Stand-aloneOther conditions: Healthy Adult ParticipantsView official trial listing → -
Not yet recruiting NCT NCT07239414
Bempedoic Acid Versus Statins in Primary-Prevention Patients With Suboptimal Statin Adherence: Effects on LDL-C Reduction and Tolerability
Not yet reported Sohaib Ashraf 690 participants Est. completion 2027-02-21Other conditions: CardiovascularView official trial listing → -
Not yet recruiting NCT NCT07254221
Rosuvastatin for Prevention of Anthracycline-induced Cardiac Dysfunction in Breast Cancer Patients
Not yet reported Shiraz University of Medical Sciences 400 participants Est. completion 2028-04-21 7 sitesOther conditions: Anthracycline-induced Cardiac Toxicity, Breast Cancer, Anthracycline Related Cardiotoxicity in Breast Cancer, Anthracycline-induced CardiotoxicityView official trial listing → -
Completed NCT NCT07255820
Dual vs Triple Lipid-Lowering Therapy in Type 2 Diabetes Mellitus Patients With Elevated LDL Cholesterol
Not yet reported Bahria University 126 participants Est. completion 2026-06-30 1 siteType 2 diabetes Other conditions: Hypercholesterolemia / Elevated LDL CholesterolView official trial listing → -
Completed NCT NCT07269756
A Study to Evaluate the Drug Interactions of HRS-7535 With Acetaminophen, Digoxin, Rosuvastatin, and Omeprazole in Obese or Overweight Subjects
Not yet reported Shandong Suncadia Medicine Co., Ltd. 40 participants Est. completion 2026-03-08 1 site Stand-aloneOther conditions: Obesity, OverweightView official trial listing → -
Not yet recruiting NCT NCT07290699
Intensive Cholesterol-Lowering Within 24 Hours of PCI Perioperative Period
Not yet reported Second Affiliated Hospital of Nanchang University 2442 participants Est. completion 2028-08-30 Stand-aloneCardiovascular diseaseView official trial listing → -
Active, not recruiting NCT NCT07300280
A Clinical Trial of Enlicitide and Rosuvastatin in Healthy Adults (MK-0616-039)
Not yet reported Merck Sharp & Dohme LLC 60 participants Est. completion 2026-10-21 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT07309042
Phase 1 Study of the Safety and Pharmacokinetics of YN001 With Rosuvastatin in Healthy Chinese Subjects
Not yet reported Beijing Inno Medicine Co., Ltd. 24 participants Est. completion 2026-03-30 1 siteCardiovascular disease Other conditions: Cerebrovascular DiseasesView official trial listing → -
Completed NCT NCT07313124
Comparative Study Between Antihyperlipidemic Agents in Treatment of Cardiovascular Diseases
Not yet reported, Not yet reported Beni-Suef University 66 participants Est. completion 2025-12-01 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT07316608
A Phase I Study Comparing the Relative Bioavailability of a Fixed-Dose Combination of Laroprovstat/Rosuvastatin vs Their Single Therapy Products in Healthy Adults
Not yet reported AstraZeneca 44 participants Est. completion 2026-06-05 2 sites Stand-aloneOther conditions: Healthy ParticipantsView official trial listing → -
Completed NCT NCT07349394
Effect of Vanzacaftor/Tezacaftor/Deutivacaftor (VNZ/TEZ/D-IVA) on the PK of Rosuvastatin in Healthy Participants
Not yet reported Vertex Pharmaceuticals Incorporated 18 participants Est. completion 2026-03-12 1 site Stand-aloneOther conditions: Cystic FibrosisView official trial listing → -
Not yet recruiting NCT NCT07378293
Effects of Selected Statins on Blood Glucose Levels in Healthy Volunteers
Not yet reported Shaheed Benazir Bhutto University Sheringal Dir Upper 100 participants Est. completion 2027-02-20 2 sites Stand-aloneOther conditions: Diabete Mellitus, Lipid ProfileView official trial listing → -
Not yet recruiting NCT NCT07389304
[Effects of Selected Statins on Cardiovascular Parameters in Healthy Volunteers]
Not yet reported Shaheed Benazir Bhutto University Sheringal Dir Upper 100 participants Est. completion 2027-02-20 1 site Stand-aloneOther conditions: Lipid Profile,Blood PressureView official trial listing → -
Not yet recruiting NCT NCT07401017
The Effects of Rosuvastatin on Running Training Adaptation and Safety
Not yet reported Taipei Medical University WanFang Hospital 40 participants Est. completion 2026-10-31 1 site Stand-aloneOther conditions: Dyslipidemia, Long-Distance Running, Endurance Training, Statin-Associated Muscle SymptomsView official trial listing → -
Completed NCT NCT07431866
A Clinical Study of the Effect of MK-2828 on Rosuvastatin or Furosemide in Healthy People (MK-2828-005)
Not yet reported Merck Sharp & Dohme LLC 41 participants Est. completion 2026-06-13 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Not yet recruiting NCT NCT07432516
Optimal Antiplatelet and Lipid Therapy in ACS With DES: OPACT Trial
Not yet reported Yonsei University 4400 participants Est. completion 2033-06 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Not yet recruiting NCT NCT07474649
A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events
Not yet reported Daiichi Sankyo 103 participants Est. completion 2028-10-02 12 sites Stand-aloneOther conditions: Coronary Atherosclerosis, Mixed Dyslipidemia, HypercholesterolemiaView official trial listing → -
Not yet recruiting NCT NCT07504198
Neuroprotection of Memantine and Rosuvastatin
Not yet reported, Not yet reported Tanta University 46 participants Est. completion 2027-05 1 siteOther conditions: Peripheral Nerve DiseaseView official trial listing → -
Completed NCT NCT07511686
Metabolic and Mitochondrial Changes in Statin-Induced Myopathy
Riga Stradins University 38 participants Est. completion 2024-10-09 1 siteOther conditions: Statin Adverse Reaction, Statin-induced MyopathyView official trial listing → -
Withdrawn NCT NCT07515339
A Study to Learn More About How Safe Nurandociguat is and How it Affects the Way the Body Processes Rosuvastatin and Dabigatran in Healthy Adults
Not yet reported Bayer Est. completion 2026-06-26 1 site Stand-aloneChronic kidney diseaseView official trial listing → -
Active, not recruiting NCT NCT07534592
A Study to Investigate the Effect of Elecoglipron on Rosuvastatin and Atorvastatin in Healthy Participants
Not yet reported AstraZeneca 48 participants Est. completion 2026-10-01 2 sites Stand-aloneOther conditions: Healthy ParticipantsView official trial listing → -
Completed NCT NCT07564726
Efficacy and Safety of Ezetimibe/Rosuvastatin and Amlodipine Patients With High Blood Pressure and High Cholesterol
Not yet reported Celltrion Pharm, Inc. 163 participants Est. completion 2024-02-13 21 sites Stand-aloneOther conditions: Hypertension, HypercholesterolemiaView official trial listing → -
Not yet recruiting NCT NCT07565441
Drug-Drug Interactions of JMKX003142 in Healthy Participants
Not yet reported Jemincare 112 participants Est. completion 2027-02-28 Stand-aloneOther conditions: ADPKD (Autosomal Dominant Polycystic Kidney Disease)View official trial listing → -
Enrolling by invitation NCT NCT07568574
Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes
Not yet reported Enhanced Emirates Limited 60 participants Est. completion 2033-03-01 1 site Stand-aloneOther conditions: Safety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite AthletesView official trial listing → -
Not yet recruiting NCT NCT07586540
Alirocumab for Stabilisation of Symptomatic Vulnerable Carotid Plaque
Not yet reported Middle East North Africa Stroke and Interventional Neurotherapies Organization 280 participants Est. completion 2030-09 14 sites Stand-aloneOther conditions: Carotid StenosisView official trial listing → -
Not yet recruiting NCT NCT07605130
Efficacy and Safety Study of Digital Cognitive Training and PCSK9 Inhibitor-Enhanced Lipid-lowering Strategy in Patients With Intracranial Atherosclerotic Stenosis: A 2x2 Factorial, Randomized, Parallel-Group, Multicenter Trial
Not yet reported Peking Union Medical College Hospital 440 participants Est. completion 2029-07-31 1 site Stand-aloneOther conditions: Intracranial Arteriosclerosis, Cognitive ImpairmentView official trial listing → -
Not yet recruiting NCT NCT07626840
Livalozet Versus High-intensity Statin in Older Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
Not yet reported Samsung Medical Center 5000 participants Est. completion 2031-12-31Other conditions: Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)View official trial listing → -
Not yet recruiting NCT NCT07674524
Management Strategy of 1L Lorlatinib With Hyperlipidemia in Stage IIIB-IV ALK Positive NSCLC
Sun Yat-sen University 160 participants Est. completion 2029-12-31 1 siteOther conditions: Non-Small Cell Lung Cancer (NSCLC), Hyperlipidemia, ALK Gene Mutation, ALK-positiveView official trial listing → -
Completed NCT NCT07692685
Pharmacokinetic Effect of Y-3 for Injection on Rosuvastatin Calcium Tablets in Healthy Participants
Not yet reported Neurodawn Pharmaceutical Co., Ltd. 20 participants Est. completion 2026-06-04 1 siteOther conditions: Drug Drug Interaction, Pharmacokinetic Profiles, SaftyView official trial listing → -
Not yet recruiting NCT NCT07699003
Endovascular Treatment of Chronic Intracranial Artery Occlusion
Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 382 participants Est. completion 2030-08-01Other conditions: Chronic Intracranial Artery OcclusionView official trial listing → -
Completed NCT NCT07717788
Therapeutic Prospects of HMG-CoA Reductase Inhibitors, Atorvastatin and Rosuvastatin, in Osteoporotic Patients
Not yet reported Alkufa university\\collage of pharmacy 65 participants Est. completion 2026-07-01 1 site Stand-aloneOther conditions: Osteoporosis, Postmenopausal, Statin TherapyView official trial listing → -
Not yet recruiting NCT NCT07736313
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors With Statin for ACS Patients
Not yet reported Assiut University 120 participants Est. completion 2029-09-01Other conditions: Acute Coronary SyndromesView official trial listing → -
Not yet recruiting NCT NCT07744386
A Study in Healthy Male Participants to Compare How CHF10196 Affects How the Body Absorbs and Processes Two Commonly Used Medicines: Dabigatran, a Blood Thinner, and Rosuvastatin, a Medicine Used to Lower Cholesterol
Not yet reported Chiesi Farmaceutici S.p.A. 24 participants Est. completion 2028-12-15 1 site Stand-aloneOther conditions: Healthy Male VolunteersView official trial listing → -
Not yet recruiting NCT NCT07748273
Rosuvastatin and Losartan Pharmacokinetics After Bariatric Surgery
Not yet reported Hospital das Clínicas de Ribeirão Preto 60 participants Est. completion 2027-05-15 1 site Stand-aloneOther conditions: Obesity & Overweight, Bariatric Surgery, Pharmacokinetics After Oral Intake, Drug AbsorptionView official trial listing → -
Not yet recruiting NCT NCT07785830
A Clinical Trial to Evaluate the Effects of MK-4646 on Rosuvastatin in Healthy Participants (MK-4646-007)
Not yet reported Merck Sharp & Dohme LLC 16 participants Est. completion 2026-11-10 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Not yet recruiting NCT NCT07799779
Early Intensive Lipid-Lowering With Inclisiran for Plaque Stabilization in Acute Coronary Syndrome
Not yet reported Seoul National University Bundang Hospital 294 participants Est. completion 2029-09 1 site Stand-aloneOther conditions: Acute Coronary Syndromes (ACS)View official trial listing → -
Not yet recruiting NCT NCT07819643
RESCUE: PCSK9 Inhibitors for Carotid Vulnerable Plaque Remodeling
Not yet reported Keqiang Zhao 120 participants Est. completion 2029-12-01 Stand-aloneOther conditions: Atherosclerosis Cerebral, Carotid Plaque, Vulnerable Plaque, Carotid StenosisView official trial listing → -
Completed NCT NCT07838987
A Clinical Trial to Evaluate MK-4208/TERN-701 in Healthy Adult Participants (MK-4208-001/TERN701-1014)
Not yet reported Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 196 participants Est. completion 2026-06-30 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Not yet recruiting NCT NCT07840950
Effects of Rosa Roxburghii Tratt Freeze-Dried Powder on Carotid Atherosclerotic Plaques: A Real-World Study
Not yet reported Xiangya Hospital of Central South University 200 participants Est. completion 2029-01-31 Stand-aloneCardiovascular disease Other conditions: Carotid Artery Plaques, AtherosclerosisView official trial listing → -
Not yet recruiting NCT NCT07862621
A Clinical Trial of MK-6916 With Midazolam and Rosuvastatin in Healthy Participants (MK-6916-012)
Not yet reported Merck Sharp & Dohme LLC 18 participants Est. completion 2027-02-19 Stand-aloneOther conditions: HealthyView official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Also known as: Rosuvastatin Calcium, Rosuvastatin
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.
